archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,2.856e-06,1.1243,0.97428,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,4.9361e-06,0.98647,0.79322,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,9.9185e-12,0.92884,0.94652,1,1
1,GO BLEB ASSEMBLY,2.801e-10,0.9284,0.98896,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,8.4415e-08,0.90638,0.75609,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,9.7068e-11,0.8856,0.79702,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,1.1858e-08,0.83755,0.79246,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.6581e-11,0.83357,0.74354,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.0922e-10,0.80349,0.75889,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,4.8076e-11,0.7972,0.76677,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.277e-11,0.79054,0.75634,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.1595e-09,0.79012,0.77427,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.2926e-08,0.75827,0.72909,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,9.4499e-11,0.75129,0.6794,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,2.5223e-10,0.73633,0.7145,1,1
1,GO ETHANOL OXIDATION,7.8124e-06,0.73098,0.54156,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,5.5016e-10,0.7199,0.69532,1,1
1,GO RESPONSE TO INTERFERON BETA,2.6362e-08,0.71686,0.69726,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.3554e-11,0.71593,0.67206,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,6.0979e-10,0.71282,0.75608,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,2.3933e-10,0.7124,0.76507,1,1
1,GO HEMIDESMOSOME ASSEMBLY,8.0712e-08,0.71097,0.76376,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.5016e-10,0.70906,0.73217,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.5277e-10,0.70605,0.72521,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.3948e-05,0.70119,0.60342,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,3.9872e-06,0.70084,0.56158,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,9.9064e-10,0.68676,0.66061,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,5.8262e-07,0.68406,0.60295,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.9047e-09,0.68135,0.57772,1,1
1,GO MEMBRANE RAFT ORGANIZATION,1.2604e-07,0.67951,0.63292,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,7.6792e-10,0.67233,0.66851,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.1535e-07,0.66924,0.50886,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.0554e-07,0.66713,0.50481,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.1789e-06,0.66496,0.6042,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.1533e-09,0.66384,0.62549,1,1
1,GO NEUTROPHIL HOMEOSTASIS,4.249e-10,0.65718,0.63597,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,1.0422e-09,0.65394,0.63155,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,4.4807e-06,0.64269,0.57987,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.9872e-09,0.64248,0.56085,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.8396e-06,0.63919,0.56106,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.4341e-06,0.63632,0.52158,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,5.5016e-10,0.63353,0.57246,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.9941e-08,0.62293,0.59571,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,1.8793e-06,0.61717,0.54779,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,2.457e-10,0.60549,0.61224,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4112e-09,0.60432,0.57006,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,4.2444e-07,0.60182,0.50975,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,1.8142e-08,0.58574,0.47449,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.0554e-07,0.58549,0.55198,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,1.2954e-05,0.58314,0.50912,1,1
1,GO RESPONSE TO TYPE I INTERFERON,6.337e-06,0.58203,0.45423,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.2604e-07,0.58122,0.5931,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,2.5934e-07,0.5809,0.50342,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,9.7991e-09,0.58061,0.51738,1,1
1,GO TOLERANCE INDUCTION,2.7804e-05,0.5746,0.41721,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.1543e-10,0.56918,0.59072,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.7154e-07,0.56423,0.48292,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.1543e-10,0.56256,0.60623,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.7041e-11,0.56236,0.52319,1,1
1,GO MYOBLAST MIGRATION,6.6578e-05,0.56145,0.45772,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,6.0205e-08,0.56129,0.49066,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,8.9487e-10,0.55924,0.578,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,8.4877e-09,0.55893,0.48123,1,1
1,GO EPIBOLY,9.4499e-11,0.5477,0.56708,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.5688e-10,0.54749,0.5273,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,1.0554e-07,0.54646,0.46816,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.3629e-10,0.54427,0.537,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,3.0156e-07,0.54187,0.5259,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.9465e-08,0.54179,0.58582,1,1
1,GO HIPPO SIGNALING,2.9805e-09,0.54153,0.52534,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,8.9047e-09,0.5395,0.6324,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,3.4296e-07,0.53617,0.50405,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,1.3693e-05,0.53341,0.46007,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,4.0868e-08,0.52967,0.5597,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.3082e-09,0.52801,0.47601,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.8419e-06,0.52669,0.57568,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.4407e-08,0.52633,0.45299,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.7356e-07,0.52613,0.48739,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,3.6361e-10,0.52591,0.5904,1,1
1,GO CYTOLYSIS,4.7963e-08,0.52496,0.47542,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.1041e-08,0.52475,0.48805,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.9064e-09,0.52436,0.54583,1,1
1,GO NOTOCHORD DEVELOPMENT,5.77e-09,0.52239,0.56239,1,1
1,GO LEUKOCYTE AGGREGATION,2.0776e-06,0.52181,0.44563,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.6823e-09,0.51951,0.52496,1,1
1,GO MUCUS SECRETION,2.3661e-05,0.51648,0.5133,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.6914e-06,0.51648,0.50755,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.8396e-06,0.51553,0.41731,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,2.3784e-07,0.51531,0.4782,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.8246e-05,0.51463,0.4033,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.4471e-09,0.51204,0.46311,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,6.5125e-09,0.50743,0.47096,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,3.2894e-09,0.50618,0.53193,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,1.5052e-06,0.50585,0.46309,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.0205e-08,0.50268,0.39924,1,1
1,GO BIOLOGICAL PHASE,3.8983e-07,0.50166,0.54228,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.8001e-06,0.499,0.47665,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.8142e-08,0.49804,0.48238,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.6981e-08,0.49287,0.38531,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.6362e-08,0.48884,0.40807,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.7668e-07,0.48881,0.41926,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.357e-07,0.48853,0.44796,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,7.969e-07,0.48742,0.59806,1,1
1,GO ZYMOGEN INHIBITION,1.0161e-09,0.48734,0.56697,1,1
1,GO SKIN MORPHOGENESIS,7.969e-07,0.48626,0.55986,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,9.6538e-08,0.48611,0.53894,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,8.4415e-08,0.48427,0.45735,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.892e-08,0.48377,0.44342,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.5037e-07,0.48205,0.41337,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.9859e-05,0.48088,0.41518,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.2733e-08,0.48071,0.44338,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,3.0905e-06,0.48011,0.44753,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.3468e-07,0.47973,0.49047,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.2321e-08,0.47781,0.39349,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.8318e-07,0.47469,0.41514,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,5.77e-09,0.47371,0.47198,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,4.7963e-08,0.47251,0.54825,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.8885e-07,0.46824,0.38873,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,1.069e-09,0.46822,0.43268,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.0554e-07,0.46703,0.51122,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,1.0958e-05,0.46547,0.36077,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,3.1729e-08,0.46497,0.56619,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.2775e-07,0.46401,0.48315,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.3617e-10,0.46334,0.40072,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,4.7963e-08,0.46312,0.47575,1,1
1,GO FIBRINOLYSIS,1.1041e-08,0.46246,0.54346,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.0398e-08,0.46237,0.40999,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,3.9822e-07,0.46216,0.54807,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.4471e-09,0.46173,0.46374,1,1
1,GO MITRAL VALVE DEVELOPMENT,2.6352e-05,0.4585,0.3946,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.6907e-08,0.45777,0.39479,1,1
1,GO ENDODERM FORMATION,1.069e-09,0.45754,0.5072,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00014129,0.45503,0.38151,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,1.2482e-05,0.45103,0.43627,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,1.2281e-06,0.45039,0.45812,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.8753e-10,0.44953,0.46081,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,4.4285e-07,0.44847,0.42793,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.4854e-10,0.44821,0.51857,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00022927,0.4478,0.53707,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,2.8262e-08,0.4467,0.45753,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,1.3999e-08,0.44667,0.42079,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,7.6446e-07,0.4458,0.40092,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.8885e-07,0.44518,0.37002,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,3.0295e-08,0.44314,0.42043,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,5.02e-08,0.44211,0.41836,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,3.6361e-10,0.44192,0.47095,1,1
1,GO ETHANOL METABOLIC PROCESS,1.6158e-05,0.441,0.39886,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,8.4415e-08,0.44098,0.42094,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.6567e-07,0.44049,0.48278,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00053704,0.44015,0.37235,1,1
1,GO ENDODERM DEVELOPMENT,1.6001e-09,0.43778,0.4431,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.9498e-07,0.43745,0.39203,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,1.2143e-08,0.43744,0.39068,1,1
1,GO INTERLEUKIN 1 PRODUCTION,3.1004e-08,0.43708,0.3981,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,3.2162e-07,0.43608,0.44267,1,1
1,GO T CELL MEDIATED IMMUNITY,1.4076e-07,0.43523,0.35796,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,6.545e-05,0.43489,0.33639,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4452e-09,0.43483,0.39312,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,2.7078e-07,0.43464,0.45396,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.6435e-08,0.43458,0.39343,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,2.6362e-08,0.43415,0.44603,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.2046e-07,0.43399,0.3562,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,5.2445e-07,0.43343,0.51662,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.00012804,0.4329,0.40502,1,1
1,GO RETINAL METABOLIC PROCESS,2.2416e-05,0.43236,0.4052,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1361e-07,0.43202,0.39471,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,3.055e-09,0.4319,0.42376,1,1
1,GO HEME METABOLIC PROCESS,1.2682e-10,0.43181,0.42722,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00010497,0.43133,0.34961,1,1
1,GO RESPONSE TO INTERLEUKIN 18,2.2824e-05,0.43099,0.52782,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.5427e-10,0.43049,0.45948,1,1
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0024609,0.42956,0.32104,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,2.0478e-05,0.42847,0.39343,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,7.6657e-06,0.42801,0.45122,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.9309e-10,0.42796,0.44508,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0001803,0.42662,0.39363,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.2792e-06,0.42638,0.44281,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.332e-06,0.42633,0.3928,1,1
1,GO VASCULOGENESIS,1.6542e-10,0.42595,0.44826,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,1.5293e-05,0.425,0.41944,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,9.9064e-10,0.424,0.45776,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.3769e-07,0.42367,0.51581,1,1
1,GO PINOCYTOSIS,1.9064e-09,0.42361,0.40308,1,1
1,GO TROPHOBLAST CELL MIGRATION,2.1807e-07,0.42335,0.45307,1,1
1,GO INTERLEUKIN 13 PRODUCTION,4.4807e-06,0.42306,0.42546,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.4701e-07,0.42291,0.43402,1,1
1,GO DEFENSE RESPONSE TO VIRUS,6.1583e-08,0.42288,0.34062,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,7.4873e-07,0.42275,0.44796,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,4.4148e-09,0.42244,0.38161,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.0776e-06,0.42224,0.41012,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.6321e-06,0.4222,0.42294,1,1
1,GO REGULATION OF PINOCYTOSIS,1.9989e-07,0.42219,0.34549,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.8673e-09,0.41983,0.40609,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,5.5127e-05,0.41952,0.34547,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.0983e-10,0.4192,0.46618,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,4.4807e-06,0.41723,0.34833,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.055e-09,0.41648,0.42984,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.6457e-05,0.41524,0.37932,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,2.6386e-06,0.414,0.43738,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,5.8262e-07,0.41307,0.43366,1,1
1,GO DETECTION OF BIOTIC STIMULUS,5.7051e-07,0.41282,0.41344,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,1.6457e-05,0.4116,0.45179,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,3.0395e-05,0.41118,0.43162,1,1
1,GO ENTRY INTO HOST,4.8673e-09,0.41098,0.39274,1,1
1,GO CD40 SIGNALING PATHWAY,8.5043e-10,0.4104,0.43287,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.9989e-07,0.41004,0.39293,1,1
1,GO ZYMOGEN ACTIVATION,1.3325e-06,0.40991,0.4108,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,5.7051e-07,0.40872,0.34745,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,1.0322e-07,0.40867,0.37242,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.3784e-07,0.40805,0.39896,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.4148e-09,0.40791,0.39241,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,6.0759e-07,0.40788,0.34741,1,1
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00084997,0.40574,0.32746,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.4163e-06,0.405,0.37361,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00040235,0.40403,0.37507,1,1
1,GO PIGMENT ACCUMULATION,6.1583e-08,0.40386,0.41354,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.484e-09,0.40345,0.3686,1,1
1,GO INTERLEUKIN 8 PRODUCTION,3.3228e-08,0.40339,0.39248,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.9175e-06,0.40301,0.41439,1,1
1,GO SERTOLI CELL DEVELOPMENT,1.3056e-06,0.40271,0.39021,1,1
1,GO CYSTEINE METABOLIC PROCESS,5.9056e-05,0.40207,0.35742,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,3.628e-05,0.40201,0.30737,1,1
1,GO INTERLEUKIN 17 PRODUCTION,5.2445e-07,0.40168,0.33738,1,1
1,GO RESPONSE TO INTERLEUKIN 12,9.5677e-09,0.40076,0.35025,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.2886e-07,0.39981,0.36499,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.9822e-07,0.39803,0.3496,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.6418e-07,0.39763,0.43896,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,7.3772e-08,0.39729,0.42644,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.9175e-06,0.39727,0.40763,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.3056e-06,0.39691,0.34224,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,1.7693e-06,0.39587,0.39203,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,1.3948e-05,0.39504,0.34358,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.2926e-08,0.39495,0.39128,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.6657e-06,0.39322,0.34869,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.2094e-09,0.39302,0.41407,1,1
1,GO LYMPH VESSEL DEVELOPMENT,3.6924e-05,0.3912,0.34701,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.3853e-09,0.39081,0.40272,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.0437e-10,0.39072,0.37739,1,1
1,GO FOCAL ADHESION ASSEMBLY,1.8723e-07,0.38946,0.37398,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.3948e-05,0.38945,0.29847,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,4.7488e-06,0.38934,0.39595,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,5.5127e-05,0.38921,0.33109,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,2.4972e-05,0.38893,0.40834,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,2.4837e-07,0.38859,0.44647,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,6.5837e-06,0.38779,0.47233,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.5868e-06,0.38756,0.36628,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,3.7605e-06,0.38747,0.37041,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,8.8389e-07,0.3868,0.40726,1,1
1,GO VIRAL GENOME REPLICATION,2.0398e-08,0.38565,0.34109,1,1
1,GO T CELL APOPTOTIC PROCESS,5.6317e-09,0.38494,0.32733,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,1.0361e-05,0.38479,0.37019,1,1
1,GO T CELL EXTRAVASATION,7.6657e-06,0.38475,0.39897,1,1
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.013546,0.38351,0.30298,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00024045,0.3835,0.31893,1,1
1,GO PLASMINOGEN ACTIVATION,2.6914e-06,0.3821,0.4033,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.7309e-08,0.38158,0.35259,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,1.9393e-05,0.3814,0.41109,1,1
1,GO POSITIVE REGULATION OF COAGULATION,3.2784e-06,0.3813,0.31885,1,1
1,GO GERMINAL CENTER FORMATION,2.4972e-05,0.38118,0.3459,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.0279e-08,0.38112,0.34749,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,7.5451e-08,0.38011,0.3869,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,8.6328e-08,0.38003,0.40488,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.0557e-05,0.38002,0.35774,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.5934e-07,0.37983,0.32047,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,6.2169e-06,0.3795,0.38403,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,7.0337e-07,0.37776,0.35178,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,8.7237e-10,0.37738,0.3841,1,1
1,GO OSTEOBLAST DEVELOPMENT,1.2886e-07,0.37728,0.35615,1,1
1,GO MONOCYTE CHEMOTAXIS,7.8124e-06,0.37681,0.30168,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.5865e-05,0.37641,0.32666,1,1
1,GO MUSCLE CELL FATE COMMITMENT,1.0169e-05,0.37613,0.33581,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00027716,0.37567,0.28865,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,1.3599e-06,0.3756,0.35333,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.0791e-07,0.3752,0.38223,1,1
1,GO RESPONSE TO SALT STRESS,1.1034e-07,0.3751,0.32162,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,1.0169e-05,0.37505,0.37218,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3878e-06,0.37426,0.29532,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.1196e-06,0.37408,0.36676,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,6.0991e-06,0.37405,0.34689,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.734e-06,0.37401,0.32194,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.5027e-08,0.37384,0.41571,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,1.7154e-07,0.37303,0.33766,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,6.545e-05,0.37159,0.30855,1,1
1,GO PROSTATE GLAND GROWTH,0.003607,0.37126,0.37319,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,9.0235e-07,0.36937,0.42933,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,3.3214e-05,0.36904,0.26595,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,1.5865e-05,0.36894,0.40601,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.475e-06,0.36886,0.3104,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0005618,0.36846,0.33091,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.5713e-07,0.36709,0.40365,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,9.4407e-08,0.36686,0.5116,1,1
1,GO I KAPPAB PHOSPHORYLATION,1.7534e-07,0.3667,0.29844,1,1
1,GO PEPTIDE CROSS LINKING,2.6828e-05,0.3664,0.3333,1,1
1,GO LYMPHANGIOGENESIS,1.3351e-08,0.3663,0.39784,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,5.6085e-05,0.36594,0.33368,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,5.6317e-09,0.36509,0.37688,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7909e-10,0.36487,0.34659,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,9.9064e-10,0.36418,0.35363,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.9014e-08,0.36409,0.3228,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.3024e-10,0.36376,0.34362,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,6.2046e-07,0.36369,0.37098,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,7.0017e-09,0.36345,0.37433,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,6.0759e-07,0.36333,0.28882,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.9624e-10,0.36285,0.4323,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00064263,0.36224,0.30329,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.734e-06,0.36146,0.41836,1,1
1,GO AMYLOID BETA CLEARANCE,1.2604e-07,0.36038,0.3326,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,3.094e-05,0.35995,0.32912,1,1
1,GO AMINE CATABOLIC PROCESS,0.00011033,0.35983,0.30073,1,1
1,GO GAP JUNCTION ASSEMBLY,3.4773e-06,0.35963,0.35803,1,1
1,GO FIBROBLAST MIGRATION,8.8282e-08,0.35954,0.33296,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.2321e-08,0.35904,0.3847,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,1.1794e-07,0.35902,0.35096,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.7078e-07,0.35746,0.34143,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,7.105e-06,0.35688,0.31509,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.8053e-06,0.35681,0.33133,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8416e-06,0.35669,0.36001,1,1
1,GO RESPONSE TO HYDROPEROXIDE,0.0021215,0.35633,0.25698,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,4.1815e-08,0.35632,0.3835,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,9.5999e-07,0.35622,0.39304,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00027284,0.35605,0.29362,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,5.02e-08,0.35604,0.44475,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,6.5906e-08,0.35577,0.32571,1,1
1,GO DNA DEAMINATION,1.1806e-05,0.35571,0.44625,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,7.8124e-06,0.35564,0.42122,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,9.0235e-07,0.35479,0.34072,1,1
1,GO REGULATION OF TRANSPOSITION,0.00027716,0.35415,0.3202,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,1.1307e-08,0.35401,0.35394,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0007901,0.35386,0.29156,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,1.3769e-07,0.35275,0.37133,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.9047e-09,0.35228,0.34614,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.1041e-08,0.35186,0.40261,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,2.1624e-06,0.35146,0.34029,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00076726,0.35129,0.3127,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,3.4773e-06,0.35112,0.31432,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,7.2414e-06,0.35083,0.36389,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.2139e-09,0.35042,0.33004,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,3.7605e-06,0.34928,0.3894,1,1
1,GO MATURATION OF LSU RRNA,1.3693e-05,0.34921,0.30677,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0056255,0.34916,0.23316,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.7963e-08,0.34889,0.32383,1,1
1,GO HYPOTONIC RESPONSE,1.1588e-05,0.34864,0.30489,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.00019541,0.34783,0.51576,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6328e-08,0.34738,0.36425,1,1
1,GO MYOBLAST PROLIFERATION,0.0012177,0.34666,0.2391,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.892e-08,0.3461,0.30993,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.00038422,0.34606,0.27084,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,3.8924e-05,0.34536,0.35322,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2792e-06,0.34526,0.40333,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,2.342e-06,0.3446,0.28913,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,1.1375e-05,0.34399,0.33606,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,5.7582e-06,0.34399,0.32614,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,6.2046e-07,0.34393,0.35071,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,7.4873e-07,0.34287,0.26623,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,5.8262e-07,0.34284,0.29966,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0024609,0.34279,0.30478,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.1196e-06,0.34248,0.29088,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,5.8698e-06,0.34218,0.30331,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.6782e-07,0.34167,0.37421,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.9102e-06,0.34147,0.46416,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,9.5677e-09,0.34147,0.36564,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.8363e-05,0.34134,0.25798,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00076726,0.34133,0.32469,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.7668e-07,0.34132,0.35769,1,1
1,GO TYPE I INTERFERON PRODUCTION,7.5451e-08,0.34072,0.29351,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,2.5756e-08,0.34046,0.31999,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.00091404,0.34044,0.25894,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,4.9694e-05,0.33984,0.35453,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0013069,0.33933,0.25249,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,3.9035e-08,0.33895,0.36502,1,1
1,GO RESPONSE TO ANGIOTENSIN,7.1726e-09,0.33871,0.36164,1,1
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0071051,0.33869,0.27238,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,3.3228e-08,0.33868,0.33538,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,7.6283e-05,0.33866,0.34688,1,1
1,GO EMBRYO IMPLANTATION,2.402e-08,0.33849,0.33859,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.3359e-07,0.33822,0.38429,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.9228e-07,0.33767,0.37023,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,7.9617e-06,0.33765,0.3689,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.5794e-07,0.33722,0.33188,1,1
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00012186,0.33715,0.32366,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,7.105e-06,0.33713,0.4017,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,1.3693e-05,0.33637,0.3252,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.0759e-07,0.33613,0.28161,1,1
1,GO INTERACTION WITH SYMBIONT,5.1101e-09,0.33605,0.29323,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,1.9175e-06,0.33601,0.44049,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.6202e-07,0.336,0.35177,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.6761e-05,0.3358,0.37855,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,4.4807e-06,0.33494,0.31122,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.4873e-07,0.33491,0.2933,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,1.0756e-05,0.33463,0.29597,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,3.3629e-10,0.33376,0.38007,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,4.7999e-05,0.33352,0.33816,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,2.0364e-06,0.33333,0.30255,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.1307e-08,0.33306,0.33653,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.0056255,0.33293,0.19648,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0023957,0.33212,0.2386,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,8.4262e-06,0.33207,0.3472,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.0905e-06,0.33186,0.35833,1,1
1,GO RESPONSE TO VIRUS,4.0868e-08,0.33168,0.2963,1,1
1,GO RESPONSE TO X RAY,6.5125e-09,0.33161,0.41991,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.9749e-05,0.3312,0.29977,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,3.9102e-06,0.33119,0.32069,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.8149e-08,0.33108,0.3665,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.9069e-08,0.33077,0.44707,1,1
1,GO REGULATION OF GASTRULATION,1.7687e-09,0.33034,0.33834,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.7693e-06,0.33014,0.29667,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.8389e-07,0.32999,0.31722,1,1
1,GO INTERFERON BETA PRODUCTION,6.8885e-07,0.32986,0.28502,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,6.3359e-07,0.32964,0.31893,1,1
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00053704,0.32961,0.23585,1,1
1,GO CELLULAR RESPONSE TO X RAY,2.206e-06,0.329,0.37803,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,5.6085e-05,0.32817,0.32069,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,4.4285e-07,0.32772,0.40023,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,5.4967e-09,0.3277,0.27517,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,3.5038e-07,0.32757,0.26573,1,1
1,GO CYTOKINE METABOLIC PROCESS,6.1583e-08,0.32679,0.31334,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00029052,0.32658,0.38166,1,1
1,GO PLATELET AGGREGATION,5.9498e-07,0.32614,0.3217,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.9166e-06,0.3258,0.28024,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,4.9228e-07,0.32413,0.36089,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.0048405,0.32385,0.33914,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00019541,0.32374,0.25965,1,1
1,GO REGULATION OF CELL KILLING,0.00027716,0.32364,0.22399,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.2733e-08,0.32334,0.30798,1,1
1,GO VIRAL TRANSLATION,7.892e-08,0.32324,0.336,1,1
1,GO CERAMIDE CATABOLIC PROCESS,2.1621e-05,0.32312,0.30704,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,1.6654e-06,0.32285,0.28832,1,1
1,GO NIK NF KAPPAB SIGNALING,1.0964e-09,0.32253,0.31294,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.8419e-06,0.32244,0.47973,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,3.5794e-07,0.3224,0.33274,1,1
1,GO KERATINOCYTE PROLIFERATION,0.00084997,0.32155,0.29593,1,1
1,GO ARTERY DEVELOPMENT,0.00018323,0.3213,0.265,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,4.2784e-08,0.32098,0.38148,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,5.2344e-05,0.32089,0.47005,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,5.3647e-09,0.32051,0.34311,1,1
1,GO HAIR FOLLICLE MATURATION,7.3803e-06,0.31973,0.33037,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.00086244,0.31972,0.29557,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.2482e-05,0.31904,0.30744,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.471e-07,0.31903,0.31599,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,8.7316e-05,0.31897,0.27095,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00037835,0.31892,0.30254,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,4.2042e-09,0.31792,0.31787,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.0478e-05,0.31774,0.27687,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.6877e-06,0.31771,0.25341,1,1
1,GO SERTOLI CELL DIFFERENTIATION,1.3693e-05,0.31691,0.30072,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,2.2824e-05,0.3169,0.38276,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.4334e-08,0.31646,0.30874,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00015838,0.31635,0.25396,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.5239e-09,0.31612,0.30524,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.4982e-08,0.31606,0.3321,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,8.6328e-08,0.31592,0.3294,1,1
1,GO PROSTANOID METABOLIC PROCESS,5.7051e-07,0.31581,0.37457,1,1
1,GO MONONUCLEAR CELL MIGRATION,4.719e-07,0.31559,0.30476,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.2775e-07,0.31544,0.25908,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,1.2534e-06,0.3154,0.2939,1,1
1,GO HYALURONAN METABOLIC PROCESS,6.2993e-08,0.31512,0.31723,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,3.7282e-08,0.31503,0.38753,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,7.2129e-08,0.31485,0.34725,1,1
1,GO PODOSOME ASSEMBLY,9.2321e-08,0.31454,0.40043,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0016806,0.31429,0.26723,1,1
1,GO B CELL MEDIATED IMMUNITY,6.0759e-07,0.31412,0.31155,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.5753e-08,0.31392,0.42081,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,3.0295e-08,0.31391,0.32164,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.2253e-05,0.31368,0.35349,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,3.2057e-05,0.31344,0.28415,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,1.7071e-05,0.31297,0.37179,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00014839,0.31263,0.28914,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.2253e-05,0.31254,0.30885,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,5.3256e-05,0.31246,0.27628,1,1
1,GO GENITALIA MORPHOGENESIS,0.00013016,0.31228,0.30364,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,5.0278e-07,0.3122,0.31693,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0013633,0.31216,0.24842,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00017741,0.3116,0.37958,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0001179,0.31159,0.22963,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.9558e-07,0.31141,0.30912,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0001803,0.31114,0.23371,1,1
1,GO MACROPHAGE CHEMOTAXIS,1.5713e-07,0.31061,0.29438,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.4296e-07,0.31042,0.3064,1,1
1,GO VIRAL LIFE CYCLE,1.5217e-09,0.31023,0.29814,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.3772e-08,0.31014,0.31331,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,4.1751e-05,0.3101,0.32712,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,9.086e-06,0.31006,0.36841,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,4.2271e-06,0.30996,0.26682,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,7.105e-06,0.30986,0.27755,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0012527,0.30984,0.35623,1,1
1,GO NEUROBLAST DIVISION,0.0016575,0.30938,0.29829,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.5233e-07,0.30924,0.29815,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,6.545e-05,0.30912,0.34403,1,1
1,GO RESPONSE TO ESTROGEN,2.5756e-08,0.30881,0.29989,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.001568,0.30873,0.28705,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,4.5233e-07,0.30865,0.33389,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,5.4184e-05,0.30852,0.29449,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0037985,0.30848,0.26725,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00044103,0.30795,0.27936,1,1
1,GO ENAMEL MINERALIZATION,0.00057029,0.30791,0.33936,1,1
1,GO T CELL CHEMOTAXIS,3.5794e-07,0.30787,0.29269,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00010852,0.30782,0.27042,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.0089251,0.30757,0.25568,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,1.8053e-06,0.30756,0.35382,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00032916,0.30747,0.40884,1,1
1,GO CELLULAR RESPONSE TO DSRNA,1.6062e-07,0.30688,0.33365,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.0361e-05,0.30679,0.28291,1,1
1,GO MACROPHAGE MIGRATION,2.4586e-08,0.30664,0.30974,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,2.2015e-05,0.30648,0.25809,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.4163e-06,0.30601,0.31456,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.2397e-08,0.30586,0.258,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,8.8796e-05,0.30521,0.21734,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00048316,0.30518,0.23116,1,1
1,GO TRACHEA DEVELOPMENT,0.00024819,0.30518,0.28895,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.7706e-05,0.30517,0.25345,1,1
1,GO TRANSPOSITION,0.00082553,0.30517,0.25998,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,1.0424e-06,0.30449,0.35071,1,1
1,GO LIVER REGENERATION,2.188e-08,0.30441,0.30745,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,2.971e-06,0.3044,0.32903,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.8416e-06,0.30433,0.27591,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0062877,0.30429,0.23385,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00026858,0.30409,0.37047,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.3355e-07,0.30344,0.28464,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,1.2792e-06,0.30335,0.31713,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.4409e-05,0.30312,0.32874,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.3999e-08,0.30304,0.29332,1,1
1,GO RIG I SIGNALING PATHWAY,1.4677e-08,0.30297,0.32562,1,1
1,GO FOREGUT MORPHOGENESIS,2.9514e-07,0.30271,0.36577,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,6.1583e-08,0.30241,0.32158,1,1
1,GO ERBB2 SIGNALING PATHWAY,4.719e-07,0.30234,0.28318,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0001803,0.30233,0.24922,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.5424e-05,0.30222,0.27096,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,7.7166e-08,0.3022,0.28541,1,1
1,GO REGULATION OF STEROL TRANSPORT,4.2444e-07,0.30211,0.30746,1,1
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0071051,0.30184,0.24068,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,1.0756e-05,0.30183,0.29795,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.8911e-05,0.30179,0.27851,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.8814e-05,0.30158,0.26584,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.8124e-06,0.30146,0.25965,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,4.9228e-07,0.30128,0.31646,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,4.4807e-06,0.30119,0.26254,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0024609,0.30074,0.23133,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,4.8839e-05,0.30072,0.27482,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.2958e-06,0.30069,0.26388,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,9.9844e-05,0.30063,0.32951,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.0776e-06,0.30053,0.27092,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.1004e-08,0.30051,0.31763,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7051e-07,0.30005,0.33225,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.0868e-08,0.30003,0.2847,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,3.5794e-07,0.29985,0.23478,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,3.6435e-08,0.29902,0.32531,1,1
1,GO PROTEIN OXIDATION,0.0039481,0.29895,0.29336,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,3.4098e-06,0.29847,0.32262,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,7.3739e-05,0.29777,0.33233,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,4.31e-06,0.29749,0.37087,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.3693e-05,0.29736,0.30653,1,1
1,GO EPITHELIAL CELL CELL ADHESION,0.0078263,0.29719,0.31198,1,1
1,GO SALIVARY GLAND DEVELOPMENT,5.4356e-06,0.29699,0.38554,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,1.6907e-08,0.29678,0.2651,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0010558,0.29669,0.24665,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,7.105e-06,0.29668,0.31927,1,1
1,GO COLLAGEN CATABOLIC PROCESS,4.2444e-07,0.29667,0.33437,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.2859e-07,0.29593,0.27117,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.8305e-05,0.29543,0.26258,1,1
1,GO CHEMOKINE PRODUCTION,3.3214e-05,0.29537,0.24756,1,1
1,GO MEMBRANE INVAGINATION,3.0156e-07,0.29528,0.28863,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.5576e-05,0.29526,0.28935,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.5293e-05,0.29525,0.28109,1,1
1,GO LAMELLIPODIUM ORGANIZATION,2.4371e-06,0.29513,0.2499,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.7693e-06,0.29504,0.31404,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.7356e-07,0.2947,0.29355,1,1
1,GO ASYMMETRIC CELL DIVISION,6.0991e-06,0.29383,0.28186,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,4.0657e-06,0.29374,0.38108,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.2534e-06,0.2935,0.34486,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,1.1588e-05,0.29348,0.23258,1,1
1,GO BONE GROWTH,1.7385e-05,0.29335,0.33707,1,1
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0012886,0.29333,0.25097,1,1
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0078263,0.29313,0.21164,1,1
1,GO INTERFERON ALPHA PRODUCTION,3.6924e-05,0.29281,0.2541,1,1
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00015838,0.29273,0.23966,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00022208,0.29236,0.30734,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.5753e-08,0.29213,0.29804,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.8246e-05,0.29201,0.25353,1,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0088198,0.29163,0.21515,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.1316e-06,0.29163,0.29159,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,3.152e-06,0.29136,0.25869,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.3784e-07,0.29129,0.27351,1,1
1,GO REGULATION OF BONE DEVELOPMENT,6.0991e-06,0.291,0.27413,1,1
1,GO T CELL MIGRATION,1.4454e-06,0.29099,0.28407,1,1
1,GO VAGINA DEVELOPMENT,1.4163e-06,0.29093,0.36112,1,1
1,GO RESPONSE TO INTERLEUKIN 15,8.7316e-05,0.2909,0.27035,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.3468e-07,0.29081,0.29072,1,1
1,GO FIBROBLAST APOPTOTIC PROCESS,6.6578e-05,0.29057,0.27657,1,1
1,GO CELL SUBSTRATE ADHESION,2.538e-07,0.29055,0.32066,1,1
1,GO RECEPTOR CATABOLIC PROCESS,9.6538e-08,0.29042,0.33763,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,1.6761e-05,0.29041,0.22036,1,1
1,GO OSTEOCLAST DEVELOPMENT,1.5052e-06,0.28982,0.33484,1,1
1,GO INNATE IMMUNE RESPONSE,9.5999e-07,0.28968,0.25719,1,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.00022927,0.28953,0.29321,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,1.3948e-05,0.2892,0.2836,1,1
1,GO MUSCLE FILAMENT SLIDING,2.7452e-06,0.28919,0.25109,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0016575,0.28872,0.30504,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.8305e-05,0.28849,0.25467,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.8135e-09,0.28847,0.29409,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.7668e-07,0.28838,0.30434,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1086e-06,0.28833,0.31411,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00024045,0.28808,0.25259,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,6.0079e-05,0.28771,0.29228,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,3.094e-05,0.28768,0.27263,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.4741e-05,0.28732,0.30941,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.3056e-06,0.28718,0.30079,1,1
1,GO AORTIC VALVE DEVELOPMENT,3.4409e-05,0.28709,0.34016,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,1.4472e-05,0.2869,0.25364,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.011e-05,0.28684,0.3155,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.9136e-07,0.28665,0.2885,1,1
1,GO T CELL PROLIFERATION,2.3661e-05,0.28603,0.22132,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,3.2631e-05,0.28576,0.34325,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.1588e-05,0.28566,0.26981,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.0323e-06,0.28554,0.2376,1,1
1,GO DENDRITIC CELL MIGRATION,0.0011021,0.28536,0.251,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,2.1375e-08,0.28503,0.34944,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0429e-07,0.28502,0.28209,1,1
1,GO INTERACTION WITH HOST,9.5677e-09,0.28498,0.29341,1,1
1,GO PROSTATE GLAND DEVELOPMENT,6.5837e-06,0.28485,0.37328,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,6.337e-06,0.28457,0.29161,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.3325e-06,0.28428,0.29051,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,1.2032e-06,0.28408,0.30503,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,5.7582e-06,0.28407,0.32895,1,1
1,GO T CELL CYTOKINE PRODUCTION,6.7105e-06,0.28407,0.25481,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00031907,0.28382,0.229,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.8369e-09,0.2837,0.32628,1,1
1,GO REGULATION OF PROTEIN MATURATION,3.4553e-09,0.28356,0.29796,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,8.5858e-05,0.28323,0.29216,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00072342,0.28322,0.20645,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.00043435,0.28319,0.25448,1,1
1,GO PROSTATIC BUD FORMATION,0.0068504,0.28316,0.26879,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.1456e-06,0.283,0.31458,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.2032e-06,0.28291,0.35753,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.1034e-07,0.28234,0.29338,1,1
1,GO MATURATION OF SSU RRNA,4.2487e-05,0.28233,0.27133,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,1.5713e-07,0.28219,0.30396,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.0212e-06,0.28192,0.31401,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.2886e-07,0.28158,0.382,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0002117,0.28148,0.26687,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,2.188e-08,0.2809,0.29499,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,1.0554e-07,0.28076,0.29882,1,1
1,GO CELL MATRIX ADHESION,1.3599e-06,0.28061,0.29692,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,1.5052e-06,0.28059,0.27491,1,1
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0012886,0.28041,0.23295,1,1
1,GO RESPONSE TO DSRNA,1.1086e-06,0.28032,0.26155,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.7385e-05,0.28023,0.26766,1,1
1,GO MACROPHAGE PROLIFERATION,0.00055343,0.28019,0.31497,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,5.1304e-06,0.27977,0.34341,1,1
1,GO AMYLOID FIBRIL FORMATION,0.0049019,0.27949,0.24492,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.4677e-08,0.27914,0.31863,1,1
1,GO ARGININE METABOLIC PROCESS,6.8396e-06,0.27914,0.30603,1,1
1,GO RESPONSE TO INTERLEUKIN 1,7.3476e-09,0.27885,0.26802,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,4.9694e-05,0.27885,0.25328,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,1.4163e-06,0.27883,0.26194,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,5.0323e-06,0.27876,0.34918,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,2.1338e-07,0.27811,0.2559,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,4.2487e-05,0.27806,0.3399,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.5424e-05,0.27778,0.25382,1,1
1,GO AORTA DEVELOPMENT,0.0020367,0.27752,0.23706,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.4771e-05,0.27716,0.24934,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,2.7312e-05,0.27705,0.23316,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0019023,0.277,0.22859,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,0.0046604,0.27684,0.18333,1,1
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00014129,0.27656,0.35666,1,1
1,GO REGULATION OF MYOBLAST FUSION,2.8305e-05,0.2763,0.3297,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,9.086e-06,0.27626,0.27923,1,1
1,GO NADPH REGENERATION,3.9102e-06,0.27615,0.28322,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.1624e-06,0.2761,0.31772,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00013899,0.27596,0.21791,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,6.4699e-07,0.27595,0.24343,1,1
1,GO RESPONSE TO MANGANESE ION,2.5934e-07,0.27587,0.26803,1,1
1,GO PORE COMPLEX ASSEMBLY,2.3891e-06,0.27583,0.24782,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,6.9711e-06,0.27577,0.27458,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,5.2538e-08,0.27566,0.27001,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0364e-06,0.27561,0.24416,1,1
1,GO MUSCLE CELL MIGRATION,0.00016361,0.27538,0.24389,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.1234e-05,0.27533,0.24906,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,3.628e-05,0.2751,0.32107,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.4701e-07,0.27493,0.29879,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,2.7804e-05,0.2749,0.32751,1,1
1,GO MATURATION OF 5 8S RRNA,7.5001e-05,0.27474,0.23161,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,2.538e-07,0.27451,0.2923,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,5.3562e-07,0.27442,0.25606,1,1
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0011021,0.27435,0.23269,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,1.1282e-07,0.27418,0.25605,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,9.2585e-06,0.2741,0.25927,1,1
1,GO PIGMENT GRANULE ORGANIZATION,4.8198e-07,0.27368,0.30411,1,1
1,GO FIBROBLAST ACTIVATION,5.2344e-05,0.27363,0.28652,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.0098086,0.27359,0.21431,1,1
1,GO SPROUTING ANGIOGENESIS,5.5864e-07,0.27344,0.30446,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00084997,0.27343,0.21922,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.4586e-08,0.27337,0.30971,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0002443,0.27336,0.22702,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00019857,0.27308,0.24462,1,1
1,GO SEQUESTERING OF METAL ION,5.2344e-05,0.27299,0.25847,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5386e-08,0.27299,0.27027,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.155e-06,0.27298,0.24867,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.5022e-05,0.27297,0.28591,1,1
1,GO MYOBLAST FUSION,1.4207e-05,0.27296,0.30822,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,1.1789e-06,0.27292,0.3489,1,1
1,GO RESPONSE TO CYTOKINE,1.7534e-07,0.27289,0.24421,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0015249,0.2722,0.28716,1,1
1,GO VIRAL GENE EXPRESSION,2.206e-06,0.27208,0.23967,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.6579e-07,0.27205,0.2365,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,2.1624e-06,0.27179,0.26094,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,0.002631,0.27165,0.21242,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.0557e-05,0.27139,0.25989,1,1
1,GO PROTEASOME ASSEMBLY,0.00013016,0.27124,0.19133,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.003607,0.27122,0.2715,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,2.8814e-05,0.27101,0.2722,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.001776,0.27095,0.23218,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.0079e-05,0.27089,0.21275,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0015463,0.27085,0.2087,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,3.094e-05,0.27043,0.23305,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,7.0072e-05,0.27041,0.25215,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.3039e-08,0.27024,0.30277,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,1.6457e-05,0.27001,0.24008,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.6317e-09,0.26995,0.29979,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.1086e-06,0.26977,0.31235,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.4163e-06,0.26977,0.2758,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0019819,0.26968,0.22869,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,1.0756e-05,0.26894,0.25766,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00014839,0.26879,0.23931,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00046165,0.26859,0.31442,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,2.7668e-07,0.26781,0.27537,1,1
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.016027,0.26777,0.19001,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,2.2015e-05,0.26774,0.28675,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00021857,0.26766,0.27517,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0011836,0.26758,0.30172,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,4.6578e-06,0.26736,0.27673,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.8363e-05,0.26728,0.24559,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,3.0302e-06,0.26703,0.27332,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.5674e-06,0.26673,0.31817,1,1
1,GO GASTRULATION,3.8149e-08,0.26654,0.29567,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.8318e-07,0.26645,0.2908,1,1
1,GO CELL REDOX HOMEOSTASIS,2.0364e-06,0.26588,0.21997,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.7166e-08,0.26579,0.25509,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5386e-08,0.26546,0.26812,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0010865,0.26511,0.26392,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,3.7282e-08,0.26498,0.29879,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,4.0314e-05,0.26482,0.2794,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.152e-06,0.2645,0.24293,1,1
1,GO ARTERY MORPHOGENESIS,0.0070192,0.26449,0.21296,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,1.439e-07,0.26448,0.23893,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,1.8032e-05,0.26414,0.23106,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.0678e-07,0.26386,0.26408,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.856e-06,0.26382,0.23797,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.023668,0.26377,0.20909,1,1
1,GO TISSUE REGENERATION,2.4371e-06,0.26368,0.24885,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,2.6386e-06,0.26334,0.24241,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0005056,0.26313,0.26342,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,5.3256e-05,0.26293,0.25029,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,4.4807e-06,0.26292,0.26334,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,7.5217e-06,0.26287,0.27975,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.6321e-06,0.26277,0.25075,1,1
1,GO NATURAL KILLER CELL ACTIVATION,1.5994e-06,0.26265,0.25556,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.0094e-07,0.26244,0.26695,1,1
1,GO TERPENOID METABOLIC PROCESS,0.00015083,0.2623,0.19624,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.2169e-06,0.26201,0.22855,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,3.4409e-05,0.26192,0.25099,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,8.4262e-06,0.26187,0.26848,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,1.2253e-05,0.26183,0.23203,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,8.9166e-06,0.2612,0.28971,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00086244,0.26107,0.20304,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.5293e-05,0.26086,0.2837,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,4.0657e-06,0.26084,0.25188,1,1
1,GO STEM CELL DIVISION,0.00019229,0.26028,0.26082,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.734e-06,0.26022,0.25616,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.2027e-05,0.26016,0.26045,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.6828e-05,0.26006,0.2526,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,6.545e-05,0.25981,0.20252,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,1.1307e-08,0.2598,0.27602,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9989e-07,0.25963,0.27827,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,7.105e-06,0.2596,0.26932,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00011218,0.25952,0.26495,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.8246e-05,0.25921,0.26722,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0005789,0.25921,0.16695,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00015583,0.25912,0.21155,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.9035e-08,0.25905,0.27772,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00036686,0.25903,0.20736,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.7534e-07,0.25899,0.26753,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,1.0361e-05,0.25897,0.30477,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,7.2414e-06,0.25889,0.24675,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.6446e-07,0.25879,0.2395,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.8839e-05,0.25866,0.2215,1,1
1,GO ALPHA BETA T CELL ACTIVATION,8.4424e-05,0.25855,0.22756,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.6062e-07,0.25849,0.2709,1,1
1,GO BLOOD VESSEL REMODELING,0.00011406,0.25793,0.27557,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.010645,0.25769,0.27476,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0011021,0.25735,0.29866,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00022565,0.25714,0.30959,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,1.9749e-05,0.25701,0.25691,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,1.8701e-05,0.25695,0.25759,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0013255,0.25675,0.19126,1,1
1,GO RESPONSE TO IONIZING RADIATION,2.5934e-07,0.25674,0.23746,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.8271e-07,0.25667,0.29266,1,1
1,GO RRNA MODIFICATION,1.6457e-05,0.25659,0.2147,1,1
1,GO TRNA METHYLATION,3.628e-05,0.25658,0.21897,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0021798,0.25651,0.22148,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00081356,0.2565,0.18378,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.00013016,0.25604,0.21057,1,1
1,GO NCRNA PROCESSING,6.337e-06,0.25589,0.21706,1,1
1,GO ISOPRENOID METABOLIC PROCESS,4.6359e-05,0.25546,0.18731,1,1
1,GO VESICLE CARGO LOADING,7.5451e-08,0.25535,0.29169,1,1
1,GO NECROTIC CELL DEATH,0.00013016,0.25505,0.21423,1,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00096848,0.25492,0.20204,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.6202e-07,0.25479,0.28064,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,8.3066e-07,0.25429,0.25543,1,1
1,GO KERATINOCYTE MIGRATION,1.5576e-05,0.25338,0.23026,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011813,0.25321,0.15074,1,1
1,GO T CELL ACTIVATION,9.6129e-06,0.25315,0.21727,1,1
1,GO IMMUNE EFFECTOR PROCESS,4.719e-07,0.25288,0.2497,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.152e-06,0.25268,0.21353,1,1
1,GO RETINOL METABOLIC PROCESS,1.3693e-05,0.25254,0.24589,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00033432,0.25155,0.35322,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00057029,0.25151,0.22134,1,1
1,GO WOUND HEALING,1.9563e-06,0.2515,0.25549,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.1041e-08,0.25146,0.28228,1,1
1,GO TRABECULA FORMATION,0.00073415,0.25128,0.29467,1,1
1,GO CHOLESTEROL EFFLUX,5.6085e-05,0.25114,0.22106,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.064e-06,0.25058,0.27017,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,7.6657e-06,0.25054,0.23702,1,1
1,GO MYOBLAST DIFFERENTIATION,1.0554e-07,0.25039,0.28899,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.6782e-07,0.25038,0.29258,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,4.2444e-07,0.25031,0.27808,1,1
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.004964,0.25029,0.26,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0042636,0.24999,0.19491,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00029052,0.24983,0.26654,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.6994e-06,0.24974,0.31473,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.4773e-06,0.24962,0.27077,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.6446e-07,0.2491,0.25533,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,1.9175e-06,0.24898,0.28244,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.5277e-10,0.24897,0.26149,1,1
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.032278,0.24894,0.24127,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.1274e-05,0.24887,0.19516,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2253e-05,0.24861,0.29437,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,6.4699e-07,0.24857,0.24927,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,2.4091e-05,0.24849,0.22665,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,1.6158e-05,0.24837,0.23636,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,2.7804e-05,0.24802,0.24483,1,1
1,GO REGULATION OF T CELL ACTIVATION,4.4771e-05,0.24791,0.19949,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.1338e-07,0.24763,0.26488,1,1
1,GO PLATELET DEGRANULATION,6.9711e-06,0.24754,0.29308,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,2.7452e-06,0.24746,0.25244,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.00013673,0.24709,0.24666,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0028872,0.24671,0.25777,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0013633,0.24668,0.2095,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00076726,0.24665,0.22489,1,1
1,GO PHAGOCYTOSIS,1.2058e-07,0.24665,0.2771,1,1
1,GO MICROVILLUS ASSEMBLY,0.032607,0.24645,0.14422,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00010497,0.2464,0.26484,1,1
1,GO PIGMENT METABOLIC PROCESS,9.6538e-08,0.24636,0.23959,1,1
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0013443,0.24633,0.19993,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,3.2057e-05,0.24632,0.29341,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.9822e-07,0.24613,0.25232,1,1
1,GO REGULATION OF LIPASE ACTIVITY,1.9558e-07,0.24581,0.24956,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0059116,0.24571,0.18231,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.00026024,0.24556,0.22131,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,1.6457e-05,0.24503,0.26521,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.1623e-05,0.24489,0.20309,1,1
1,GO FIBROBLAST PROLIFERATION,5.7582e-06,0.24487,0.26309,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00013232,0.24486,0.29008,1,1
1,GO PROTEIN DEMANNOSYLATION,0.00024819,0.24465,0.22741,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0018006,0.24454,0.21662,1,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0066851,0.24449,0.23022,1,1
1,GO P38MAPK CASCADE,1.2253e-05,0.24448,0.24774,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.2534e-06,0.24447,0.24416,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,4.4771e-05,0.24427,0.26304,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,1.0361e-05,0.24413,0.24886,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,5.9834e-06,0.24412,0.25093,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.5994e-06,0.24395,0.28247,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.8363e-05,0.24349,0.23009,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,2.1624e-06,0.24339,0.30258,1,1
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.015674,0.24335,0.19084,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.0322e-07,0.24332,0.27132,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,2.2824e-05,0.2429,0.19684,1,1
1,GO REPLACEMENT OSSIFICATION,0.00026024,0.24287,0.28533,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0011668,0.24269,0.23037,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,4.6881e-08,0.24266,0.26314,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0022095,0.24257,0.19147,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.6129e-06,0.24257,0.22836,1,1
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.036048,0.24252,0.15415,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00042777,0.2425,0.29776,1,1
1,GO ACTIN FILAMENT SEVERING,0.0049019,0.24245,0.26441,1,1
1,GO REPLICATIVE SENESCENCE,0.018091,0.24235,0.16175,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.019523,0.242,0.22115,1,1
1,GO CYTOKINE PRODUCTION,6.7461e-07,0.24193,0.23605,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,1.8032e-05,0.24184,0.29005,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,4.7999e-05,0.24178,0.23374,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0022396,0.24175,0.21755,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.0756e-05,0.24144,0.24104,1,1
1,GO CERAMIDE TRANSPORT,1.8701e-05,0.2414,0.29687,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00061456,0.24101,0.26037,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00048316,0.24051,0.19833,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,6.7724e-05,0.23999,0.27385,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,8.8389e-07,0.23978,0.22126,1,1
1,GO CELLULAR RESPONSE TO VIRUS,2.1196e-06,0.23971,0.24665,1,1
1,GO COPPER ION HOMEOSTASIS,8.8389e-07,0.23968,0.29805,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00071283,0.23957,0.3265,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012527,0.23957,0.22205,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.206e-06,0.23945,0.31539,1,1
1,GO NUCLEAR PORE ORGANIZATION,1.5293e-05,0.23937,0.24447,1,1
1,GO RNA 5 END PROCESSING,5.1446e-05,0.23925,0.23412,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00020835,0.23916,0.21287,1,1
1,GO REGULATION OF WOUND HEALING,5.5127e-05,0.23914,0.243,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,5.4982e-08,0.23905,0.24789,1,1
1,GO PRIMARY MIRNA PROCESSING,5.5412e-06,0.23882,0.30187,1,1
1,GO ERK1 AND ERK2 CASCADE,1.5994e-06,0.23835,0.22301,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.00027284,0.23827,0.25046,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.6578e-06,0.23809,0.23384,1,1
1,GO VASCULATURE DEVELOPMENT,8.6579e-07,0.23795,0.26037,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.4371e-06,0.23784,0.21876,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00020835,0.23763,0.19268,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.5372e-07,0.23758,0.26346,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.4741e-05,0.23758,0.23722,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.4356e-06,0.23758,0.24057,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,4.2487e-05,0.23747,0.2631,1,1
1,GO LEUKOCYTE PROLIFERATION,7.2497e-05,0.23733,0.20122,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,2.1621e-05,0.23662,0.24939,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,8.4262e-06,0.23643,0.22335,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,4.3946e-06,0.23594,0.34121,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00052901,0.23586,0.23309,1,1
1,GO ERBB SIGNALING PATHWAY,7.3803e-06,0.23574,0.21137,1,1
1,GO COAGULATION,1.0756e-05,0.23554,0.21833,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.795e-06,0.23535,0.1936,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.0011341,0.23529,0.21308,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.2146e-06,0.23513,0.23408,1,1
1,GO ERYTHROCYTE DEVELOPMENT,0.00026438,0.23505,0.19011,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,1.0424e-06,0.23501,0.26321,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,8.5867e-06,0.23494,0.21967,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.0776e-06,0.2349,0.25797,1,1
1,GO RESPONSE TO RETINOIC ACID,7.3803e-06,0.23481,0.23571,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,6.4341e-05,0.23475,0.23216,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0001179,0.23457,0.20596,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0017517,0.23447,0.18357,1,1
1,GO STEROL TRANSPORT,3.628e-05,0.23447,0.21297,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.8793e-06,0.23438,0.25419,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00029976,0.23406,0.20615,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,9.404e-07,0.234,0.23411,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00064263,0.23399,0.22796,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.1588e-05,0.23374,0.29968,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0005056,0.23369,0.18968,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,8.8796e-05,0.23347,0.21457,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,3.0395e-05,0.23325,0.27586,1,1
1,GO RESPONSE TO BACTERIUM,1.9175e-06,0.23309,0.2215,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00045468,0.23278,0.25829,1,1
1,GO BILE ACID AND BILE SALT TRANSPORT,0.010041,0.23276,0.16134,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,8.8796e-05,0.23273,0.25732,1,1
1,GO ASTROCYTE DEVELOPMENT,5.9056e-05,0.23243,0.23756,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.0361e-05,0.23237,0.2322,1,1
1,GO MACROPHAGE DIFFERENTIATION,1.2954e-05,0.23218,0.26283,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.0429e-07,0.23206,0.26316,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,8.5858e-05,0.23202,0.2862,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0010865,0.23197,0.21842,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,2.913e-06,0.23179,0.20875,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.3948e-05,0.23178,0.27887,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.0060595,0.23173,0.18156,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.5867e-06,0.23173,0.22101,1,1
1,GO REGULATION OF CELL AGING,1.5052e-06,0.23161,0.20409,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.00022927,0.23132,0.20326,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.0364e-06,0.23125,0.30571,1,1
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.037139,0.23117,0.11855,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,5.332e-06,0.23084,0.26218,1,1
1,GO HISTONE H4 DEACETYLATION,0.00043435,0.23076,0.22034,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,5.5864e-07,0.2307,0.2708,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00019541,0.2305,0.20974,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,6.4592e-06,0.23041,0.2504,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00016361,0.23029,0.21438,1,1
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.00046872,0.23024,0.22796,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.00012186,0.22987,0.2627,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,3.3214e-05,0.22981,0.21594,1,1
1,GO COPPER ION TRANSPORT,1.3693e-05,0.22972,0.24284,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0023637,0.22964,0.19683,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.1789e-06,0.22933,0.29844,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.000662,0.22919,0.22349,1,1
1,GO RNA DECAPPING,1.2954e-05,0.22904,0.19371,1,1
1,GO LAMELLIPODIUM ASSEMBLY,1.7706e-05,0.22899,0.21724,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.001776,0.22899,0.16825,1,1
1,GO STEROID ESTERIFICATION,0.0050269,0.22885,0.18188,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.1165e-05,0.2287,0.1984,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.4334e-08,0.22855,0.25383,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.9694e-05,0.22851,0.24969,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00024819,0.22804,0.20697,1,1
1,GO AUTOPHAGY OF NUCLEUS,8.4262e-06,0.22798,0.23094,1,1
1,GO STRESS FIBER ASSEMBLY,7.105e-06,0.22789,0.25555,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.0035146,0.22788,0.20112,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.2792e-06,0.22787,0.23484,1,1
1,GO GLIAL CELL ACTIVATION,0.00012388,0.2275,0.21699,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.2397e-08,0.22739,0.25013,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,0.00014129,0.22701,0.18961,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0078263,0.22649,0.23699,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.5412e-06,0.22645,0.22942,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,3.7605e-06,0.22638,0.23379,1,1
1,GO RESPONSE TO TUMOR CELL,0.0022396,0.22623,0.22565,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.1806e-05,0.22605,0.2256,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.1375e-05,0.226,0.25088,1,1
1,GO GLAND MORPHOGENESIS,2.5884e-05,0.22597,0.30936,1,1
1,GO TISSUE MIGRATION,4.0657e-06,0.22593,0.26782,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,8.1623e-05,0.22591,0.18492,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.010895,0.22591,0.18289,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,6.2175e-05,0.22579,0.22988,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,5.8049e-05,0.22561,0.19482,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.5994e-06,0.22559,0.2344,1,1
1,GO TONGUE MORPHOGENESIS,0.01995,0.22549,0.19201,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.8911e-05,0.22543,0.18902,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,8.9166e-06,0.22538,0.21998,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.2027e-05,0.22533,0.20154,1,1
1,GO SYNCYTIUM FORMATION,1.064e-06,0.22526,0.29907,1,1
1,GO GTP METABOLIC PROCESS,1.1316e-06,0.22518,0.27265,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0048405,0.22507,0.19433,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,1.4472e-05,0.22505,0.23515,1,1
1,GO FOAM CELL DIFFERENTIATION,0.000286,0.22484,0.23608,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00054518,0.22474,0.23314,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00042777,0.22465,0.22707,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.00029052,0.22448,0.23554,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,7.6657e-06,0.2244,0.2249,1,1
1,GO SYMBIOTIC PROCESS,5.7923e-10,0.22435,0.22139,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,6.5837e-06,0.22429,0.32116,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0429e-07,0.22422,0.2065,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.2146e-06,0.22385,0.27304,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0011668,0.2237,0.22534,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,7.3739e-05,0.22353,0.17355,1,1
1,GO INTERFERON GAMMA PRODUCTION,4.3236e-05,0.22342,0.2166,1,1
1,GO MESODERM MORPHOGENESIS,9.2118e-07,0.22341,0.23881,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00032916,0.22338,0.29634,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.3174e-07,0.2233,0.24521,1,1
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00017176,0.22312,0.2128,1,1
1,GO MULTI ORGANISM LOCALIZATION,9.2321e-08,0.22304,0.22955,1,1
1,GO RRNA METHYLATION,5.0563e-05,0.22296,0.20984,1,1
1,GO FATTY ACID BETA OXIDATION,1.1375e-05,0.22292,0.19556,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.004156,0.22278,0.23408,1,1
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0040509,0.22271,0.18174,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,1.0004e-06,0.22264,0.26329,1,1
1,GO SELECTIVE AUTOPHAGY,7.1726e-09,0.22243,0.24244,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,4.6359e-05,0.22226,0.27742,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,8.0256e-05,0.22197,0.22173,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,2.0478e-05,0.22188,0.19128,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.7909e-10,0.22185,0.24243,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,5.3256e-05,0.22164,0.21394,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00042777,0.22147,0.17899,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0070192,0.22102,0.19526,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.3249e-05,0.22082,0.16991,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.4207e-05,0.22057,0.23816,1,1
1,GO REGULATION OF CELL SHAPE,6.3249e-05,0.22056,0.2161,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0016806,0.22043,0.1942,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00065224,0.22036,0.24658,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,1.6994e-06,0.22005,0.2512,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,2.2416e-05,0.21988,0.23965,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,3.6162e-06,0.21952,0.24735,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.6914e-06,0.21931,0.23418,1,1
1,GO PROTEIN HYDROXYLATION,0.0014624,0.21929,0.2502,1,1
1,GO PROTEIN TARGETING TO VACUOLE,7.0072e-05,0.21925,0.19844,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,0.00022565,0.21919,0.2482,1,1
1,GO ENDOTHELIAL CELL MIGRATION,5.6487e-06,0.2185,0.27569,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,1.9175e-06,0.21845,0.2355,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.024947,0.21812,0.15863,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00015083,0.21797,0.25289,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,4.2487e-05,0.21797,0.26421,1,1
1,GO RESPONSE TO WOUNDING,1.2027e-05,0.21791,0.21656,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.0853e-05,0.21777,0.18322,1,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.003654,0.21772,0.17354,1,1
1,GO CHONDROCYTE DIFFERENTIATION,2.4091e-05,0.21744,0.24789,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00044103,0.21741,0.21909,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00063314,0.21736,0.20325,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.8416e-06,0.21729,0.25098,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0005618,0.21715,0.20327,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,2.6914e-06,0.21712,0.23043,1,1
1,GO HISTONE H2B UBIQUITINATION,9.3381e-05,0.21708,0.18685,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0027747,0.21694,0.19886,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.6162e-06,0.21689,0.22198,1,1
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0030839,0.21681,0.19158,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.0853e-05,0.21668,0.21187,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,2.206e-06,0.21661,0.20628,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00052901,0.21658,0.21144,1,1
1,GO REGULATION OF IMMUNE RESPONSE,2.6386e-06,0.21655,0.20861,1,1
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.057179,0.21655,0.15774,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.7452e-06,0.2163,0.17793,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.5865e-05,0.21624,0.20235,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,2.0853e-05,0.21621,0.21352,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.014658,0.21611,0.1608,1,1
1,GO RESPONSE TO INTERLEUKIN 7,9.03e-05,0.21602,0.20166,1,1
1,GO NCRNA METABOLIC PROCESS,1.6761e-05,0.21597,0.1879,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,1.1794e-07,0.21585,0.23221,1,1
1,GO SNRNA PROCESSING,0.00022565,0.2158,0.29614,1,1
1,GO BARBED END ACTIN FILAMENT CAPPING,0.0028492,0.21579,0.24185,1,1
1,GO ERYTHROCYTE MATURATION,0.0019819,0.21576,0.23519,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.001118,0.21565,0.21192,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0002443,0.21565,0.24232,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,2.5884e-05,0.21549,0.27305,1,1
1,GO BLASTODERM SEGMENTATION,0.027118,0.21544,0.17631,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00091404,0.21533,0.21282,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.6352e-05,0.21528,0.17957,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,5.9834e-06,0.21507,0.30575,1,1
1,GO ASTROCYTE ACTIVATION,0.00029511,0.21507,0.18939,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.7488e-06,0.21473,0.25362,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,2.8305e-05,0.2147,0.23895,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.064e-06,0.21466,0.23994,1,1
1,GO SECRETION BY TISSUE,0.0018508,0.21457,0.18597,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,1.7071e-05,0.21457,0.25158,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,5.0563e-05,0.21455,0.23007,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00073415,0.21423,0.20061,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00026858,0.21402,0.23503,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,1.3878e-06,0.21397,0.21038,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00023667,0.21353,0.19735,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.2416e-05,0.21332,0.1967,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00042128,0.21325,0.19604,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,2.4972e-05,0.21304,0.22916,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0013443,0.213,0.30268,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00010852,0.2125,0.18117,1,1
1,GO ERAD PATHWAY,1.2792e-06,0.21243,0.19707,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,1.536e-06,0.21234,0.24085,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,8.2686e-06,0.21207,0.22548,1,1
1,GO REGULATION OF CELL CELL ADHESION,0.00045468,0.21204,0.17727,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,4.1456e-06,0.21192,0.21185,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,4.0314e-05,0.21173,0.2654,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00054518,0.21164,0.24166,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00015331,0.21161,0.23687,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00020504,0.21134,0.28859,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00015331,0.21133,0.21176,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00012594,0.21096,0.24798,1,1
1,GO OSTEOCLAST DIFFERENTIATION,1.3693e-05,0.2109,0.20295,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.9136e-07,0.21088,0.22823,1,1
1,GO REGULATION OF MRNA BINDING,4.1026e-05,0.2108,0.23888,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00019541,0.21076,0.16226,1,1
1,GO TOOTH MINERALIZATION,0.0030436,0.21067,0.23655,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00029052,0.21061,0.20607,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00010852,0.21035,0.19773,1,1
1,GO DEFENSE RESPONSE,9.795e-06,0.21025,0.19567,1,1
1,GO AUTOPHAGOSOME MATURATION,1.7922e-07,0.21016,0.22437,1,1
1,GO ANIMAL ORGAN REGENERATION,8.6579e-07,0.2101,0.24392,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.00054518,0.20996,0.21185,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0042095,0.20984,0.19517,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00059648,0.20977,0.21401,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,2.856e-06,0.20972,0.23911,1,1
1,GO REGULATION OF HEMOPOIESIS,7.969e-07,0.20947,0.212,1,1
1,GO RIBOSOME BIOGENESIS,1.9044e-05,0.20934,0.22581,1,1
1,GO NEURAL TUBE PATTERNING,0.00070238,0.20931,0.19964,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.971e-06,0.20927,0.1876,1,1
1,GO TRANSLATIONAL INITIATION,0.000286,0.20908,0.19398,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,7.2129e-08,0.20908,0.20375,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,2.9859e-05,0.20894,0.21045,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,2.0853e-05,0.2089,0.20207,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,4.9228e-07,0.20881,0.20293,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00024819,0.2088,0.21674,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,5.1446e-05,0.20867,0.22075,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6761e-05,0.20865,0.23131,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,5.9834e-06,0.20863,0.18362,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,1.8363e-05,0.20854,0.30327,1,1
1,GO PLACENTA DEVELOPMENT,0.00030928,0.20845,0.16843,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00046165,0.20841,0.1895,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,8.2686e-06,0.2083,0.23421,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.9859e-05,0.20791,0.20846,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0030038,0.20787,0.18544,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0061347,0.20783,0.14051,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,9.03e-05,0.20783,0.19854,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,0.00022927,0.20768,0.19228,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.000286,0.20751,0.20018,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,2.1234e-05,0.20747,0.24147,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.7999e-05,0.20734,0.20623,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,3.5038e-07,0.20727,0.22914,1,1
1,GO LIPID OXIDATION,2.2416e-05,0.20686,0.18324,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,7.9617e-06,0.20677,0.20607,1,1
1,GO L SERINE METABOLIC PROCESS,0.058787,0.20658,0.112,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.3239e-05,0.20631,0.22954,1,1
1,GO TOXIN TRANSPORT,6.4341e-05,0.20594,0.18356,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00013016,0.20588,0.2003,1,1
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00037835,0.20585,0.22801,1,1
1,GO RRNA METABOLIC PROCESS,3.2631e-05,0.20585,0.21271,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0038478,0.20585,0.15059,1,1
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,6.8888e-05,0.20585,0.21706,1,1
1,GO CELLULAR RESPONSE TO LIPID,1.2482e-05,0.20579,0.17897,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.1196e-06,0.20579,0.23549,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00025215,0.20525,0.23592,1,1
1,GO REGULATION OF CELL ADHESION,0.00015838,0.20524,0.19345,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0050269,0.20521,0.24207,1,1
1,GO HISTONE H3 K4 TRIMETHYLATION,0.01128,0.205,0.1647,1,1
1,GO REGENERATION,1.475e-06,0.20487,0.20411,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.0323e-06,0.20476,0.19566,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0056255,0.20475,0.15785,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.031631,0.20461,0.13559,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,4.7488e-06,0.20439,0.21227,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.4771e-05,0.2043,0.30602,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0020929,0.20423,0.19169,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00099681,0.2042,0.21377,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.8396e-06,0.20413,0.22661,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.6994e-06,0.20412,0.19518,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.033608,0.20412,0.20112,1,1
1,GO CYTOPLASMIC TRANSLATION,0.0030436,0.20391,0.17065,1,1
1,GO PLATELET ACTIVATION,0.00053704,0.20386,0.19088,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0025617,0.20384,0.19702,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.3878e-06,0.20377,0.22206,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0081133,0.20363,0.22129,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,3.0156e-07,0.20339,0.19534,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,6.7724e-05,0.20332,0.17951,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0023321,0.20319,0.23203,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,3.628e-05,0.2026,0.1932,1,1
1,GO RESPONSE TO CORTICOSTEROID,4.8839e-05,0.20254,0.19422,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0002117,0.2025,0.21271,1,1
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.03902,0.20245,0.12202,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00027284,0.20228,0.1881,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00020178,0.20206,0.21056,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,5.02e-08,0.2019,0.20179,1,1
1,GO PEPTIDE CATABOLIC PROCESS,1.9563e-06,0.20181,0.25868,1,1
1,GO RESPONSE TO GAMMA RADIATION,3.9102e-06,0.20178,0.22379,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.2954e-05,0.20153,0.21668,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0050269,0.2015,0.30302,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.0010113,0.20145,0.18735,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,1.0756e-05,0.20115,0.28729,1,1
1,GO LIPID STORAGE,2.5424e-05,0.2008,0.20105,1,1
1,GO CELL CELL RECOGNITION,1.7721e-08,0.20073,0.21122,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00061456,0.20046,0.27248,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.003607,0.20033,0.21423,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.00027716,0.19999,0.22593,1,1
1,GO REGULATION OF GENE SILENCING,7.4873e-07,0.19993,0.18508,1,1
1,GO MANGANESE ION TRANSPORT,0.00041488,0.19982,0.18373,1,1
1,GO MALE GENITALIA DEVELOPMENT,0.023668,0.19975,0.15698,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0032078,0.19938,0.18444,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,0.00094089,0.19934,0.20747,1,1
1,GO RECEPTOR RECYCLING,0.00017457,0.19932,0.16857,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,3.6877e-06,0.19927,0.19466,1,1
1,GO IRON ION HOMEOSTASIS,9.404e-07,0.19925,0.21417,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,4.7488e-06,0.19922,0.22552,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,1.5293e-05,0.19889,0.18265,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,4.1026e-05,0.19808,0.21792,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,1.1086e-06,0.198,0.20073,1,1
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0011341,0.19772,0.16504,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,9.404e-07,0.1976,0.2091,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.007921,0.19742,0.17352,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,9.6538e-08,0.1973,0.22847,1,1
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.024173,0.19723,0.22605,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0056255,0.1969,0.18843,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.3803e-06,0.19673,0.20293,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00033955,0.19624,0.1864,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00010152,0.1959,0.23197,1,1
1,GO TRNA MODIFICATION,0.00033955,0.19547,0.16327,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.00094089,0.19537,0.26126,1,1
1,GO GLYCINE METABOLIC PROCESS,0.017506,0.19533,0.14564,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0018508,0.19528,0.21582,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.0424e-06,0.19515,0.24086,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,8.4424e-05,0.1951,0.25219,1,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0025277,0.19498,0.16576,1,1
1,GO RESPONSE TO VITAMIN A,0.0022396,0.19482,0.1669,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0043184,0.19476,0.13359,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00027284,0.1947,0.21949,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,9.795e-06,0.19467,0.23845,1,1
1,GO DNA LIGATION,0.0002117,0.19464,0.19099,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00043435,0.19461,0.22836,1,1
1,GO MUSCLE CELL PROLIFERATION,1.6321e-06,0.1945,0.2445,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.155e-06,0.19445,0.19181,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.001235,0.19426,0.1671,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,9.086e-06,0.19426,0.1945,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0030436,0.19413,0.19834,1,1
1,GO REGULATION OF CELL ACTIVATION,1.4472e-05,0.19409,0.19867,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,1.2716e-05,0.19397,0.23209,1,1
1,GO TRNA CATABOLIC PROCESS,0.026561,0.19384,0.20644,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00044781,0.1938,0.28151,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,9.4959e-05,0.19374,0.22106,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0054192,0.1935,0.30167,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00037835,0.19345,0.24384,1,1
1,GO RNA METHYLATION,3.5022e-05,0.19327,0.18766,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,9.086e-06,0.19326,0.19719,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0005789,0.193,0.16548,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,2.4528e-05,0.1924,0.18238,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00083767,0.19227,0.19505,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.001235,0.19216,0.21058,1,1
1,GO TUMOR NECROSIS FACTOR SECRETION,0.00090088,0.19196,0.16275,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00032408,0.19177,0.19989,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00012594,0.19175,0.22535,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0054192,0.19158,0.14823,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0022095,0.19144,0.198,1,1
1,GO B CELL HOMEOSTASIS,0.027401,0.19141,0.13915,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00071283,0.1913,0.17868,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00071283,0.19075,0.1966,1,1
1,GO REGULATION OF T CELL MIGRATION,0.00092737,0.19075,0.1855,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.9056e-05,0.19017,0.1972,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,1.7071e-05,0.18951,0.18072,1,1
1,GO RNA DESTABILIZATION,5.4184e-05,0.18943,0.19898,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,2.2958e-06,0.18936,0.20722,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.0657e-06,0.18926,0.23903,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,9.9844e-05,0.18924,0.17073,1,1
1,GO NUCLEOSIDE SALVAGE,0.0068504,0.18906,0.17368,1,1
1,GO MYELOID CELL HOMEOSTASIS,1.996e-06,0.18897,0.203,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,8.1623e-05,0.18886,0.24157,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,2.4528e-05,0.18885,0.1526,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.734e-06,0.18878,0.17478,1,1
1,GO REGULATION OF DEFENSE RESPONSE,1.1375e-05,0.18854,0.18604,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0044298,0.18816,0.14725,1,1
1,GO COPII COATED VESICLE CARGO LOADING,8.5867e-06,0.18813,0.21018,1,1
1,GO RESPONSE TO ANTIBIOTIC,1.2253e-05,0.18788,0.19062,1,1
1,GO LEUKOCYTE DIFFERENTIATION,3.628e-05,0.18781,0.18548,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00054518,0.18763,0.23117,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,4.3946e-06,0.1876,0.23081,1,1
1,GO CELL ACTIVATION,3.3435e-06,0.1876,0.20043,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010152,0.18758,0.16526,1,1
1,GO PROTEIN KINASE B SIGNALING,5.6085e-05,0.18749,0.17523,1,1
1,GO HISTONE PHOSPHORYLATION,0.00013451,0.18734,0.16093,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,1.6654e-06,0.1872,0.2126,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,3.8924e-05,0.18713,0.25363,1,1
1,GO PROTEIN KINASE A SIGNALING,9.4959e-05,0.18692,0.17192,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,6.4592e-06,0.18658,0.1852,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00035024,0.18657,0.18044,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,8.3066e-07,0.18651,0.19021,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,2.2416e-05,0.18638,0.23135,1,1
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0042095,0.18624,0.1695,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00064263,0.18617,0.18751,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.013243,0.18607,0.2179,1,1
1,GO PLASMA MEMBRANE TUBULATION,8.0256e-05,0.18606,0.22449,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00010323,0.18584,0.17716,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.001568,0.18581,0.17826,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,7.8911e-05,0.18542,0.15138,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021505,0.18542,0.22858,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0011668,0.18539,0.17561,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,1.2027e-05,0.1853,0.1965,1,1
1,GO TRNA 5 END PROCESSING,0.00032916,0.18483,0.19525,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,2.5884e-05,0.18478,0.21652,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00098255,0.18466,0.13224,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0011341,0.18462,0.30242,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,3.9613e-05,0.18459,0.19546,1,1
1,GO CYTOKINETIC PROCESS,8.1138e-06,0.18421,0.21053,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0050904,0.18415,0.144,1,1
1,GO RNA INTERFERENCE,0.014823,0.18411,0.11606,1,1
1,GO NCRNA 3 END PROCESSING,0.00019541,0.18405,0.22222,1,1
1,GO RRNA TRANSCRIPTION,0.00017457,0.18378,0.18861,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0017277,0.18376,0.24339,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00016901,0.1837,0.1974,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,1.9749e-05,0.18349,0.17189,1,1
1,GO LYMPHOCYTE ACTIVATION,8.9166e-06,0.18335,0.19392,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.9613e-05,0.18332,0.18768,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,7.1274e-05,0.18316,0.18874,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0011021,0.18313,0.19227,1,1
1,GO REGULATION OF PROTEOLYSIS,4.4807e-06,0.18304,0.17136,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0072795,0.18302,0.16968,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00098255,0.18267,0.20813,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0094686,0.18266,0.18885,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,3.4296e-07,0.18244,0.18084,1,1
1,GO RESPONSE TO UV C,0.00037257,0.18225,0.24394,1,1
1,GO RNA MODIFICATION,1.9393e-05,0.18224,0.17978,1,1
1,GO LYMPHOCYTE MIGRATION,1.7071e-05,0.18224,0.21074,1,1
1,GO REGULATION OF HEART GROWTH,0.00022565,0.18215,0.18762,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,6.7461e-07,0.18209,0.18362,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.8723e-07,0.18187,0.19112,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00039622,0.18182,0.16785,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0094686,0.18161,0.15019,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0025277,0.18128,0.19335,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.4454e-06,0.18105,0.25445,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.2859e-07,0.18103,0.22856,1,1
1,GO BONE DEVELOPMENT,2.4091e-05,0.18069,0.22902,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0011021,0.18067,0.20832,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,5.1304e-06,0.1806,0.20718,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00011033,0.18059,0.21796,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.00046165,0.18051,0.21993,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.6158e-05,0.18046,0.15244,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0015249,0.18037,0.18561,1,1
1,GO CARTILAGE DEVELOPMENT,5.8049e-05,0.18031,0.21951,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,2.2416e-05,0.1801,0.21918,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,4.6202e-07,0.1801,0.17013,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00044103,0.17993,0.18192,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00073415,0.17993,0.17728,1,1
1,GO PLASMA MEMBRANE FUSION,0.020828,0.17987,0.18348,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,2.0853e-05,0.17936,0.17363,1,1
1,GO RESPONSE TO ISCHEMIA,0.000286,0.17909,0.17382,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.001118,0.17893,0.18281,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,1.3442e-05,0.17891,0.18665,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0020929,0.17871,0.16598,1,1
1,GO RESPONSE TO TESTOSTERONE,1.7071e-05,0.17854,0.2144,1,1
1,GO REGULATION OF TELOMERASE ACTIVITY,0.001704,0.17837,0.14677,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,9.3381e-05,0.17831,0.21231,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00067188,0.17827,0.1914,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0068504,0.1782,0.20632,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.0051547,0.178,0.086591,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.0478e-05,0.178,0.14124,1,1
1,GO ODONTOGENESIS,0.0023321,0.1779,0.19143,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.000286,0.17765,0.17026,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00028155,0.17755,0.18802,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,5.0323e-06,0.17751,0.21063,1,1
1,GO TONGUE DEVELOPMENT,0.0069343,0.177,0.18848,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.00040235,0.17674,0.19787,1,1
1,GO ETHER METABOLIC PROCESS,0.00023294,0.17668,0.2339,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00015083,0.17644,0.23257,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00031907,0.17631,0.1539,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00046165,0.17628,0.24329,1,1
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.011678,0.17619,0.2338,1,1
1,GO VIRION ASSEMBLY,4.5558e-05,0.17611,0.14678,1,1
1,GO NCRNA CATABOLIC PROCESS,0.004156,0.17606,0.14144,1,1
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0090315,0.17592,0.22331,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.8814e-05,0.17581,0.18475,1,1
1,GO REGULATION OF CELL FATE COMMITMENT,0.017125,0.17567,0.18188,1,1
1,GO TRNA METABOLIC PROCESS,0.00024045,0.17564,0.14492,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0047798,0.17533,0.16449,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00033432,0.17512,0.25166,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00076726,0.17487,0.1983,1,1
1,GO LIPID IMPORT INTO CELL,0.0044864,0.17481,0.16252,1,1
1,GO GLIAL CELL MIGRATION,0.010041,0.17464,0.15085,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.0019023,0.17424,0.19102,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00071283,0.17399,0.19966,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0065235,0.17398,0.17793,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,7.3739e-05,0.17357,0.17007,1,1
1,GO MYELOID CELL DIFFERENTIATION,3.4773e-06,0.17338,0.19457,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.041383,0.17338,0.14358,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00075607,0.1733,0.21022,1,1
1,GO DECIDUALIZATION,0.0053519,0.17316,0.20965,1,1
1,GO VIRAL RELEASE FROM HOST CELL,2.0776e-06,0.17302,0.20019,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00033432,0.17282,0.22512,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0057669,0.17255,0.20926,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00159,0.17234,0.1749,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0050269,0.17229,0.12873,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.001776,0.17218,0.29458,1,1
1,GO RNA CATABOLIC PROCESS,2.8886e-07,0.17216,0.17522,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,7.7586e-05,0.1721,0.19618,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0037016,0.17198,0.18797,1,1
1,GO MYELOID CELL DEVELOPMENT,0.0038977,0.17195,0.15407,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.3948e-05,0.17184,0.18844,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.6877e-06,0.17159,0.20574,1,1
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0072795,0.17156,0.17686,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00012388,0.17147,0.17409,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.3435e-06,0.17141,0.20089,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,3.3214e-05,0.17131,0.18936,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.0557e-05,0.17119,0.21474,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,6.8888e-05,0.17115,0.17518,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,6.1119e-05,0.17114,0.16248,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.00021511,0.17113,0.15473,1,1
1,GO MITOTIC RECOMBINATION,0.011151,0.17108,0.13472,1,1
1,GO AMELOGENESIS,0.018091,0.17078,0.18666,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00016361,0.17076,0.14733,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.037509,0.17054,0.10188,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00084997,0.17038,0.152,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.2416e-05,0.17027,0.16572,1,1
1,GO NEURAL TUBE FORMATION,0.00045468,0.16976,0.17992,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0071918,0.16974,0.15503,1,1
1,GO MESODERM DEVELOPMENT,1.3693e-05,0.16957,0.1727,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,6.545e-05,0.1693,0.15845,1,1
1,GO SNRNA METABOLIC PROCESS,0.00021511,0.16899,0.23393,1,1
1,GO TRACHEA MORPHOGENESIS,0.0013443,0.16894,0.21406,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0035146,0.16875,0.18882,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.017894,0.16868,0.17697,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00026024,0.16839,0.17164,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00021511,0.16831,0.17051,1,1
1,GO ACTIVATED T CELL PROLIFERATION,0.0088198,0.16822,0.14573,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.00081356,0.1681,0.20718,1,1
1,GO ACUTE PHASE RESPONSE,0.013856,0.16775,0.13505,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0018006,0.16758,0.20214,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.00012804,0.16753,0.16389,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0068504,0.16752,0.19246,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,3.7605e-06,0.16751,0.1901,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.001118,0.16744,0.18078,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00082553,0.16733,0.21864,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.00053704,0.16721,0.14878,1,1
1,GO RESPONSE TO CHEMOKINE,6.7724e-05,0.16718,0.17583,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.0015463,0.16713,0.13279,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,2.6914e-06,0.16712,0.1572,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00036124,0.16703,0.17855,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.00026024,0.16692,0.22495,1,1
1,GO FACE DEVELOPMENT,0.00031907,0.16682,0.2304,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0031247,0.16666,0.16995,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.010645,0.16659,0.19316,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0014022,0.16649,0.14808,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0022701,0.16639,0.21389,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.00025617,0.16621,0.18039,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00017176,0.16617,0.14255,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.00017176,0.16599,0.18931,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.033271,0.16589,0.11575,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0010113,0.16586,0.15928,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.6994e-06,0.16584,0.19498,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,1.5576e-05,0.16569,0.15422,1,1
1,GO RESPONSE TO UV B,0.040187,0.16565,0.17398,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.00040235,0.16562,0.15593,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.00034485,0.1656,0.12664,1,1
1,GO AMINO ACID ACTIVATION,0.0024609,0.16547,0.15055,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,1.3442e-05,0.16508,0.18051,1,1
1,GO CELL AGING,4.0657e-06,0.16481,0.1712,1,1
1,GO REGULATION OF RNA BINDING,5.9056e-05,0.16479,0.18173,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.9749e-05,0.16473,0.20445,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00090088,0.16469,0.17659,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0037016,0.16468,0.14422,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00045468,0.16447,0.20825,1,1
1,GO REGULATION OF LIPID STORAGE,4.3997e-05,0.16445,0.19932,1,1
1,GO GENITALIA DEVELOPMENT,0.0010865,0.16437,0.15579,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00052901,0.16432,0.15564,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00020178,0.1643,0.20464,1,1
1,GO MRNA TRANSCRIPTION,5.6487e-06,0.16426,0.26372,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,7.5001e-05,0.16406,0.1588,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00055343,0.16367,0.18637,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,2.9332e-05,0.16358,0.19068,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.00013673,0.16349,0.15868,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00032408,0.16345,0.19764,1,1
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.028556,0.16345,0.1619,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.0012177,0.16335,0.14983,1,1
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.023919,0.16325,0.20206,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.010645,0.16294,0.11622,1,1
1,GO TUBE MORPHOGENESIS,3.6924e-05,0.16287,0.20079,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,2.9859e-05,0.16268,0.18317,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.00048316,0.16265,0.18323,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,6.2175e-05,0.16263,0.15829,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00059648,0.1626,0.17579,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,7.105e-06,0.16251,0.17435,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,5.4184e-05,0.16218,0.16302,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00029052,0.16203,0.18365,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0028118,0.16194,0.16902,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,7.3803e-06,0.16193,0.17083,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00042128,0.16164,0.18422,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00063314,0.16159,0.15629,1,1
1,GO VESICLE TARGETING,9.6562e-05,0.16143,0.1546,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00036686,0.1614,0.11391,1,1
1,GO RESPONSE TO PROGESTERONE,0.0061347,0.16139,0.17037,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4472e-05,0.16133,0.19862,1,1
1,GO REGULATION OF LIPID KINASE ACTIVITY,0.00060545,0.16115,0.17104,1,1
1,GO REGULATION OF ORGAN GROWTH,1.6994e-06,0.16113,0.22366,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,3.628e-05,0.16106,0.14855,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.024173,0.16076,0.16833,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.018091,0.16059,0.14893,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.0072795,0.16037,0.12118,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00036686,0.16015,0.15776,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0010113,0.16005,0.098366,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0084096,0.15997,0.1665,1,1
1,GO LIPID MODIFICATION,0.00047589,0.15995,0.12967,1,1
1,GO MITOTIC CYTOKINESIS,0.00036686,0.1599,0.14456,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00039018,0.1596,0.18229,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1.8419e-06,0.15954,0.15779,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.017506,0.15949,0.30944,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00017457,0.15946,0.16644,1,1
1,GO RESPONSE TO OSMOTIC STRESS,7.0072e-05,0.1594,0.16504,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0037985,0.15931,0.1509,1,1
1,GO TRANSCYTOSIS,0.0068504,0.15928,0.14989,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,8.7502e-06,0.15914,0.16803,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,7.8124e-06,0.1584,0.19219,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,4.3236e-05,0.15839,0.12264,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,4.8839e-05,0.15804,0.13891,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0015463,0.15796,0.1523,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0047798,0.15795,0.16079,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0013826,0.15793,0.14721,1,1
1,GO NEPHRON DEVELOPMENT,0.0071051,0.15788,0.16812,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,5.9834e-06,0.15785,0.16935,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00025215,0.1578,0.22049,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.045155,0.1577,0.11154,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,6.8885e-07,0.15766,0.17238,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,7.0522e-08,0.15743,0.1576,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.0005618,0.15739,0.17016,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0034692,0.15718,0.13298,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.9228e-07,0.15717,0.16013,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00053704,0.15711,0.15364,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0095807,0.15701,0.11707,1,1
1,GO RNA LOCALIZATION,4.9694e-05,0.15692,0.15549,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0033799,0.15657,0.16101,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,5.9056e-05,0.15645,0.1719,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0065235,0.15624,0.13028,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.019104,0.15612,0.12383,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0056255,0.15585,0.12678,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00039622,0.15564,0.17985,1,1
1,GO RESPONSE TO LIPID,0.00023294,0.1553,0.14673,1,1
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0042095,0.15508,0.15279,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00054518,0.15497,0.16117,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,7.6283e-05,0.15485,0.17644,1,1
1,GO NADP METABOLIC PROCESS,0.0026663,0.15468,0.16253,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,3.3214e-05,0.15455,0.16525,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00049053,0.15444,0.15467,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00022208,0.1544,0.13924,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,8.1623e-05,0.15411,0.16511,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.0169e-05,0.15406,0.16877,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,1.2716e-05,0.15404,0.15487,1,1
1,GO SPERM EGG RECOGNITION,8.5858e-05,0.154,0.14323,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.001568,0.15391,0.11513,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,0.00013899,0.15381,0.17706,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.0021798,0.15374,0.16934,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.0007786,0.15352,0.1246,1,1
1,GO LEFT RIGHT PATTERN FORMATION,0.0038478,0.15345,0.19214,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0005133,0.15337,0.16691,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00012594,0.15336,0.19556,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,8.0256e-05,0.15302,0.17148,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.026838,0.153,0.16626,1,1
1,GO B CELL DIFFERENTIATION,0.0017277,0.15296,0.16086,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,9.9803e-06,0.15272,0.16298,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.3739e-05,0.15263,0.13596,1,1
1,GO TRNA TRANSPORT,0.00061456,0.15257,0.14308,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0020929,0.15243,0.17963,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,3.4409e-05,0.15237,0.1773,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0051547,0.15236,0.145,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.048746,0.15181,0.12461,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.024173,0.15176,0.11015,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0045438,0.15171,0.13452,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.00054518,0.15166,0.13196,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.010522,0.15165,0.13906,1,1
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0037016,0.15152,0.13572,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,6.7724e-05,0.15152,0.19108,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,7.8124e-06,0.15144,0.23026,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00081356,0.1514,0.13573,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.017894,0.15135,0.19537,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,1.0361e-05,0.15109,0.14618,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.00041488,0.15094,0.13111,1,1
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.0069343,0.15093,0.17055,1,1
1,GO PROTEIN PROCESSING,0.00012186,0.15078,0.15782,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0070192,0.15074,0.18328,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,3.3214e-05,0.15064,0.2027,1,1
1,GO DRUG METABOLIC PROCESS,0.0085105,0.15054,0.13741,1,1
1,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0038977,0.15035,0.1136,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00010323,0.15023,0.16915,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00041488,0.1502,0.16282,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.003607,0.15014,0.15576,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.001442,0.15009,0.13077,1,1
1,GO STEM CELL DIFFERENTIATION,1.9044e-05,0.15,0.17004,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0056958,0.14999,0.13582,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.002631,0.14992,0.14565,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00063314,0.14967,0.16826,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.010041,0.14921,0.11475,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00027284,0.14891,0.1314,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,9.6562e-05,0.14889,0.15159,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0025617,0.14875,0.1041,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00019857,0.14868,0.15108,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0039481,0.14846,0.12248,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.038258,0.14841,0.13746,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.00013016,0.14825,0.13859,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,7.1274e-05,0.14823,0.1692,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00094089,0.14823,0.19591,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0022095,0.14818,0.10569,1,1
1,GO RNA SURVEILLANCE,0.0029256,0.14793,0.13471,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,2.9332e-05,0.14786,0.15795,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,2.6914e-06,0.1478,0.16869,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,4.2487e-05,0.14771,0.16536,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.001955,0.14766,0.19517,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00047589,0.14748,0.18504,1,1
1,GO HISTONE DEACETYLATION,0.00055343,0.14725,0.12317,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.013546,0.1472,0.17686,1,1
1,GO MAINTENANCE OF CELL NUMBER,0.0031247,0.14683,0.15473,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0052854,0.14679,0.21648,1,1
1,GO TISSUE MORPHOGENESIS,0.00025617,0.14679,0.15248,1,1
1,GO REGULATION OF URINE VOLUME,3.1494e-05,0.14664,0.21377,1,1
1,GO MRNA TRANSPORT,3.094e-05,0.14645,0.15149,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,7.7586e-05,0.14642,0.13986,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0021505,0.14624,0.17522,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00098255,0.14609,0.12911,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0088198,0.14602,0.15653,1,1
1,GO MIRNA METABOLIC PROCESS,0.0017277,0.14592,0.14937,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.010522,0.14571,0.13219,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0041031,0.14566,0.14919,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.017506,0.1456,0.14629,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.009139,0.14558,0.12455,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0027747,0.14554,0.17311,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00054518,0.14543,0.13874,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0025277,0.14535,0.12965,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.014494,0.14534,0.12445,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,9.404e-07,0.14509,0.17366,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00031907,0.14505,0.15006,1,1
1,GO PIGMENT CELL DIFFERENTIATION,0.022686,0.14495,0.11934,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.8698e-06,0.14489,0.14323,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00081356,0.14485,0.18807,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0011836,0.14475,0.14649,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00075607,0.14437,0.13613,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0018256,0.14432,0.18427,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.001955,0.14404,0.11916,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.3381e-05,0.14401,0.14322,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,1.1375e-05,0.14396,0.15607,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00032408,0.14385,0.1506,1,1
1,GO OSTEOBLAST DIFFERENTIATION,3.6924e-05,0.14382,0.21442,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0005618,0.14374,0.13657,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0076401,0.14356,0.19251,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.00058763,0.14352,0.13228,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0062877,0.14351,0.15581,1,1
1,GO RESPONSE TO UV,0.00011406,0.14344,0.15108,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,8.3013e-05,0.14336,0.18179,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.8053e-06,0.14331,0.17936,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00036124,0.14318,0.13655,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00044103,0.14309,0.16505,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.012653,0.14308,0.18266,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00030449,0.14305,0.18235,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,4.3946e-06,0.14271,0.14531,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0022396,0.14262,0.12674,1,1
1,GO PROTEIN SUMOYLATION,0.0007786,0.14254,0.11739,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.0077327,0.1424,0.11978,1,1
1,GO BLASTOCYST FORMATION,4.7172e-05,0.14225,0.15766,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.5037e-07,0.14223,0.1434,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.7724e-05,0.14218,0.16692,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,5.0323e-06,0.14217,0.13586,1,1
1,GO PEPTIDE METABOLIC PROCESS,6.0759e-07,0.14212,0.14885,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0018256,0.14211,0.16546,1,1
1,GO NUCLEAR EXPORT,1.2253e-05,0.14206,0.14987,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,2.2824e-05,0.14174,0.19425,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00083767,0.14171,0.10888,1,1
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.045155,0.14166,0.07878,1,1
1,GO PROTEIN IMPORT,1.5576e-05,0.14111,0.14717,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0010865,0.1411,0.15508,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.038637,0.14102,0.15856,1,1
1,GO KERATINOCYTE DIFFERENTIATION,0.054582,0.14101,0.15233,1,1
1,GO MITOPHAGY,0.00026438,0.14097,0.16888,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0012886,0.1407,0.17403,1,1
1,GO PIGMENTATION,0.051595,0.14062,0.084782,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.0048405,0.14062,0.18364,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,7.0072e-05,0.14025,0.14467,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0017277,0.13983,0.17743,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,8.8389e-07,0.13976,0.12761,1,1
1,GO REGULATION OF RESPONSE TO STRESS,1.2716e-05,0.13946,0.14424,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0018508,0.13923,0.18001,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00049053,0.13906,0.14898,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00159,0.13903,0.11468,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,2.9332e-05,0.13902,0.15438,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00094089,0.13881,0.14704,1,1
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.045155,0.13867,0.12867,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00010497,0.13867,0.1591,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00037835,0.13851,0.15363,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.8053e-06,0.13833,0.16779,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0005211,0.13832,0.16987,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0096941,0.13815,0.13815,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.8793e-06,0.13804,0.15537,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00041488,0.13795,0.14729,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0058389,0.13788,0.13244,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.0018508,0.13781,0.15118,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.1165e-05,0.13773,0.13121,1,1
1,GO RNA PROCESSING,0.00016629,0.13758,0.13135,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00022208,0.1375,0.11999,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.033948,0.13747,0.079112,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.00021857,0.13745,0.13235,1,1
1,GO RNA POLYADENYLATION,0.0023321,0.13744,0.12232,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00015083,0.13716,0.14843,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,7.3739e-05,0.13714,0.15396,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00022565,0.13702,0.16271,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.049681,0.13702,0.14499,1,1
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0029256,0.13693,0.15744,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.2585e-06,0.13691,0.16166,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00024045,0.13689,0.12915,1,1
1,GO AGING,4.6359e-05,0.13685,0.13408,1,1
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.032938,0.13672,0.19291,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.00069207,0.13666,0.1422,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.0021798,0.13654,0.1515,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0012886,0.13636,0.13527,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0057669,0.13631,0.18306,1,1
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011151,0.1363,0.13853,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.8814e-05,0.13624,0.13231,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0065235,0.13624,0.11881,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.0557e-05,0.13622,0.15664,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,7.5001e-05,0.13617,0.14493,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.022686,0.13615,0.12897,1,1
1,GO CELLULAR RESPONSE TO UV,0.00013016,0.1361,0.15586,1,1
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.022686,0.13605,0.15142,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.1304e-06,0.13566,0.15799,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00015583,0.13559,0.14637,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0041031,0.13549,0.16947,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,6.2175e-05,0.13524,0.12477,1,1
1,GO MALE SEX DIFFERENTIATION,0.019104,0.13521,0.11006,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,3.5646e-05,0.13507,0.11462,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0065235,0.13497,0.11229,1,1
1,GO NUCLEUS LOCALIZATION,0.015329,0.13487,0.14681,1,1
1,GO ENDOCRINE PROCESS,0.0016806,0.13473,0.15419,1,1
1,GO OSSIFICATION,0.0011836,0.1346,0.15579,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0043737,0.13437,0.1539,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,9.9844e-05,0.13431,0.16354,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.0049019,0.13427,0.12999,1,1
1,GO LIPID HOMEOSTASIS,0.0011341,0.13421,0.13604,1,1
1,GO REGULATION OF CELL DEATH,0.00024819,0.13408,0.12152,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00035024,0.13403,0.1772,1,1
1,GO RESPONSE TO INTERLEUKIN 4,2.7804e-05,0.13401,0.19028,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00075607,0.13397,0.1512,1,1
1,GO BIOLOGICAL ADHESION,0.0060595,0.13382,0.13137,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0016806,0.1336,0.13325,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,2.538e-07,0.13338,0.13847,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0078263,0.13315,0.12226,1,1
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.020605,0.13301,0.10501,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00024045,0.13287,0.13567,1,1
1,GO RESPONSE TO STEROL,0.012798,0.13278,0.14341,1,1
1,GO CARNITINE SHUTTLE,0.010279,0.13273,0.14762,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00013899,0.1326,0.13478,1,1
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00055343,0.13252,0.16456,1,1
1,GO BODY FLUID SECRETION,2.2824e-05,0.13243,0.17543,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00064263,0.13237,0.16656,1,1
1,GO TISSUE HOMEOSTASIS,0.0072795,0.13234,0.1091,1,1
1,GO REGULATION OF VASCULOGENESIS,0.047827,0.13221,0.18577,1,1
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.0046018,0.13217,0.13755,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00064263,0.1321,0.21498,1,1
1,GO GOLGI VESICLE TRANSPORT,2.913e-06,0.13196,0.14858,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00039622,0.13192,0.13067,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0012527,0.13184,0.16039,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.001955,0.13177,0.11769,1,1
1,GO PROTEIN MATURATION,9.6562e-05,0.13167,0.12561,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00030449,0.13159,0.12163,1,1
1,GO JNK CASCADE,0.0087156,0.13145,0.10322,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.0059852,0.13139,0.1529,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0078263,0.13129,0.1503,1,1
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0033799,0.13114,0.13543,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.043866,0.131,0.13725,1,1
1,GO MEMBRANE DISASSEMBLY,0.05063,0.131,0.12459,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.0020367,0.13068,0.096667,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.0056958,0.13059,0.12204,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.035336,0.13046,0.12386,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.0067673,0.13033,0.15255,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00063314,0.13029,0.14412,1,1
1,GO DE NOVO PROTEIN FOLDING,0.024947,0.13007,0.10309,1,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.028264,0.12999,0.095204,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0095807,0.12986,0.13294,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0018256,0.12982,0.11849,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0023321,0.12979,0.10843,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.4472e-05,0.12964,0.15347,1,1
1,GO IMPORT INTO NUCLEUS,0.00010323,0.12961,0.13142,1,1
1,GO EPITHELIAL TUBE FORMATION,0.0059116,0.12946,0.1398,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.00010673,0.12936,0.15334,1,1
1,GO RESPONSE TO NUTRIENT,0.003607,0.12934,0.13751,1,1
1,GO RNA 3 END PROCESSING,5.7059e-05,0.1293,0.13935,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.02945,0.12929,0.10806,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,9.1829e-05,0.12877,0.15271,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00018323,0.12875,0.15835,1,1
1,GO OVULATION,0.028556,0.1287,0.14707,1,1
1,GO RESPONSE TO HEAT,0.00027284,0.12838,0.13678,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00015083,0.12824,0.15954,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.016938,0.12812,0.11569,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00033432,0.12792,0.15768,1,1
1,GO CHOLESTEROL STORAGE,0.011022,0.12771,0.21105,1,1
1,GO GOLGI VESICLE BUDDING,0.00026858,0.12758,0.13517,1,1
1,GO FAT CELL DIFFERENTIATION,0.006444,0.1274,0.12696,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00046872,0.12739,0.11353,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.01849,0.12731,0.13405,1,1
1,GO ANION HOMEOSTASIS,0.0052854,0.12701,0.13515,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00081356,0.12682,0.16183,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.025743,0.12678,0.14824,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0022396,0.12673,0.14418,1,1
1,GO PROTEIN STABILIZATION,0.00023294,0.12625,0.12726,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.027686,0.12624,0.083955,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.039406,0.12624,0.13414,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.013243,0.12617,0.15856,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,1.8363e-05,0.12614,0.12999,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026024,0.1261,0.1042,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,6.6578e-05,0.12605,0.15161,1,1
1,GO REGULATION OF LIPID METABOLIC PROCESS,0.0010408,0.12602,0.12988,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011022,0.12599,0.16669,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.036048,0.12597,0.10436,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00033955,0.12574,0.1447,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.1588e-05,0.12563,0.17722,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.032278,0.1256,0.070263,1,1
1,GO RESPONSE TO KETONE,0.004156,0.12555,0.12043,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.00034485,0.12549,0.15998,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.0030038,0.12533,0.10194,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00044103,0.12508,0.12814,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.015329,0.12498,0.098829,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0002117,0.12483,0.17585,1,1
1,GO NUCLEAR TRANSPORT,4.8839e-05,0.12449,0.12226,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.021973,0.12442,0.11218,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0092477,0.12437,0.13781,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00042128,0.12427,0.18955,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00091404,0.12421,0.13792,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0049019,0.12407,0.15598,1,1
1,GO CARNITINE METABOLIC PROCESS,0.0050269,0.12403,0.19178,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0016347,0.12382,0.11239,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.042197,0.12381,0.13452,1,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.063836,0.12374,0.071487,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,3.8924e-05,0.12372,0.13326,1,1
1,GO SPINDLE LOCALIZATION,0.0056255,0.12365,0.11164,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00010152,0.12325,0.15461,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00076726,0.12297,0.13488,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00086244,0.12292,0.1334,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.037882,0.12282,0.14104,1,1
1,GO CELLULAR RESPONSE TO RADIATION,2.4972e-05,0.12279,0.15755,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00059648,0.12275,0.13899,1,1
1,GO COPII COATED VESICLE BUDDING,0.00041488,0.12259,0.13138,1,1
1,GO REGULATION OF JUN KINASE ACTIVITY,0.028852,0.12251,0.11071,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00087508,0.12222,0.12172,1,1
1,GO CELLULAR RESPONSE TO ALCOHOL,0.012653,0.12219,0.13468,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00027716,0.12215,0.15036,1,1
1,GO TUBE DEVELOPMENT,0.00043435,0.12215,0.16275,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.0029645,0.12178,0.12187,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00053704,0.12157,0.13432,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,1.8053e-06,0.12129,0.13752,1,1
1,GO REGULATION OF MAPK CASCADE,0.0005211,0.12114,0.1367,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.023173,0.12087,0.12619,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00090088,0.12082,0.11853,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.056652,0.12075,0.13166,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,8.4262e-06,0.12047,0.11476,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.3256e-05,0.12041,0.16204,1,1
1,GO PROTEOLYSIS,3.628e-05,0.12023,0.12113,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00064263,0.11999,0.12245,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0030436,0.11998,0.148,1,1
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.021053,0.11978,0.09314,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0046018,0.11977,0.11724,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.0054192,0.11971,0.12303,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0005056,0.11971,0.12681,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0010408,0.11941,0.17488,1,1
1,GO LIPID CATABOLIC PROCESS,0.00076726,0.11933,0.11673,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0022095,0.11928,0.12578,1,1
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0024281,0.11905,0.14641,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0066851,0.11903,0.14855,1,1
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.014172,0.11897,0.1717,1,1
1,GO MRNA 3 END PROCESSING,0.003166,0.11879,0.10091,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00016629,0.11877,0.12676,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0010408,0.11861,0.10658,1,1
1,GO HISTONE DEUBIQUITINATION,0.040981,0.1185,0.099968,1,1
1,GO TUBE FORMATION,0.004964,0.11849,0.14005,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.3806e-05,0.11848,0.11769,1,1
1,GO POSITIVE REGULATION OF JNK CASCADE,0.013243,0.11811,0.1127,1,1
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0037498,0.118,0.1504,1,1
1,GO REGULATION OF CATABOLIC PROCESS,6.8396e-06,0.11785,0.12641,1,1
1,GO BONE CELL DEVELOPMENT,0.037139,0.11767,0.14966,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,6.2175e-05,0.11766,0.13921,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.2716e-05,0.1176,0.14905,1,1
1,GO ACETYL COA METABOLIC PROCESS,0.011949,0.11743,0.13796,1,1
1,GO PROTEIN CATABOLIC PROCESS,3.094e-05,0.11732,0.11741,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0059116,0.11644,0.078404,1,1
1,GO CELLULAR LIPID METABOLIC PROCESS,0.0013633,0.11631,0.11193,1,1
1,GO MRNA METABOLIC PROCESS,0.00013016,0.11624,0.11475,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0011836,0.11621,0.10719,1,1
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.019735,0.11618,0.12511,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00033432,0.11611,0.1124,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,2.1196e-06,0.11596,0.13498,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,1.8363e-05,0.11562,0.12276,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00010497,0.11542,0.1124,1,1
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.027686,0.11537,0.11386,1,1
1,GO VACUOLAR TRANSPORT,0.00040235,0.11496,0.13052,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.7385e-05,0.11491,0.1431,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.060432,0.11475,0.088284,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00011596,0.1146,0.11884,1,1
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0035146,0.11431,0.12442,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,3.152e-06,0.11416,0.13241,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0018256,0.11411,0.14904,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0010558,0.11383,0.10935,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.016568,0.11365,0.093355,1,1
1,GO TELOMERE ORGANIZATION,0.00033432,0.11362,0.10403,1,1
1,GO CELL CELL SIGNALING BY WNT,0.0070192,0.11338,0.1072,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00018323,0.11337,0.12977,1,1
1,GO RESPONSE TO GROWTH FACTOR,0.0053519,0.11335,0.12296,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00014839,0.11324,0.13816,1,1
1,GO ACTIVATION OF GTPASE ACTIVITY,0.028556,0.113,0.099754,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.020828,0.11242,0.092821,1,1
1,GO APOPTOTIC PROCESS,0.00063314,0.11242,0.10713,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.015501,0.11232,0.11811,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0046604,0.11209,0.11976,1,1
1,GO P BODY ASSEMBLY,0.051111,0.11198,0.083746,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00034485,0.11189,0.12894,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.001422,0.11185,0.11609,1,1
1,GO PEROXISOMAL TRANSPORT,0.0013826,0.11175,0.1333,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.017125,0.11154,0.12189,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00013232,0.11153,0.13955,1,1
1,GO ORGANELLE INHERITANCE,0.024687,0.11146,0.08464,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00061456,0.11145,0.13583,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0012005,0.1114,0.11274,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021798,0.11132,0.16173,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.01251,0.11092,0.087594,1,1
1,GO RESPONSE TO PEPTIDE,0.0045438,0.11083,0.09874,1,1
1,GO REGULATION OF PROTEIN STABILITY,0.00010673,0.11077,0.1206,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00037835,0.11034,0.11666,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023294,0.11028,0.11579,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0010259,0.11015,0.11296,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0054872,0.11013,0.15183,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0090315,0.10984,0.095816,1,1
1,GO VACUOLE ORGANIZATION,0.00019857,0.10974,0.137,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0033799,0.10971,0.14114,1,1
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.03006,0.10958,0.15302,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.013243,0.10934,0.1398,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0057669,0.1092,0.12253,1,1
1,GO ORGAN GROWTH,0.00073415,0.1091,0.17979,1,1
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.018693,0.10907,0.12921,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.024173,0.10901,0.11961,1,1
1,GO RESPONSE TO DRUG,0.0065235,0.10863,0.1087,1,1
1,GO CYTOKINESIS,0.040582,0.10848,0.066553,1,1
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.039795,0.10845,0.088332,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.027401,0.10844,0.17379,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.0022095,0.10841,0.12457,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0089251,0.10823,0.070021,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0038977,0.10813,0.11255,1,1
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.063258,0.10811,0.065262,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.038637,0.10803,0.12858,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0034692,0.10788,0.12565,1,1
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0010558,0.10761,0.11946,1,1
1,GO ER NUCLEUS SIGNALING PATHWAY,0.03902,0.10756,0.098167,1,1
1,GO REGULATION OF DNA REPAIR,0.01499,0.10733,0.062626,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.016752,0.10728,0.089655,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0019819,0.10726,0.13337,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.015501,0.10687,0.09594,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0011021,0.10686,0.10959,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00021857,0.10675,0.13584,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,5.4184e-05,0.10674,0.13349,1,1
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.066192,0.10668,0.089591,1,1
1,GO GOLGI RIBBON FORMATION,0.016938,0.10666,0.14577,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0033799,0.1063,0.079115,1,1
1,GO DNA BIOSYNTHETIC PROCESS,0.00011218,0.10617,0.10479,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0013069,0.10613,0.081145,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0014624,0.10609,0.11095,1,1
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0030839,0.10598,0.10998,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0017277,0.10564,0.11069,1,1
1,GO RRNA 3 END PROCESSING,0.013546,0.10551,0.095376,1,1
1,GO PEROXISOME ORGANIZATION,0.00080175,0.10541,0.13085,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0012005,0.10528,0.118,1,1
1,GO LIPID METABOLIC PROCESS,0.0018764,0.10508,0.10525,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.2344e-05,0.1048,0.117,1,1
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.006444,0.10478,0.084787,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00015583,0.10464,0.11521,1,1
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0040509,0.10463,0.12855,1,1
1,GO GLYCEROLIPID METABOLIC PROCESS,0.0017277,0.10442,0.10768,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.010895,0.10438,0.13001,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.4771e-05,0.10434,0.10221,1,1
1,GO PROTEIN NEDDYLATION,0.0073682,0.10426,0.10596,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011151,0.10423,0.11948,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,8.7316e-05,0.10409,0.14122,1,1
1,GO REGULATION OF MITOPHAGY,0.02945,0.10403,0.12511,1,1
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0052854,0.10403,0.10065,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.013093,0.10389,0.13755,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00029052,0.10369,0.10366,1,1
1,GO B CELL APOPTOTIC PROCESS,0.027401,0.10342,0.13704,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.043025,0.1034,0.1482,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.0032501,0.10325,0.10921,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00039622,0.103,0.11413,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00024819,0.10297,0.10688,1,1
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.052083,0.1029,0.082585,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00094089,0.10271,0.12289,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.001118,0.10258,0.11032,1,1
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.026561,0.1024,0.089794,1,1
1,GO MAINTENANCE OF LOCATION,7.6283e-05,0.10223,0.13907,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0021798,0.10182,0.14245,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0035605,0.10128,0.12923,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.02521,0.10085,0.15909,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0014624,0.10073,0.1117,1,1
1,GO PROTEIN AUTOUBIQUITINATION,0.03068,0.10073,0.07377,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0019285,0.10031,0.11832,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0054872,0.1003,0.12475,1,1
1,GO GENE SILENCING,0.00014362,0.1002,0.11932,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0050904,0.10001,0.1179,1,1
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.029754,0.099967,0.097536,1,1
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00071283,0.099874,0.11277,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0010558,0.099346,0.12713,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00014129,0.099253,0.12408,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.016027,0.0991,0.13033,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.01016,0.098837,0.09715,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.010279,0.098761,0.10807,1,1
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.007921,0.098694,0.11443,1,1
1,GO SNORNA METABOLIC PROCESS,0.065005,0.098575,0.082896,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0016806,0.097933,0.10154,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.025743,0.097918,0.061505,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00022208,0.097867,0.10021,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.014494,0.097862,0.10516,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.052083,0.097594,0.089322,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0034243,0.096948,0.1174,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0013826,0.096932,0.13303,1,1
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0096941,0.096879,0.10427,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00074504,0.096793,0.11292,1,1
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.0022095,0.096729,0.1088,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0023321,0.096455,0.10636,1,1
1,GO POSTREPLICATION REPAIR,0.011151,0.096348,0.067343,1,1
1,GO ANIMAL ORGAN FORMATION,0.041789,0.096345,0.12719,1,1
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00032408,0.096239,0.10793,1,1
1,GO BLASTOCYST GROWTH,0.0023321,0.095902,0.17729,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.017315,0.095704,0.15309,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.0028492,0.095562,0.15392,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0058389,0.095494,0.083719,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.02945,0.094979,0.13745,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.019104,0.094658,0.1457,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00096848,0.09456,0.1064,1,1
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.053071,0.094497,0.11764,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,9.4959e-05,0.094471,0.11885,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.002702,0.094465,0.099784,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.0050904,0.094387,0.093239,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00013899,0.094161,0.11893,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.011151,0.093901,0.064703,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.039406,0.093661,0.075272,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0042636,0.093475,0.093245,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.007921,0.093405,0.090301,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0094686,0.092919,0.092402,1,1
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.025743,0.092888,0.08553,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0016347,0.092877,0.12147,1,1
1,GO HYPEROSMOTIC RESPONSE,0.021053,0.092858,0.11775,1,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.01849,0.092836,0.12249,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0039992,0.092816,0.090748,1,1
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.012367,0.092697,0.095319,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0055559,0.092631,0.11486,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00025617,0.092596,0.11265,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0033799,0.092377,0.10999,1,1
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.01849,0.092291,0.1101,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.055609,0.092031,0.10477,1,1
1,GO CELL DIVISION,0.012945,0.091883,0.070017,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0019023,0.091683,0.1051,1,1
1,GO RESPONSE TO ESTRADIOL,0.037139,0.091546,0.090637,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.015329,0.091496,0.1456,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00067188,0.091277,0.11662,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.0066851,0.09114,0.087864,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.0041031,0.090903,0.12198,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0054872,0.090818,0.096284,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.023419,0.090725,0.12782,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0012705,0.090702,0.10167,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0063654,0.090288,0.089575,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0092477,0.090158,0.097509,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0056255,0.09007,0.11778,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00044103,0.08984,0.10097,1,1
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.01829,0.08972,0.12214,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.019104,0.089653,0.091385,1,1
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00072342,0.089552,0.11409,1,1
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.054074,0.089458,0.083377,1,1
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0019819,0.08936,0.10732,1,1
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0010113,0.088848,0.1814,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.027686,0.088475,0.084829,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.03006,0.088406,0.063289,1,1
1,GO DNA METHYLATION,0.058787,0.088239,0.067356,1,1
1,GO TRANSLESION SYNTHESIS,0.024687,0.088171,0.068033,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.027686,0.088032,0.08792,1,1
1,GO OXIDATION REDUCTION PROCESS,0.0010113,0.087933,0.097057,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.01995,0.0878,0.076876,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.027401,0.087753,0.10931,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.030994,0.087524,0.09437,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00038422,0.087395,0.093145,1,1
1,GO DNA DEALKYLATION,0.0067673,0.087279,0.14869,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,6.0079e-05,0.0872,0.10859,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014823,0.087124,0.10708,1,1
1,GO ENDOSOMAL TRANSPORT,0.0024281,0.087106,0.10037,1,1
1,GO REGULATION OF GTPASE ACTIVITY,0.043025,0.086766,0.0929,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0075485,0.086715,0.06339,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0050904,0.086463,0.085439,1,1
1,GO DNA MODIFICATION,0.013546,0.086338,0.079898,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.049681,0.086176,0.052409,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00045468,0.085702,0.091036,1,1
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.028556,0.085426,0.1139,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0021798,0.085395,0.091794,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.016205,0.085056,0.081349,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0137,0.084734,0.087893,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.02128,0.08456,0.097898,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0090315,0.084511,0.084601,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0033361,0.084487,0.14764,1,1
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.02945,0.084445,0.1096,1,1
1,GO CELL VOLUME HOMEOSTASIS,0.016568,0.083892,0.10567,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.0029256,0.083482,0.10878,1,1
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0098086,0.083325,0.091642,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.011949,0.083098,0.11532,1,1
1,GO MACROAUTOPHAGY,7.8911e-05,0.083091,0.11752,1,1
1,GO ENDOSOME ORGANIZATION,0.00082553,0.082691,0.12734,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.014494,0.082633,0.13792,1,1
1,GO DNA RECOMBINATION,0.0093576,0.081906,0.073155,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0042636,0.081489,0.084872,1,1
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0011341,0.081089,0.088728,1,1
1,GO DNA GEOMETRIC CHANGE,0.006444,0.080748,0.088867,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0050269,0.080721,0.12295,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.023419,0.080678,0.077344,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0050904,0.080612,0.10023,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.002702,0.080472,0.076853,1,1
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.032938,0.080108,0.10637,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0022701,0.07971,0.10983,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0053519,0.079611,0.078995,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0093576,0.079128,0.064825,1,1
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.067397,0.079049,0.077625,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.046031,0.07903,0.045849,1,1
1,GO NUCLEUS ORGANIZATION,0.022209,0.078935,0.075293,1,1
1,GO HISTONE H3 ACETYLATION,0.049212,0.078469,0.07273,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0035146,0.07842,0.067514,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.011151,0.078254,0.11613,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.016027,0.077496,0.075777,1,1
1,GO PROTEIN DESTABILIZATION,0.026286,0.077435,0.095827,1,1
1,GO ACTIVATION OF MAPK ACTIVITY,0.042609,0.077207,0.079668,1,1
1,GO DNA METABOLIC PROCESS,0.0015463,0.076487,0.065252,1,1
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0038977,0.076463,0.10908,1,1
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0046018,0.07633,0.11366,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0074579,0.076105,0.091112,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.025743,0.076027,0.10362,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00029976,0.076005,0.083687,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0070192,0.075789,0.11185,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0038977,0.075632,0.10785,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.0066851,0.075438,0.070419,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.014823,0.075021,0.061143,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.01128,0.074794,0.087605,1,1
1,GO MITOTIC CELL CYCLE,0.0038478,0.07466,0.071628,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0043737,0.073222,0.077305,1,1
1,GO CYTOSKELETON ORGANIZATION,0.065596,0.073181,0.071629,1,1
1,GO HORMONE METABOLIC PROCESS,0.05357,0.072779,0.076599,1,1
1,GO PROTEIN TARGETING,0.00035024,0.072632,0.10925,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00021857,0.072618,0.097676,1,1
1,GO PROTEIN TETRAMERIZATION,0.0096941,0.072189,0.088877,1,1
1,GO CELLULAR SENESCENCE,0.0013633,0.071635,0.12545,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.030994,0.071151,0.079785,1,1
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.023419,0.070839,0.084987,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0068504,0.070687,0.089731,1,1
1,GO SULFATE TRANSPORT,0.034984,0.070464,0.085551,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.027118,0.069976,0.058579,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.02128,0.069633,0.085313,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.015501,0.069236,0.079379,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00038422,0.069216,0.10513,1,1
1,GO BASE EXCISION REPAIR,0.046474,0.069147,0.055625,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.024173,0.06912,0.09894,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.003166,0.068539,0.074014,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0087156,0.067565,0.087651,1,1
1,GO HEART GROWTH,0.0070192,0.067255,0.13762,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.036772,0.065758,0.069993,1,1
1,GO MACROMOLECULE DEACYLATION,0.012227,0.06552,0.082805,1,1
1,GO RESPONSE TO RADIATION,0.0083098,0.065269,0.077421,1,1
1,GO SNRNA TRANSCRIPTION,0.038258,0.065267,0.06388,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.058787,0.065234,0.053333,1,1
1,GO REGULATION OF CELL CYCLE,0.023668,0.06458,0.053273,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0032078,0.063801,0.066937,1,1
1,GO CELL CYCLE PROCESS,0.009139,0.06367,0.057682,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.049212,0.063374,0.061362,1,1
1,GO CELL CYCLE CHECKPOINT,0.058787,0.062751,0.046375,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.057179,0.062403,0.12847,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.00069207,0.06211,0.082409,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0068504,0.060733,0.082264,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.014172,0.06008,0.10794,1,1
1,GO DNA METHYLATION OR DEMETHYLATION,0.048285,0.059916,0.072859,1,1
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.011022,0.059374,0.080455,1,1
1,GO REGULATION OF AUTOPHAGY,0.0011836,0.058796,0.10262,1,1
1,GO NCRNA TRANSCRIPTION,0.038637,0.058281,0.068098,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.028852,0.055106,0.080035,1,1
1,GO DNA REPAIR,0.01128,0.054104,0.049078,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.024947,0.054004,0.079811,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.012227,0.05372,0.080726,1,1
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.017315,0.053146,0.078079,1,1
1,GO CELL CYCLE,0.016027,0.051178,0.05248,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.042197,0.050243,0.060606,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0074579,0.045053,0.096948,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.012653,0.040782,0.071231,1,1
2,GO REGULATION OF SYNAPSE MATURATION,4.8673e-09,0.81286,0.67492,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,4.9872e-09,0.78886,0.76211,1,1
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.1338e-07,0.73535,0.66684,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,8.6328e-08,0.72875,0.73446,1,1
2,GO VOCALIZATION BEHAVIOR,9.1205e-09,0.69355,0.64198,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.4334e-08,0.69093,0.72033,1,1
2,GO SYNAPSE MATURATION,2.5066e-09,0.68262,0.66544,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,6.6717e-09,0.65483,0.57057,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,3.6293e-09,0.64,0.59056,1,1
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,2.5695e-09,0.63395,0.63837,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.9624e-10,0.6296,0.6666,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.7166e-08,0.62521,0.5898,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,7.2202e-11,0.62002,0.58658,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,1.1858e-08,0.61903,0.56753,1,1
2,GO DENTATE GYRUS DEVELOPMENT,1.2434e-08,0.61884,0.62972,1,1
2,GO COMMISSURAL NEURON AXON GUIDANCE,6.5906e-08,0.60862,0.57494,1,1
2,GO PREPULSE INHIBITION,4.8673e-09,0.60138,0.58596,1,1
2,GO CARDIAC VENTRICLE FORMATION,5.4967e-09,0.59794,0.62947,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,4.2784e-08,0.58862,0.64706,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.9558e-07,0.58276,0.53059,1,1
2,GO SYNAPTIC VESICLE CLUSTERING,2.6981e-08,0.57544,0.64,1,1
2,GO POSTSYNAPSE ASSEMBLY,4.7125e-10,0.57073,0.63371,1,1
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,1.5052e-06,0.56609,0.52069,1,1
2,GO NEURONAL ION CHANNEL CLUSTERING,1.7154e-07,0.56517,0.54101,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,3.7282e-08,0.55813,0.53926,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,8.5043e-10,0.52913,0.56079,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.205e-09,0.52345,0.49204,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,1.4207e-05,0.52111,0.50096,1,1
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,1.0161e-09,0.52072,0.5207,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,3.7282e-08,0.51068,0.44145,1,1
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,3.4296e-07,0.50948,0.45222,1,1
2,GO DENSE CORE GRANULE TRANSPORT,3.3806e-05,0.5082,0.39499,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.4837e-07,0.50639,0.54124,1,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.5066e-09,0.50322,0.49463,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,6.8406e-11,0.50285,0.49938,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,2.7668e-07,0.50152,0.53963,1,1
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.9465e-08,0.49671,0.52841,1,1
2,GO NEURON CELL CELL ADHESION,1.5994e-06,0.49425,0.5453,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,4.1815e-08,0.49261,0.51025,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.7e-09,0.48518,0.49626,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.0964e-09,0.48279,0.49406,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,1.0212e-06,0.47974,0.40351,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,1.6129e-08,0.47898,0.48102,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.3761e-09,0.47572,0.47099,1,1
2,GO MECHANOSENSORY BEHAVIOR,5.7059e-05,0.47435,0.49693,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,1.3671e-08,0.47222,0.45396,1,1
2,GO RESPONSE TO L GLUTAMATE,5.3647e-09,0.47184,0.4665,1,1
2,GO REGULATION OF NEURON MIGRATION,1.3419e-09,0.47019,0.46024,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,9.3415e-09,0.468,0.53794,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,5.5078e-11,0.4679,0.44827,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,8.2543e-08,0.46393,0.48786,1,1
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.00018323,0.46374,0.39038,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,7.105e-06,0.46332,0.60158,1,1
2,GO CARDIAC CHAMBER FORMATION,4.5822e-08,0.45978,0.52134,1,1
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,2.3268e-09,0.45616,0.47461,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.4471e-09,0.45492,0.5079,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,3.6435e-08,0.45417,0.39535,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.9514e-07,0.45324,0.49831,1,1
2,GO PROTEIN LOCALIZATION TO AXON,2.3274e-07,0.452,0.54591,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,2.0881e-08,0.44414,0.45686,1,1
2,GO MICROTUBULE DEPOLYMERIZATION,3.5038e-07,0.44254,0.35527,1,1
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.0781e-08,0.44142,0.47198,1,1
2,GO CEREBELLAR CORTEX MORPHOGENESIS,8.4871e-11,0.43752,0.41296,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,1.3325e-06,0.43336,0.43215,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,5.77e-09,0.43311,0.41063,1,1
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,1.0422e-09,0.43005,0.41536,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.00013673,0.42777,0.36233,1,1
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,3.0296e-10,0.42602,0.43175,1,1
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,1.3948e-05,0.42527,0.40789,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,2.011e-05,0.42429,0.39335,1,1
2,GO LIMB BUD FORMATION,2.1621e-05,0.4242,0.40416,1,1
2,GO DIVALENT METAL ION EXPORT,3.247e-08,0.42376,0.45403,1,1
2,GO SECRETORY GRANULE LOCALIZATION,2.6914e-06,0.42317,0.39676,1,1
2,GO CEREBELLAR CORTEX FORMATION,7.3476e-09,0.42142,0.39372,1,1
2,GO BEHAVIORAL RESPONSE TO COCAINE,1.6761e-05,0.41956,0.40387,1,1
2,GO GENITALIA MORPHOGENESIS,0.0031247,0.41767,0.32122,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.00011218,0.41601,0.36857,1,1
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,9.8716e-08,0.4156,0.4144,1,1
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,3.8118e-09,0.41456,0.41426,1,1
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.4454e-06,0.41133,0.42015,1,1
2,GO DENDRITIC SPINE MORPHOGENESIS,5.5016e-10,0.4112,0.42211,1,1
2,GO NEURON RECOGNITION,1.0322e-07,0.40987,0.38471,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,3.6435e-08,0.40664,0.4063,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.247e-08,0.4063,0.41733,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,1.6158e-05,0.40525,0.36411,1,1
2,GO AXONAL FASCICULATION,8.6579e-07,0.40253,0.39835,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,8.2903e-10,0.40221,0.42886,1,1
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,7.0337e-07,0.39938,0.4378,1,1
2,GO CEREBELLAR CORTEX DEVELOPMENT,1.5529e-11,0.39826,0.40086,1,1
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,1.6158e-05,0.39369,0.32373,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.4452e-09,0.39367,0.40673,1,1
2,GO RESPONSE TO ACETYLCHOLINE,4.0868e-08,0.3935,0.41697,1,1
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,5.9116e-09,0.3926,0.39908,1,1
2,GO CORONARY VASCULATURE MORPHOGENESIS,2.4861e-06,0.38981,0.3797,1,1
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,7.6283e-05,0.38853,0.47405,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,8.8282e-08,0.38713,0.40844,1,1
2,GO HEART VALVE FORMATION,2.7452e-06,0.38702,0.4594,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,7.3772e-08,0.38612,0.35667,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,2.2775e-07,0.38428,0.46886,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00046872,0.3836,0.29871,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.9116e-09,0.38196,0.45039,1,1
2,GO REGULATION OF COLLATERAL SPROUTING,4.9361e-06,0.3817,0.3406,1,1
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,9.6129e-06,0.38154,0.375,1,1
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,5.6487e-06,0.38029,0.32718,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,9.5999e-07,0.37953,0.38867,1,1
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,9.404e-07,0.37932,0.34754,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.2303e-06,0.37813,0.33393,1,1
2,GO LONG TERM SYNAPTIC DEPRESSION,6.7461e-07,0.37773,0.33468,1,1
2,GO FOREBRAIN NEURON DEVELOPMENT,1.1806e-05,0.37507,0.35225,1,1
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.00090088,0.37491,0.33683,1,1
2,GO FOREBRAIN REGIONALIZATION,1.0212e-06,0.37279,0.3911,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,9.9064e-10,0.37086,0.40107,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.6362e-08,0.37022,0.37588,1,1
2,GO VITAMIN CATABOLIC PROCESS,0.0010865,0.36936,0.39368,1,1
2,GO SUCKLING BEHAVIOR,6.5837e-06,0.36921,0.39389,1,1
2,GO THALAMUS DEVELOPMENT,5.1304e-06,0.36888,0.35313,1,1
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,6.2993e-08,0.36853,0.39243,1,1
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.1806e-05,0.367,0.28766,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.9064e-09,0.36676,0.38589,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,2.0879e-07,0.36506,0.39596,1,1
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.6158e-05,0.36462,0.33638,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.9323e-10,0.36455,0.39554,1,1
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.7501e-09,0.36318,0.38855,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,1.2534e-06,0.36281,0.36987,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,3.4409e-05,0.36207,0.29601,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.8118e-09,0.36147,0.40567,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.9624e-10,0.36029,0.37394,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.1533e-09,0.35974,0.39636,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,6.7411e-08,0.35935,0.34099,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0048405,0.35684,0.23203,1,1
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,8.7502e-06,0.35671,0.3589,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,5.6487e-06,0.35659,0.34723,1,1
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.00011033,0.35628,0.29241,1,1
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,1.2032e-06,0.35582,0.40193,1,1
2,GO POSTSYNAPSE ORGANIZATION,9.4157e-10,0.35578,0.36566,1,1
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.4076e-07,0.35495,0.43052,1,1
2,GO NEURON PROJECTION ORGANIZATION,8.4877e-09,0.35465,0.35907,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00015583,0.35373,0.30443,1,1
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,4.6359e-05,0.35306,0.35331,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,4.9872e-09,0.35258,0.35201,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,1.536e-06,0.35075,0.28216,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.1789e-06,0.35052,0.35647,1,1
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,4.7488e-06,0.35036,0.32973,1,1
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.011949,0.34965,0.26588,1,1
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.0088198,0.34961,0.24453,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.4471e-09,0.34818,0.38153,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,6.4434e-08,0.34796,0.34212,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,3.6877e-06,0.34786,0.31535,1,1
2,GO DENDRITIC TRANSPORT,2.6981e-08,0.34704,0.40162,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.4148e-09,0.34395,0.36801,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,2.5756e-08,0.34257,0.3404,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,2.004e-09,0.34127,0.34432,1,1
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.0554e-07,0.34072,0.33531,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,4.3774e-08,0.33911,0.32244,1,1
2,GO AXONAL TRANSPORT OF MITOCHONDRION,7.333e-07,0.33899,0.38619,1,1
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0099244,0.33882,0.28051,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.5027e-08,0.33879,0.3756,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.5052e-06,0.33799,0.37165,1,1
2,GO PROTEIN LOCALIZATION TO SYNAPSE,1.3999e-08,0.33662,0.3696,1,1
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.2886e-07,0.33506,0.34939,1,1
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,3.628e-05,0.33256,0.27417,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0010408,0.33204,0.29489,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,3.5646e-05,0.3314,0.27277,1,1
2,GO DORSAL SPINAL CORD DEVELOPMENT,1.2792e-06,0.33005,0.38278,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,7.3772e-08,0.32975,0.36664,1,1
2,GO RENAL VESICLE DEVELOPMENT,2.913e-06,0.32946,0.32831,1,1
2,GO METENCEPHALON DEVELOPMENT,2.8753e-10,0.3293,0.34602,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,3.2784e-06,0.32808,0.37934,1,1
2,GO CGMP METABOLIC PROCESS,1.5865e-05,0.32762,0.39287,1,1
2,GO NEURON PROJECTION GUIDANCE,3.9064e-09,0.32745,0.33684,1,1
2,GO PRESYNAPSE ORGANIZATION,8.0712e-08,0.3271,0.33718,1,1
2,GO NEUROTRANSMITTER REUPTAKE,8.5867e-06,0.32636,0.29535,1,1
2,GO SEROTONIN TRANSPORT,6.8396e-06,0.3253,0.31641,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,2.801e-10,0.32467,0.35628,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.0045438,0.32411,0.27844,1,1
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,7.9617e-06,0.32368,0.44715,1,1
2,GO RESPONSE TO AUDITORY STIMULUS,0.00012388,0.32314,0.36371,1,1
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,3.1494e-05,0.31919,0.34208,1,1
2,GO STARTLE RESPONSE,7.6657e-06,0.31884,0.33897,1,1
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,1.5713e-07,0.31621,0.32028,1,1
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,2.3891e-06,0.31421,0.31332,1,1
2,GO NEGATIVE REGULATION OF AXON EXTENSION,3.4296e-07,0.31331,0.32059,1,1
2,GO REGULATION OF AXONOGENESIS,6.3569e-09,0.31293,0.33318,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.0279e-08,0.31275,0.31906,1,1
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,1.6907e-08,0.31267,0.33116,1,1
2,GO PROSTATE GLAND MORPHOGENESIS,0.0065235,0.31254,0.2371,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.01251,0.31239,0.21002,1,1
2,GO MICROTUBULE ANCHORING AT CENTROSOME,2.1196e-06,0.31236,0.30278,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,2.0881e-08,0.31234,0.30958,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,3.1004e-08,0.31222,0.3032,1,1
2,GO NEURON MIGRATION,1.9546e-09,0.31187,0.36842,1,1
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,3.247e-08,0.31171,0.3437,1,1
2,GO DENDRITE MORPHOGENESIS,2.7e-09,0.31132,0.33723,1,1
2,GO HINDBRAIN MORPHOGENESIS,1.7721e-08,0.31101,0.28079,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,5.5016e-10,0.30994,0.33793,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,8.5043e-10,0.30946,0.34218,1,1
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,3.1479e-07,0.30931,0.30635,1,1
2,GO EXPLORATION BEHAVIOR,4.3997e-05,0.30853,0.27585,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,8.3013e-05,0.30734,0.43289,1,1
2,GO MRNA SPLICE SITE SELECTION,1.5037e-07,0.30598,0.3011,1,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0039992,0.30592,0.25202,1,1
2,GO LEARNING,1.1828e-09,0.3058,0.33138,1,1
2,GO ADULT HEART DEVELOPMENT,5.6085e-05,0.30568,0.29438,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,2.0478e-05,0.30529,0.2959,1,1
2,GO MAST CELL MIGRATION,0.0039992,0.30415,0.29914,1,1
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00018923,0.30161,0.32124,1,1
2,GO ACTIN CROSSLINK FORMATION,4.31e-06,0.30096,0.33937,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,4.0868e-08,0.30046,0.27254,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,2.5424e-05,0.30029,0.25907,1,1
2,GO RESPONSE TO POTASSIUM ION,4.9694e-05,0.29963,0.30157,1,1
2,GO SOMATIC STEM CELL DIVISION,0.0090315,0.29885,0.25838,1,1
2,GO NEURAL RETINA DEVELOPMENT,1.5674e-06,0.29815,0.27869,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,1.1789e-06,0.29808,0.28225,1,1
2,GO SIALYLATION,1.3056e-06,0.29686,0.43189,1,1
2,GO SYNAPSE ORGANIZATION,5.4967e-09,0.29553,0.30888,1,1
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,5.4982e-08,0.2942,0.32694,1,1
2,GO NEUROTRANSMITTER SECRETION,4.6881e-08,0.29397,0.32806,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.057179,0.29245,0.16339,1,1
2,GO BRAIN MORPHOGENESIS,4.9361e-06,0.29208,0.26753,1,1
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,1.2281e-06,0.29203,0.3095,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,9.3415e-09,0.29088,0.30122,1,1
2,GO NEUROBLAST PROLIFERATION,1.5994e-06,0.29085,0.28061,1,1
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.064e-06,0.29064,0.27665,1,1
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,9.3381e-05,0.29053,0.32408,1,1
2,GO COLLATERAL SPROUTING,6.0991e-06,0.29046,0.29438,1,1
2,GO CARTILAGE MORPHOGENESIS,0.01849,0.28956,0.21828,1,1
2,GO COCHLEA MORPHOGENESIS,0.00083767,0.28911,0.24679,1,1
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.7282e-08,0.28872,0.30909,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.0861e-06,0.28871,0.26963,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,4.8416e-06,0.28866,0.26764,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,2.4837e-07,0.28755,0.34036,1,1
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.7195e-09,0.28727,0.30039,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,3.7195e-09,0.28699,0.30607,1,1
2,GO POSITIVE REGULATION OF AXONOGENESIS,2.1375e-08,0.28611,0.31638,1,1
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0057669,0.28572,0.18072,1,1
2,GO CATECHOLAMINE UPTAKE,1.8701e-05,0.28461,0.31066,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,2.8001e-06,0.28427,0.2693,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,2.3312e-10,0.28419,0.31848,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,2.342e-06,0.28412,0.29047,1,1
2,GO ACROSOME ASSEMBLY,7.1274e-05,0.28394,0.25579,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.014658,0.28389,0.19929,1,1
2,GO NEURON MATURATION,6.6066e-07,0.28381,0.28097,1,1
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0048405,0.28314,0.27314,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,1.6418e-07,0.28254,0.31674,1,1
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,7.1274e-05,0.28242,0.27207,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00062378,0.28176,0.29757,1,1
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,2.6352e-05,0.28136,0.27911,1,1
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00026858,0.28127,0.24364,1,1
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.00073415,0.28094,0.24167,1,1
2,GO MIDGUT DEVELOPMENT,0.0007901,0.2809,0.26012,1,1
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00026024,0.28088,0.22861,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,1.2143e-08,0.28082,0.32102,1,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0057669,0.27903,0.29799,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,1.1245e-09,0.27898,0.3079,1,1
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,9.5999e-07,0.27824,0.24483,1,1
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,1.9926e-08,0.27804,0.31303,1,1
2,GO NEGATIVE CHEMOTAXIS,7.5001e-05,0.27781,0.28975,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.2146e-06,0.27742,0.32532,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,9.1205e-09,0.27725,0.32071,1,1
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0040509,0.27669,0.21936,1,1
2,GO FORELIMB MORPHOGENESIS,0.0012886,0.27555,0.2287,1,1
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0054872,0.27524,0.2071,1,1
2,GO NEURAL TUBE PATTERNING,4.1026e-05,0.27499,0.2195,1,1
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0037985,0.27477,0.29005,1,1
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.094e-05,0.27462,0.25806,1,1
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0088198,0.27374,0.18001,1,1
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,8.1623e-05,0.27357,0.27325,1,1
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.00072342,0.2732,0.25658,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,8.5867e-06,0.27292,0.26842,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.00015331,0.27195,0.26647,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.0010558,0.27186,0.25223,1,1
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,3.5646e-05,0.27117,0.24597,1,1
2,GO REGULATION OF VESICLE FUSION,0.020605,0.27105,0.17657,1,1
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.030368,0.27026,0.18452,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,2.8001e-06,0.2686,0.22881,1,1
2,GO ADULT BEHAVIOR,2.3467e-08,0.26851,0.30092,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,6.0205e-08,0.2683,0.29703,1,1
2,GO NEUROTRANSMITTER TRANSPORT,9.8716e-08,0.26758,0.30443,1,1
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,1.9558e-07,0.26747,0.2528,1,1
2,GO NOREPINEPHRINE TRANSPORT,1.2027e-05,0.26712,0.27525,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,3.8149e-08,0.26696,0.26685,1,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,4.3236e-05,0.26667,0.26018,1,1
2,GO SYNAPSE ASSEMBLY,8.4415e-08,0.26657,0.30341,1,1
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00060545,0.26619,0.21747,1,1
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.0044298,0.26573,0.36637,1,1
2,GO DENDRITE SELF AVOIDANCE,0.00042128,0.2653,0.25371,1,1
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.021509,0.26505,0.23728,1,1
2,GO CELL PART MORPHOGENESIS,6.3569e-09,0.26452,0.28314,1,1
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,1.0036e-08,0.26412,0.29359,1,1
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.0018508,0.26405,0.21592,1,1
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,5.5127e-05,0.26287,0.26922,1,1
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00022927,0.26278,0.2751,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0003557,0.26278,0.22058,1,1
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.00014599,0.26226,0.20751,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,8.1623e-05,0.26182,0.27524,1,1
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0066039,0.26126,0.2513,1,1
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,7.0072e-05,0.26029,0.25305,1,1
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,9.0235e-07,0.25991,0.27156,1,1
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00086244,0.25975,0.28463,1,1
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0032078,0.25957,0.18785,1,1
2,GO HINDBRAIN DEVELOPMENT,1.6418e-07,0.25713,0.2518,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.2416e-05,0.25694,0.33578,1,1
2,GO PHOTORECEPTOR CELL MAINTENANCE,8.3013e-05,0.25611,0.18589,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,2.7078e-07,0.25549,0.26749,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.1552e-07,0.25476,0.25139,1,1
2,GO POSITIVE REGULATION OF AXON EXTENSION,2.4861e-06,0.25416,0.26782,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0020367,0.25399,0.25834,1,1
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,5.5127e-05,0.25248,0.27318,1,1
2,GO URETER DEVELOPMENT,0.0044298,0.25232,0.30714,1,1
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,1.5576e-05,0.25189,0.26194,1,1
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0054192,0.25133,0.21285,1,1
2,GO DENDRITE DEVELOPMENT,4.3082e-09,0.25091,0.29308,1,1
2,GO RESPONSE TO NICOTINE,2.206e-06,0.25011,0.27404,1,1
2,GO WALKING BEHAVIOR,1.5994e-06,0.24941,0.28348,1,1
2,GO REGULATION OF STEM CELL PROLIFERATION,3.0395e-05,0.2494,0.21842,1,1
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.00023294,0.24884,0.27335,1,1
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.001422,0.24878,0.21755,1,1
2,GO REGULATION OF BEHAVIOR,2.1624e-06,0.24763,0.23195,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,2.2505e-06,0.24724,0.3137,1,1
2,GO PROTEIN LOCALIZATION TO CILIUM,0.00015838,0.24704,0.21439,1,1
2,GO DOPAMINE TRANSPORT,7.6283e-05,0.24677,0.32857,1,1
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.002702,0.24668,0.25568,1,1
2,GO INNER DYNEIN ARM ASSEMBLY,0.026561,0.24577,0.24996,1,1
2,GO METANEPHROS MORPHOGENESIS,9.4959e-05,0.24502,0.23014,1,1
2,GO NEURAL CREST FORMATION,0.027973,0.24472,0.16018,1,1
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0053519,0.2443,0.19235,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00014362,0.24332,0.20712,1,1
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.6761e-05,0.24326,0.28218,1,1
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2716e-05,0.24312,0.23339,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.001483,0.24294,0.21481,1,1
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,4.31e-06,0.24252,0.25035,1,1
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.0012527,0.24235,0.23715,1,1
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.03006,0.24173,0.17166,1,1
2,GO MEMBRANE HYPERPOLARIZATION,0.00024819,0.24156,0.27113,1,1
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0015038,0.24128,0.20164,1,1
2,GO REGULATION OF DOPAMINE SECRETION,5.1446e-05,0.24121,0.39083,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,8.4262e-06,0.24055,0.28361,1,1
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,5.4356e-06,0.24014,0.22305,1,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0022396,0.24009,0.25566,1,1
2,GO OVULATION CYCLE PROCESS,1.5293e-05,0.23992,0.21319,1,1
2,GO LIMBIC SYSTEM DEVELOPMENT,9.7991e-09,0.23961,0.25729,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,6.545e-05,0.23943,0.26717,1,1
2,GO REGULATION OF FILOPODIUM ASSEMBLY,4.6359e-05,0.23936,0.23085,1,1
2,GO STRESS GRANULE ASSEMBLY,0.00014129,0.23926,0.20058,1,1
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.002702,0.23903,0.22718,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.012227,0.23896,0.17051,1,1
2,GO INTRACILIARY TRANSPORT,0.001235,0.23878,0.19903,1,1
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,3.4296e-07,0.23857,0.26804,1,1
2,GO HISTONE H3 K27 METHYLATION,6.3249e-05,0.23824,0.21807,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,1.2792e-06,0.23813,0.25718,1,1
2,GO MYELIN MAINTENANCE,0.010645,0.23811,0.22143,1,1
2,GO EPITHELIAL CELL MATURATION,0.003607,0.23811,0.19051,1,1
2,GO AXONAL TRANSPORT,8.3066e-07,0.23794,0.24494,1,1
2,GO SPINAL CORD DEVELOPMENT,6.6066e-07,0.23786,0.28031,1,1
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.0075485,0.23774,0.24158,1,1
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,1.6457e-05,0.23728,0.24584,1,1
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,2.4305e-07,0.2371,0.28248,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00062378,0.23688,0.22518,1,1
2,GO NEURON PROJECTION EXTENSION,8.4415e-08,0.23618,0.26616,1,1
2,GO SYNAPTIC SIGNALING,8.4877e-09,0.23604,0.27932,1,1
2,GO CHEMOSENSORY BEHAVIOR,1.9749e-05,0.23594,0.20309,1,1
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.010769,0.23561,0.23421,1,1
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0023637,0.2356,0.1972,1,1
2,GO ANTEROGRADE AXONAL TRANSPORT,1.4454e-06,0.23467,0.23869,1,1
2,GO NEUROTRANSMITTER UPTAKE,1.3442e-05,0.23397,0.24119,1,1
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0059116,0.23392,0.19836,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,7.5001e-05,0.23332,0.38237,1,1
2,GO REGULATION OF CATION CHANNEL ACTIVITY,5.8698e-06,0.23244,0.22533,1,1
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00069207,0.2316,0.17945,1,1
2,GO TONGUE DEVELOPMENT,0.041383,0.22957,0.15785,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0012886,0.22923,0.2127,1,1
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.2538e-08,0.22856,0.25468,1,1
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,1.8701e-05,0.22856,0.33324,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,9.819e-05,0.22848,0.19364,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013069,0.22844,0.22938,1,1
2,GO OVULATION CYCLE,9.4341e-06,0.22827,0.21173,1,1
2,GO REGULATION OF TUBULIN DEACETYLATION,5.9056e-05,0.22819,0.27237,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,3.5022e-05,0.22805,0.22666,1,1
2,GO CENTRIOLE CENTRIOLE COHESION,4.9694e-05,0.22804,0.26905,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.1494e-05,0.22711,0.26203,1,1
2,GO REGULATION OF RECEPTOR INTERNALIZATION,2.5934e-07,0.22695,0.24058,1,1
2,GO RESPONSE TO COCAINE,1.5052e-06,0.22674,0.25309,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,4.1552e-07,0.22647,0.26284,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING,2.4837e-07,0.22633,0.22834,1,1
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.020385,0.22584,0.17534,1,1
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,9.4407e-08,0.22469,0.23895,1,1
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0014624,0.22402,0.22545,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,4.3997e-05,0.224,0.28789,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.027118,0.22324,0.26021,1,1
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.00063314,0.22297,0.22603,1,1
2,GO ASSOCIATIVE LEARNING,1.5713e-07,0.22243,0.24098,1,1
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.020385,0.22236,0.17387,1,1
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00013899,0.22135,0.22047,1,1
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,1.2058e-07,0.22118,0.24076,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.00024045,0.2209,0.20992,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.015501,0.22064,0.17474,1,1
2,GO NUCLEAR MIGRATION,0.0005056,0.22025,0.23224,1,1
2,GO POST ANAL TAIL MORPHOGENESIS,0.00044781,0.22002,0.22309,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0023957,0.21976,0.26011,1,1
2,GO NEURAL CREST CELL MIGRATION,7.3739e-05,0.21925,0.25727,1,1
2,GO TELENCEPHALON DEVELOPMENT,2.4586e-08,0.2188,0.25311,1,1
2,GO ATRIAL SEPTUM DEVELOPMENT,0.024687,0.21722,0.17295,1,1
2,GO AXON EXTENSION,5.4982e-08,0.21718,0.28354,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0047198,0.2162,0.23945,1,1
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0013069,0.21607,0.27825,1,1
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.062114,0.21544,0.33605,1,1
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.039795,0.21478,0.16776,1,1
2,GO NEPHRIC DUCT MORPHOGENESIS,0.010279,0.21438,0.19392,1,1
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,2.7312e-05,0.21307,0.21738,1,1
2,GO FOREBRAIN DEVELOPMENT,1.471e-07,0.21286,0.23363,1,1
2,GO MITOCHONDRION DISTRIBUTION,1.8053e-06,0.21274,0.25038,1,1
2,GO NUCLEUS LOCALIZATION,0.00023294,0.21253,0.22678,1,1
2,GO LOCOMOTORY BEHAVIOR,6.4699e-07,0.21139,0.26088,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.00052901,0.21121,0.30392,1,1
2,GO SPERMATID NUCLEUS DIFFERENTIATION,1.0557e-05,0.21116,0.22133,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00047589,0.21106,0.30558,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,3.628e-05,0.21067,0.28357,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.012945,0.21043,0.1599,1,1
2,GO COGNITION,5.1356e-08,0.21035,0.23272,1,1
2,GO EMBRYONIC EYE MORPHOGENESIS,0.00029511,0.21008,0.20654,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,2.3784e-07,0.20983,0.2177,1,1
2,GO REGULATION OF CAMP MEDIATED SIGNALING,5.7582e-06,0.20961,0.22845,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0022095,0.20948,0.18331,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0042636,0.2091,0.20794,1,1
2,GO HISTONE H3 K9 METHYLATION,0.0063654,0.20871,0.17243,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,4.1751e-05,0.20855,0.2636,1,1
2,GO PALLIUM DEVELOPMENT,5.4982e-08,0.2081,0.23569,1,1
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,4.9228e-07,0.20792,0.20749,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,9.03e-05,0.20777,0.23275,1,1
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,6.3359e-07,0.20754,0.23281,1,1
2,GO SEROTONIN SECRETION,0.00084997,0.20729,0.25821,1,1
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,3.9613e-05,0.20657,0.17041,1,1
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,3.0156e-07,0.20629,0.21412,1,1
2,GO SMOOTH MUSCLE CONTRACTION,7.8911e-05,0.20618,0.16371,1,1
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,8.3013e-05,0.20597,0.21529,1,1
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0037498,0.20592,0.17448,1,1
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.034984,0.20568,0.14064,1,1
2,GO PRESYNAPTIC ENDOCYTOSIS,1.475e-06,0.20563,0.24693,1,1
2,GO SMOOTHENED SIGNALING PATHWAY,0.00015083,0.20514,0.17669,1,1
2,GO REVERSE CHOLESTEROL TRANSPORT,0.0080166,0.20507,0.20756,1,1
2,GO CATECHOLAMINE SECRETION,2.011e-05,0.20469,0.32568,1,1
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0049019,0.2041,0.18108,1,1
2,GO FEEDING BEHAVIOR,1.2253e-05,0.20401,0.1959,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0005618,0.20399,0.19909,1,1
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0023637,0.20367,0.23061,1,1
2,GO REGULATION OF HEAT GENERATION,0.0011503,0.2031,0.22156,1,1
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0028492,0.20275,0.18719,1,1
2,GO REGULATION OF HEART MORPHOGENESIS,0.060988,0.20226,0.12087,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.00022927,0.20185,0.19922,1,1
2,GO CGMP MEDIATED SIGNALING,0.022686,0.20172,0.14254,1,1
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00019541,0.20162,0.24434,1,1
2,GO REGULATION OF MEMBRANE POTENTIAL,4.8416e-06,0.20136,0.20935,1,1
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,9.03e-05,0.20118,0.25891,1,1
2,GO BEHAVIOR,3.1729e-08,0.20111,0.2317,1,1
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,2.4861e-06,0.20106,0.19769,1,1
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,9.2118e-07,0.20104,0.23566,1,1
2,GO AXO DENDRITIC TRANSPORT,1.475e-06,0.20087,0.21972,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0011836,0.20011,0.20919,1,1
2,GO GROWTH HORMONE SECRETION,0.00018323,0.19999,0.34525,1,1
2,GO TRANSPORT ALONG MICROTUBULE,2.5868e-06,0.19966,0.191,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0066039,0.19943,0.18462,1,1
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0031247,0.19903,0.18359,1,1
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0050269,0.19889,0.17377,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00025215,0.19877,0.20685,1,1
2,GO MOTILE CILIUM ASSEMBLY,0.060432,0.19849,0.12607,1,1
2,GO REGULATION OF RESPONSE TO FOOD,5.8049e-05,0.1984,0.2163,1,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00019541,0.1977,0.17125,1,1
2,GO RECEPTOR INTERNALIZATION,4.1456e-06,0.19674,0.1918,1,1
2,GO RESPIRATORY SYSTEM PROCESS,0.00031414,0.19653,0.20426,1,1
2,GO FILOPODIUM ASSEMBLY,0.0001179,0.19608,0.19559,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.00091404,0.19601,0.20317,1,1
2,GO PROSTATE GLAND GROWTH,0.0063654,0.19589,0.22314,1,1
2,GO PROTEIN DEMETHYLATION,0.00086244,0.19579,0.17779,1,1
2,GO HEAD DEVELOPMENT,5.1351e-07,0.19564,0.19839,1,1
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,3.8347e-06,0.19528,0.22459,1,1
2,GO GLIAL CELL MIGRATION,0.0093576,0.19512,0.14182,1,1
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.057179,0.19488,0.12176,1,1
2,GO MEMORY,2.1196e-06,0.19468,0.20771,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,8.7502e-06,0.19381,0.19205,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.044292,0.1937,0.12098,1,1
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0005211,0.19368,0.19521,1,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,7.2497e-05,0.1927,0.1674,1,1
2,GO CHROMATIN SILENCING AT TELOMERE,0.00013451,0.1923,0.17503,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.029754,0.19223,0.14632,1,1
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.00024045,0.19191,0.20115,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00010497,0.1919,0.18382,1,1
2,GO GANGLIOSIDE METABOLIC PROCESS,0.0002117,0.19046,0.21618,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.2253e-05,0.19024,0.186,1,1
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,3.5646e-05,0.19009,0.19516,1,1
2,GO UTERUS DEVELOPMENT,0.0034692,0.18966,0.20837,1,1
2,GO RESPONSE TO LEUCINE,0.0047798,0.18876,0.19335,1,1
2,GO INCLUSION BODY ASSEMBLY,0.0012705,0.18875,0.22925,1,1
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,2.5934e-07,0.18874,0.2004,1,1
2,GO VENTRICULAR SYSTEM DEVELOPMENT,1.0557e-05,0.18852,0.21633,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0012005,0.1883,0.17721,1,1
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,7.5001e-05,0.1878,0.18375,1,1
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0015463,0.18774,0.18808,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.059331,0.1877,0.11323,1,1
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0021798,0.18769,0.20627,1,1
2,GO NEUROPEPTIDE SIGNALING PATHWAY,4.8839e-05,0.18753,0.2159,1,1
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0020092,0.18733,0.17464,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0042095,0.18708,0.16232,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.0011341,0.18676,0.16243,1,1
2,GO ACIDIC AMINO ACID TRANSPORT,1.2954e-05,0.18675,0.20384,1,1
2,GO MESENCHYMAL CELL PROLIFERATION,0.011151,0.18654,0.18107,1,1
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0016347,0.18617,0.20976,1,1
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.0090315,0.18614,0.19481,1,1
2,GO AXONEME ASSEMBLY,0.0030839,0.18598,0.18311,1,1
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.00022208,0.18596,0.23235,1,1
2,GO CLATHRIN COAT ASSEMBLY,0.014013,0.18595,0.13921,1,1
2,GO CELLULAR RESPONSE TO X RAY,0.0058389,0.18583,0.12502,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.00091404,0.18516,0.16907,1,1
2,GO REGULATION OF FEEDING BEHAVIOR,5.5127e-05,0.18501,0.24115,1,1
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,5.6085e-05,0.1848,0.2704,1,1
2,GO MONOAMINE TRANSPORT,2.4091e-05,0.18403,0.27455,1,1
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.006444,0.18388,0.1699,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00099681,0.18355,0.18244,1,1
2,GO SPERM AXONEME ASSEMBLY,0.003654,0.18354,0.17118,1,1
2,GO UV PROTECTION,0.0067673,0.1827,0.17625,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0002117,0.18264,0.17025,1,1
2,GO RESPONSE TO DOPAMINE,2.1624e-06,0.18245,0.20782,1,1
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00042777,0.18242,0.21911,1,1
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.016568,0.18172,0.15937,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.2482e-05,0.1815,0.18448,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.8701e-05,0.18147,0.19487,1,1
2,GO CORONARY VASCULATURE DEVELOPMENT,0.00055343,0.18095,0.1939,1,1
2,GO REGULATION OF MICROTUBULE BINDING,0.0012527,0.18044,0.22168,1,1
2,GO SECRETORY GRANULE ORGANIZATION,0.0054192,0.18032,0.13673,1,1
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,5.3256e-05,0.17994,0.18284,1,1
2,GO SOMITE DEVELOPMENT,8.4424e-05,0.17968,0.17021,1,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.035336,0.17887,0.10754,1,1
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00042777,0.17838,0.19534,1,1
2,GO NOREPINEPHRINE SECRETION,0.0015463,0.17835,0.21532,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.00013899,0.17834,0.17982,1,1
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0013255,0.17822,0.13632,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0010259,0.17822,0.15295,1,1
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00028155,0.17796,0.16285,1,1
2,GO ADHERENS JUNCTION ASSEMBLY,0.056652,0.17759,0.12155,1,1
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00052901,0.17744,0.16652,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,4.6202e-07,0.17743,0.20274,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,8.8796e-05,0.17735,0.184,1,1
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,1.1165e-05,0.1772,0.17386,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.045155,0.17705,0.16072,1,1
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.054582,0.17635,0.15904,1,1
2,GO MICROTUBULE BASED TRANSPORT,1.0958e-05,0.17623,0.18797,1,1
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.015159,0.17619,0.12515,1,1
2,GO APPENDAGE MORPHOGENESIS,0.0072795,0.17608,0.14375,1,1
2,GO POTASSIUM ION TRANSPORT,9.086e-06,0.17603,0.20118,1,1
2,GO MICROTUBULE ANCHORING,2.1234e-05,0.17591,0.20215,1,1
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00053704,0.17525,0.19969,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0044864,0.17517,0.19793,1,1
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.023419,0.17494,0.1249,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.001442,0.17493,0.17569,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0051547,0.17458,0.16844,1,1
2,GO CARDIAC ATRIUM DEVELOPMENT,0.023919,0.17454,0.14655,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0020646,0.17376,0.19956,1,1
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0038977,0.17275,0.20134,1,1
2,GO HISTONE H3 K9 MODIFICATION,0.013394,0.17238,0.14691,1,1
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.042609,0.17215,0.15582,1,1
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.058787,0.17168,0.15152,1,1
2,GO MICROTUBULE BASED MOVEMENT,7.8124e-06,0.1716,0.17656,1,1
2,GO REGULATION OF CILIUM MOVEMENT,0.00072342,0.17146,0.1613,1,1
2,GO OUTER DYNEIN ARM ASSEMBLY,0.030368,0.17142,0.16055,1,1
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00019229,0.17142,0.16542,1,1
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0014624,0.17121,0.16668,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.045591,0.17117,0.11991,1,1
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.012087,0.17093,0.15507,1,1
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0010865,0.17092,0.19266,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.025743,0.17082,0.13204,1,1
2,GO ORGANIC CATION TRANSPORT,0.00020178,0.17054,0.18719,1,1
2,GO DENDRITIC SPINE MAINTENANCE,0.0069343,0.1705,0.193,1,1
2,GO GLIAL CELL DIFFERENTIATION,2.9332e-05,0.17047,0.18086,1,1
2,GO SYNAPTIC VESICLE TRANSPORT,0.00059648,0.17005,0.18819,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,7.8911e-05,0.1699,0.17873,1,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.043866,0.16966,0.14323,1,1
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0037498,0.16942,0.16529,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.019104,0.16941,0.14365,1,1
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.00035024,0.1691,0.17609,1,1
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.8698e-06,0.16888,0.18323,1,1
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.036048,0.16785,0.11901,1,1
2,GO REGULATION OF SENSORY PERCEPTION,0.0002117,0.16733,0.17877,1,1
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0043737,0.16666,0.15516,1,1
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00023294,0.16646,0.17978,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.00092737,0.16611,0.1847,1,1
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,7.1274e-05,0.16608,0.17717,1,1
2,GO REGULATION OF TRANSPORTER ACTIVITY,1.5014e-05,0.16601,0.1801,1,1
2,GO STEM CELL DIVISION,0.013243,0.16538,0.13955,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,8.1138e-06,0.16532,0.21257,1,1
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0046018,0.16443,0.16704,1,1
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.00091404,0.16439,0.14733,1,1
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.00044781,0.16325,0.21721,1,1
2,GO TOOTH MINERALIZATION,0.01585,0.16254,0.16608,1,1
2,GO PROTEIN PALMITOYLATION,0.00018923,0.16227,0.18944,1,1
2,GO MEMBRANE REPOLARIZATION,0.011949,0.1622,0.14866,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.026561,0.16213,0.11023,1,1
2,GO EXTRACELLULAR TRANSPORT,0.036048,0.16194,0.12605,1,1
2,GO SEGMENTATION,0.00023294,0.16186,0.15905,1,1
2,GO FEAR RESPONSE,0.0001179,0.16168,0.17923,1,1
2,GO TRANSMISSION OF NERVE IMPULSE,0.0011503,0.16161,0.21947,1,1
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0074579,0.16154,0.1206,1,1
2,GO MEMBRANE BIOGENESIS,0.00046872,0.16153,0.21706,1,1
2,GO REGULATION OF CELL SIZE,1.155e-06,0.16108,0.20791,1,1
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.011411,0.16092,0.17959,1,1
2,GO PEPTIDE HORMONE SECRETION,0.00017741,0.16092,0.16276,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.00017176,0.16058,0.1987,1,1
2,GO MATING,7.2414e-06,0.16046,0.18124,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.0059116,0.16042,0.15968,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.033948,0.16022,0.14663,1,1
2,GO TRACHEA DEVELOPMENT,0.03068,0.15907,0.14305,1,1
2,GO SINGLE STRAND BREAK REPAIR,0.017894,0.15906,0.12117,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00071283,0.1589,0.25597,1,1
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,1.9749e-05,0.15863,0.20029,1,1
2,GO HISTONE H3 K9 TRIMETHYLATION,0.00012186,0.15859,0.1788,1,1
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,1.9749e-05,0.15831,0.1642,1,1
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,5.8049e-05,0.15805,0.17881,1,1
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0033361,0.15803,0.15184,1,1
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.00064263,0.15797,0.17865,1,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.00049053,0.15791,0.22282,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0043737,0.15751,0.12347,1,1
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,1.9563e-06,0.15745,0.1728,1,1
2,GO L GLUTAMATE IMPORT,0.023919,0.15704,0.12132,1,1
2,GO ECTODERM DEVELOPMENT,0.016386,0.15688,0.11901,1,1
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0086125,0.15671,0.13546,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0028118,0.15655,0.13653,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.000662,0.15622,0.15033,1,1
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0011836,0.15609,0.18143,1,1
2,GO PLASMA MEMBRANE TUBULATION,0.054074,0.15598,0.1045,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0014624,0.15572,0.17044,1,1
2,GO SCHWANN CELL DEVELOPMENT,0.001776,0.15422,0.16627,1,1
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.00073415,0.1542,0.18101,1,1
2,GO CELL RECOGNITION,8.5858e-05,0.15377,0.16039,1,1
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,4.0657e-06,0.15336,0.18463,1,1
2,GO PATTERN SPECIFICATION PROCESS,0.0001803,0.15326,0.15504,1,1
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.031311,0.15323,0.15448,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.011151,0.15309,0.15729,1,1
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0012177,0.15305,0.23712,1,1
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.03429,0.153,0.15565,1,1
2,GO CELLULAR RESPONSE TO STEROL,8.4424e-05,0.15298,0.23435,1,1
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.05063,0.15287,0.11046,1,1
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,2.4528e-05,0.15276,0.15576,1,1
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.0027747,0.15224,0.22087,1,1
2,GO POSITIVE REGULATION OF DNA REPAIR,0.0011668,0.15204,0.1392,1,1
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0024609,0.15185,0.16758,1,1
2,GO NEPHRIC DUCT DEVELOPMENT,0.046474,0.15126,0.13412,1,1
2,GO RESPONSE TO FOOD,0.0078263,0.151,0.12427,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.011151,0.15078,0.19145,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.0076401,0.15055,0.1222,1,1
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.012227,0.15054,0.17248,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02945,0.15029,0.11949,1,1
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00012388,0.15021,0.1633,1,1
2,GO AMINE TRANSPORT,0.0015463,0.14985,0.21427,1,1
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0017517,0.14966,0.11865,1,1
2,GO FUCOSYLATION,0.021509,0.14948,0.12236,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.024947,0.14907,0.11036,1,1
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0022396,0.14903,0.1499,1,1
2,GO MALE GAMETE GENERATION,0.00023667,0.14902,0.13033,1,1
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.03429,0.14815,0.11277,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.01829,0.14731,0.12656,1,1
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.0033361,0.14719,0.13967,1,1
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00036686,0.14663,0.18339,1,1
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00088789,0.14643,0.15167,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0020092,0.14642,0.16206,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0028118,0.14638,0.13789,1,1
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.017894,0.14561,0.1243,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0049019,0.14557,0.16048,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.00015838,0.14539,0.12278,1,1
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.0042636,0.14533,0.16393,1,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.013093,0.14531,0.16725,1,1
2,GO GLIAL CELL DEVELOPMENT,0.00027716,0.14528,0.16895,1,1
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0084096,0.14499,0.19097,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0086125,0.14496,0.14138,1,1
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.03068,0.14487,0.14024,1,1
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.021973,0.1436,0.21992,1,1
2,GO REGULATION OF DNA BINDING,0.00015838,0.14352,0.13856,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.2416e-05,0.14322,0.16302,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0035146,0.14293,0.11931,1,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.063258,0.1429,0.11915,1,1
2,GO GERM CELL DEVELOPMENT,0.00036686,0.14284,0.13692,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.014494,0.14282,0.14496,1,1
2,GO REGULATION OF VASCULAR PERMEABILITY,0.043866,0.14262,0.10995,1,1
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.020605,0.14248,0.13978,1,1
2,GO INSULIN SECRETION,0.00076726,0.14227,0.15158,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.015674,0.14208,0.11247,1,1
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00072342,0.14136,0.14398,1,1
2,GO RESPONSE TO MUSCLE ACTIVITY,0.015674,0.14136,0.13138,1,1
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00013899,0.14127,0.15931,1,1
2,GO REGULATION OF APPETITE,0.0039481,0.14127,0.11083,1,1
2,GO DEVELOPMENTAL GROWTH,1.3693e-05,0.14075,0.16092,1,1
2,GO REGULATION OF EXOCYTOSIS,0.00013016,0.1405,0.16524,1,1
2,GO SPERM MOTILITY,0.00015083,0.14006,0.15416,1,1
2,GO FATTY ACID HOMEOSTASIS,0.010645,0.14001,0.17057,1,1
2,GO REGULATION OF MICROTUBULE BASED PROCESS,1.1588e-05,0.13973,0.1671,1,1
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.0034692,0.13969,0.13194,1,1
2,GO MULTICELLULAR ORGANISM GROWTH,3.8246e-05,0.13938,0.16198,1,1
2,GO ASTROCYTE DIFFERENTIATION,0.0037498,0.13934,0.14519,1,1
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,6.5837e-06,0.13932,0.16302,1,1
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.0013069,0.13919,0.12498,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.024687,0.13916,0.12791,1,1
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.00046872,0.1391,0.17343,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,4.9361e-06,0.139,0.19901,1,1
2,GO HEART MORPHOGENESIS,0.0028492,0.13866,0.1363,1,1
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.9749e-05,0.13849,0.16755,1,1
2,GO FEVER GENERATION,0.047827,0.13848,0.1115,1,1
2,GO REGULATION OF HORMONE SECRETION,0.0024609,0.13838,0.12284,1,1
2,GO ODONTOGENESIS,0.0078263,0.13799,0.14482,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,4.0657e-06,0.13771,0.16376,1,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.057711,0.13728,0.10586,1,1
2,GO HISTONE METHYLATION,0.00081356,0.13685,0.15139,1,1
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00017741,0.13649,0.16155,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0060595,0.13645,0.1386,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.038637,0.1362,0.102,1,1
2,GO FUCOSE METABOLIC PROCESS,0.033608,0.13612,0.10995,1,1
2,GO REGULATION OF HISTONE METHYLATION,0.00030449,0.1359,0.15701,1,1
2,GO REGULATION OF INSULIN SECRETION,0.0001803,0.13587,0.16217,1,1
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0012705,0.13575,0.14812,1,1
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0023957,0.13563,0.15481,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0056255,0.13556,0.12843,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00037257,0.13533,0.13926,1,1
2,GO P BODY ASSEMBLY,0.010522,0.1349,0.1154,1,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.011813,0.13478,0.11596,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.0038977,0.1342,0.1438,1,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.014823,0.13413,0.12076,1,1
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.054074,0.1339,0.11206,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.03902,0.13361,0.087525,1,1
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00012804,0.13347,0.13337,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0086125,0.13346,0.155,1,1
2,GO REGULATION OF HEART GROWTH,0.033948,0.13303,0.094882,1,1
2,GO CHROMATIN SILENCING,0.00010673,0.13303,0.15462,1,1
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0057669,0.13268,0.12072,1,1
2,GO VASCULOGENESIS,0.066192,0.13208,0.1197,1,1
2,GO CELLULAR RESPONSE TO ATP,0.0034243,0.13184,0.1348,1,1
2,GO ENSHEATHMENT OF NEURONS,0.0010865,0.13176,0.1396,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.041383,0.13069,0.11477,1,1
2,GO HEAT GENERATION,0.0042636,0.13039,0.15425,1,1
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0074579,0.13039,0.12743,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.028556,0.13015,0.12498,1,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.011949,0.12981,0.11805,1,1
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.054582,0.12978,0.16303,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.00060545,0.12972,0.13486,1,1
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.030994,0.12961,0.15448,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.046031,0.12951,0.089425,1,1
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00015083,0.12951,0.15091,1,1
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.031311,0.12942,0.089666,1,1
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0018256,0.12912,0.15928,1,1
2,GO APPENDAGE DEVELOPMENT,0.0086125,0.12896,0.12613,1,1
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0021505,0.12875,0.18184,1,1
2,GO MUSCLE FIBER DEVELOPMENT,0.0020092,0.12867,0.16639,1,1
2,GO NON MOTILE CILIUM ASSEMBLY,0.042609,0.12867,0.11083,1,1
2,GO GAMETE GENERATION,0.00038422,0.12866,0.12856,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0038478,0.12854,0.10556,1,1
2,GO POSITIVE REGULATION OF DNA BINDING,0.0033361,0.12854,0.12492,1,1
2,GO HEART VALVE DEVELOPMENT,0.013394,0.12787,0.14071,1,1
2,GO SPECIFICATION OF SYMMETRY,0.001568,0.12754,0.11405,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0044864,0.12729,0.12625,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.02915,0.12708,0.086553,1,1
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0041031,0.12697,0.12995,1,1
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03068,0.12692,0.12254,1,1
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.018693,0.12655,0.12695,1,1
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0010408,0.12639,0.13714,1,1
2,GO TUBE FORMATION,0.057179,0.12544,0.093773,1,1
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.016027,0.12461,0.14307,1,1
2,GO MYOBLAST PROLIFERATION,0.0053519,0.12454,0.1348,1,1
2,GO POSITIVE REGULATION OF CELL DIVISION,0.0069343,0.12433,0.12869,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.0018508,0.1242,0.15746,1,1
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.047372,0.12417,0.10588,1,1
2,GO REGULATION OF CENTRIOLE REPLICATION,0.058247,0.1237,0.13815,1,1
2,GO AXIS SPECIFICATION,0.0078263,0.12355,0.12093,1,1
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.026561,0.12265,0.12108,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001776,0.12258,0.16957,1,1
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.00096848,0.12253,0.11934,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.023419,0.12247,0.098849,1,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.052575,0.12238,0.099288,1,1
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.046474,0.1223,0.11561,1,1
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.030368,0.12213,0.087178,1,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.010279,0.12206,0.14153,1,1
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.00082553,0.12178,0.13777,1,1
2,GO REGULATION OF SODIUM ION TRANSPORT,0.001568,0.12146,0.15421,1,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.028264,0.12113,0.12937,1,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.022686,0.12103,0.086767,1,1
2,GO GROOMING BEHAVIOR,0.0078263,0.12069,0.15595,1,1
2,GO CARDIAC SEPTUM DEVELOPMENT,0.0098086,0.12067,0.14567,1,1
2,GO REGULATION OF PHOSPHATASE ACTIVITY,5.4184e-05,0.12037,0.14844,1,1
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.00159,0.12029,0.1051,1,1
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.025475,0.1201,0.12117,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0044298,0.12002,0.097012,1,1
2,GO REGULATION OF GLIOGENESIS,0.0032078,0.11952,0.12598,1,1
2,GO COVALENT CHROMATIN MODIFICATION,0.0003557,0.1195,0.12862,1,1
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.0023957,0.11918,0.1245,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0088198,0.1189,0.13326,1,1
2,GO REGULATION OF CHROMATIN BINDING,0.010645,0.11854,0.17199,1,1
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.5359e-06,0.11852,0.1651,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.021509,0.11815,0.13379,1,1
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.00046872,0.11788,0.12016,1,1
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.038258,0.11783,0.13163,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.020605,0.11773,0.090821,1,1
2,GO NAD METABOLIC PROCESS,0.018898,0.11749,0.14367,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.00010497,0.11744,0.14468,1,1
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.00032916,0.11616,0.12075,1,1
2,GO SEXUAL REPRODUCTION,0.00022565,0.11541,0.12164,1,1
2,GO ACTION POTENTIAL,0.002702,0.11526,0.1546,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0044298,0.11489,0.12507,1,1
2,GO REGULATION OF RNA SPLICING,0.00098255,0.11472,0.12225,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.002631,0.11466,0.11609,1,1
2,GO RESPONSE TO AMYLOID BETA,0.027973,0.11433,0.11742,1,1
2,GO RRNA CATABOLIC PROCESS,0.034984,0.11417,0.10446,1,1
2,GO CILIUM MOVEMENT,0.001235,0.11317,0.14931,1,1
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.034636,0.11289,0.113,1,1
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0007786,0.11245,0.11624,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.001955,0.11241,0.13223,1,1
2,GO RHYTHMIC PROCESS,0.00025215,0.11241,0.13347,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.0021505,0.11229,0.1399,1,1
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0005789,0.11143,0.11365,1,1
2,GO SPERMATID DIFFERENTIATION,0.00074504,0.11112,0.12446,1,1
2,GO MICROTUBULE BASED PROCESS,1.2253e-05,0.11085,0.1602,1,1
2,GO CELL CYCLE ARREST,0.001776,0.11076,0.11364,1,1
2,GO RECEPTOR METABOLIC PROCESS,0.00088789,0.11053,0.12734,1,1
2,GO HORMONE TRANSPORT,0.0066851,0.11009,0.1126,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0023957,0.10984,0.11149,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0035146,0.10958,0.10454,1,1
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.065005,0.10949,0.069522,1,1
2,GO POSITIVE REGULATION OF MYELINATION,0.02128,0.10949,0.09861,1,1
2,GO GROWTH,0.0013826,0.10945,0.10837,1,1
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.062114,0.10933,0.089575,1,1
2,GO MISMATCH REPAIR,0.01585,0.10916,0.11244,1,1
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0028492,0.10915,0.13483,1,1
2,GO REGULATION OF GLIAL CELL MIGRATION,0.022928,0.10901,0.086221,1,1
2,GO FEMALE GAMETE GENERATION,0.003607,0.1087,0.10605,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0062108,0.1085,0.091894,1,1
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.027401,0.10844,0.093441,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.045155,0.10834,0.091753,1,1
2,GO EATING BEHAVIOR,0.021509,0.10812,0.11121,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0098086,0.10713,0.13036,1,1
2,GO PEPTIDYL LYSINE METHYLATION,0.0032501,0.10701,0.13771,1,1
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.044292,0.10661,0.17825,1,1
2,GO ONE CARBON METABOLIC PROCESS,0.02945,0.1064,0.11264,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.054582,0.10551,0.10458,1,1
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0016347,0.10544,0.1495,1,1
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.00030928,0.1053,0.15688,1,1
2,GO LENS FIBER CELL DIFFERENTIATION,0.040981,0.10422,0.12157,1,1
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.049212,0.10363,0.11354,1,1
2,GO CALCINEURIN MEDIATED SIGNALING,0.0059852,0.10311,0.1531,1,1
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.00036686,0.10289,0.14528,1,1
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.018693,0.10278,0.10721,1,1
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0098086,0.1026,0.13358,1,1
2,GO REGULATION OF DEPHOSPHORYLATION,0.00021857,0.10254,0.13033,1,1
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.050154,0.10222,0.1159,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.011813,0.10215,0.12096,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.053071,0.1016,0.10454,1,1
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.01829,0.10104,0.10047,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.021509,0.10084,0.078576,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.027973,0.10081,0.11872,1,1
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00068191,0.10017,0.12241,1,1
2,GO CHROMATIN ORGANIZATION,0.0037498,0.099545,0.11798,1,1
2,GO MULTI ORGANISM PROCESS,0.0020646,0.099511,0.098288,1,1
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0043737,0.099262,0.11228,1,1
2,GO REGULATION OF PROTEIN DEACETYLATION,0.013546,0.098979,0.11058,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.002631,0.098826,0.1166,1,1
2,GO RESPONSE TO AMINO ACID STARVATION,0.01585,0.098609,0.10865,1,1
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.00022927,0.098524,0.095863,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.037139,0.0983,0.079254,1,1
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.0027747,0.098275,0.13585,1,1
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.001422,0.098178,0.10486,1,1
2,GO SODIUM ION TRANSPORT,0.0017517,0.097594,0.12211,1,1
2,GO ESTABLISHMENT OF CELL POLARITY,0.0062877,0.097567,0.11711,1,1
2,GO NEURON DEATH,0.0018256,0.097471,0.10884,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.012945,0.096085,0.12201,1,1
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.025475,0.095833,0.096977,1,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.046921,0.095562,0.080052,1,1
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.016752,0.095468,0.11827,1,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.0039992,0.095103,0.10704,1,1
2,GO ORGAN GROWTH,0.012653,0.095023,0.093087,1,1
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00099681,0.094868,0.10846,1,1
2,GO REGULATION OF ORGAN GROWTH,0.041789,0.094508,0.084831,1,1
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.02174,0.093824,0.13079,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.025743,0.093814,0.092004,1,1
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.020166,0.093781,0.089707,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.046031,0.093728,0.091872,1,1
2,GO NEGATIVE REGULATION OF BINDING,0.001071,0.093453,0.11803,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.011544,0.093186,0.11617,1,1
2,GO REGULATION OF CIRCADIAN RHYTHM,0.0020646,0.09289,0.13527,1,1
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.0023637,0.092364,0.11849,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.013856,0.09182,0.10743,1,1
2,GO LIPID PHOSPHORYLATION,0.012367,0.091808,0.11156,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.018693,0.091599,0.10272,1,1
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.001118,0.091394,0.11321,1,1
2,GO RESPONSE TO ACID CHEMICAL,0.026286,0.090973,0.0874,1,1
2,GO SKELETAL MUSCLE CONTRACTION,0.0047198,0.090753,0.14997,1,1
2,GO RESPONSE TO ATP,0.0137,0.089887,0.098347,1,1
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.038258,0.08977,0.10801,1,1
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.01995,0.089679,0.12365,1,1
2,GO CALCIUM MEDIATED SIGNALING,0.024687,0.089137,0.06938,1,1
2,GO REGULATION OF HISTONE MODIFICATION,0.0039481,0.088452,0.1042,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0011668,0.087882,0.13975,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.052083,0.087481,0.13115,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.046921,0.087134,0.091885,1,1
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.040187,0.08711,0.075598,1,1
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.011813,0.087046,0.10109,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.062114,0.086732,0.080563,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.052575,0.086638,0.096607,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.020385,0.086427,0.082119,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.044292,0.086231,0.077498,1,1
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.026286,0.082822,0.079018,1,1
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0034243,0.082673,0.11189,1,1
2,GO REPRODUCTION,0.013546,0.081644,0.085827,1,1
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.004964,0.08154,0.10981,1,1
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.058247,0.080373,0.096754,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00029511,0.079479,0.14305,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.048285,0.07919,0.078179,1,1
2,GO PROTEIN METHYLATION,0.0085105,0.078036,0.12223,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.017506,0.077327,0.09534,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.014494,0.076738,0.092012,1,1
2,GO DEVELOPMENTAL INDUCTION,0.045155,0.076593,0.125,1,1
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.019312,0.075753,0.084063,1,1
2,GO REGULATION OF GROWTH,0.0054192,0.075626,0.095314,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.019735,0.075177,0.10057,1,1
2,GO REGULATION OF PROTEIN TARGETING,0.0032928,0.073257,0.10381,1,1
2,GO STEM CELL DIFFERENTIATION,0.041789,0.073211,0.068264,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.018898,0.072385,0.08209,1,1
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.01849,0.07133,0.10284,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.019523,0.071157,0.082242,1,1
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.064418,0.070807,0.076038,1,1
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.02945,0.070614,0.088527,1,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.05357,0.070325,0.068175,1,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.01128,0.070191,0.093262,1,1
2,GO FERTILIZATION,0.0050269,0.069748,0.096603,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE,0.045591,0.06963,0.059412,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0044864,0.069375,0.1093,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.054074,0.069157,0.10161,1,1
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.017699,0.068947,0.082577,1,1
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.052575,0.068821,0.089538,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.017699,0.067289,0.080663,1,1
2,GO SINGLE FERTILIZATION,0.046474,0.067285,0.077886,1,1
2,GO POSITIVE REGULATION OF TRANSPORT,0.044722,0.066907,0.071117,1,1
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.028264,0.066678,0.096608,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.013856,0.065557,0.084402,1,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.032938,0.064306,0.070181,1,1
2,GO NADH METABOLIC PROCESS,0.029754,0.063689,0.13495,1,1
2,GO MACROMOLECULE DEACYLATION,0.0039992,0.063644,0.11171,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.018693,0.063433,0.07859,1,1
2,GO GENE SILENCING,0.042197,0.063312,0.071891,1,1
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.045591,0.060887,0.11163,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.047827,0.05934,0.069099,1,1
2,GO NEGATIVE REGULATION OF SECRETION,0.032607,0.058128,0.072329,1,1
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.026286,0.0572,0.088052,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.043444,0.048146,0.080277,1,1
2,GO REGULATION OF CELL CYCLE,0.017125,0.047587,0.08528,1,1
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.065596,0.045623,0.10033,1,1
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.019735,0.044818,0.069782,1,1
2,GO CELL CYCLE PROCESS,0.017125,0.042848,0.089562,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.013243,0.20147,0.18596,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.016386,0.18082,0.1434,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.027973,0.16095,0.081438,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.057711,0.15341,0.1093,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.033948,0.14948,0.081229,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.043866,0.10291,0.074179,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.8416e-06,1.2219,1.0612,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,2.7452e-06,0.96801,0.94622,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.8793e-06,0.81543,0.81286,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.2444e-07,0.80615,0.85797,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,4.8839e-05,0.7649,0.59297,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,6.7724e-05,0.69323,0.62361,1,1
4,GO HISTAMINE SECRETION,6.586e-10,0.68516,0.66002,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,4.9624e-10,0.65798,0.74534,1,1
4,GO TOLERANCE INDUCTION,3.7356e-07,0.6405,0.58528,1,1
4,GO RESPONSE TO TYPE I INTERFERON,4.6881e-08,0.63633,0.58365,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.4877e-10,0.63621,0.60173,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,4.4148e-09,0.63546,0.58628,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.1729e-08,0.63328,0.57442,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8032e-05,0.61212,0.4694,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.457e-10,0.60984,0.5986,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,2.2416e-05,0.59998,0.5052,1,1
4,GO HISTAMINE TRANSPORT,1.6986e-10,0.59743,0.61775,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.7078e-07,0.59501,0.60536,1,1
4,GO DETECTION OF OTHER ORGANISM,4.9069e-08,0.59224,0.54875,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.5052e-06,0.58629,0.51031,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00010852,0.58134,0.49821,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,6.1583e-08,0.5759,0.60493,1,1
4,GO MUCUS SECRETION,1.4741e-05,0.56486,0.50617,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.7385e-05,0.562,0.54134,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,2.2958e-06,0.54551,0.45255,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,1.3468e-07,0.54082,0.55848,1,1
4,GO NEGATIVE REGULATION OF CELL KILLING,0.00038422,0.53797,0.41428,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,5.4982e-08,0.53567,0.5414,1,1
4,GO O GLYCAN PROCESSING,5.793e-12,0.53566,0.53456,1,1
4,GO RENAL ABSORPTION,1.7534e-07,0.53281,0.52361,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.6981e-08,0.52752,0.53214,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,1.9926e-08,0.52497,0.45308,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,9.5999e-07,0.52331,0.48598,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.8573e-08,0.52318,0.61421,1,1
4,GO REGULATION OF PLATELET AGGREGATION,6.7411e-08,0.52237,0.50101,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,4.9228e-07,0.5213,0.51035,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.9822e-07,0.52078,0.50376,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,2.4972e-05,0.51948,0.43393,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,5.4967e-09,0.51807,0.51113,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,4.5239e-09,0.51578,0.64744,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.6129e-08,0.50534,0.5413,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.5864e-07,0.50511,0.45978,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,1.1165e-05,0.50498,0.47702,1,1
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00084997,0.50106,0.33183,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.9393e-05,0.49948,0.45475,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,2.0364e-06,0.49813,0.49152,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.7605e-06,0.49373,0.43583,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.0036e-08,0.48917,0.48454,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.8032e-05,0.48891,0.45291,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,1.3599e-06,0.48767,0.48091,1,1
4,GO INTESTINAL ABSORPTION,3.9064e-09,0.48248,0.53487,1,1
4,GO REFLEX,1.2281e-06,0.47944,0.48205,1,1
4,GO RESPONSE TO INTERFERON BETA,1.6761e-05,0.47856,0.4686,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,1.9926e-08,0.47827,0.46767,1,1
4,GO MICROVILLUS ORGANIZATION,2.6362e-08,0.47685,0.42936,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,1.5014e-05,0.47622,0.36447,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.9822e-07,0.47458,0.4961,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,2.5934e-07,0.47328,0.48176,1,1
4,GO REGULATION OF PLATELET ACTIVATION,7.892e-08,0.47275,0.43544,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,1.5674e-06,0.47107,0.47768,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.00016098,0.46843,0.42848,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,7.1819e-07,0.4684,0.42227,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,2.188e-08,0.46702,0.48351,1,1
4,GO TOXIN METABOLIC PROCESS,1.8881e-10,0.46515,0.50126,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,1.4334e-08,0.46395,0.45766,1,1
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0012886,0.46341,0.30793,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.7282e-08,0.46338,0.55024,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.4454e-06,0.46293,0.4492,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,5.8698e-06,0.46084,0.45878,1,1
4,GO GALACTOSE METABOLIC PROCESS,3.4296e-07,0.45971,0.46641,1,1
4,GO GERMINAL CENTER FORMATION,2.1375e-08,0.45666,0.50057,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,4.6202e-07,0.4558,0.5236,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,5.9056e-05,0.45306,0.41809,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,9.9064e-10,0.45055,0.44154,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.6386e-06,0.45027,0.41022,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.8161e-07,0.44997,0.41493,1,1
4,GO REGULATION OF ANOIKIS,1.0527e-08,0.44732,0.49611,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,3.2162e-07,0.44641,0.40321,1,1
4,GO EOSINOPHIL MIGRATION,6.4699e-07,0.44639,0.41826,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,7.105e-06,0.44627,0.37638,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0036e-08,0.44625,0.47277,1,1
4,GO EOSINOPHIL CHEMOTAXIS,3.7356e-07,0.44461,0.44134,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.734e-06,0.44298,0.39865,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.2444e-07,0.44258,0.48612,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.402e-08,0.4404,0.41701,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,1.475e-06,0.43962,0.47966,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.3228e-08,0.43948,0.4696,1,1
4,GO LIPOXYGENASE PATHWAY,0.00012186,0.43936,0.369,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.5451e-08,0.439,0.44051,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.2792e-06,0.43898,0.40894,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,9.7998e-07,0.43869,0.4112,1,1
4,GO VITAMIN D METABOLIC PROCESS,7.892e-08,0.43833,0.41318,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,5.1304e-06,0.43597,0.42775,1,1
4,GO GAP JUNCTION ASSEMBLY,2.7804e-05,0.43531,0.34545,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.1494e-05,0.43465,0.38345,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,2.1807e-07,0.43314,0.51035,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.332e-06,0.43256,0.39625,1,1
4,GO REGULATION OF VASCULOGENESIS,1.8318e-07,0.43219,0.43915,1,1
4,GO CELLULAR DEFENSE RESPONSE,5.9116e-09,0.43151,0.38174,1,1
4,GO NEURONAL ACTION POTENTIAL,2.5164e-08,0.43108,0.45677,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,5.4184e-05,0.4307,0.37421,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,7.5217e-06,0.43069,0.42503,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,2.6386e-06,0.42999,0.40068,1,1
4,GO MATURE B CELL DIFFERENTIATION,8.9166e-06,0.42998,0.34815,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,4.6881e-08,0.42994,0.4008,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,8.4877e-09,0.42828,0.493,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,2.0776e-06,0.42798,0.42752,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.6162e-06,0.42738,0.36012,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,6.0991e-06,0.42607,0.46373,1,1
4,GO RESPONSE TO THYROID HORMONE,4.8839e-05,0.42606,0.30059,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,2.5695e-09,0.42523,0.42412,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,6.0205e-08,0.42397,0.39003,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.2416e-05,0.42294,0.42541,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.9803e-06,0.42281,0.34011,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.7488e-06,0.41825,0.39832,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,4.7172e-05,0.41793,0.42859,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.3056e-06,0.41735,0.40113,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,5.9498e-07,0.41716,0.42451,1,1
4,GO RESPONSE TO PAIN,1.0964e-09,0.41661,0.42212,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.4967e-09,0.41658,0.43366,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,4.9228e-07,0.4147,0.36333,1,1
4,GO RESPONSE TO MAGNESIUM ION,2.1807e-07,0.41413,0.43914,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,7.7166e-08,0.41259,0.39688,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.3174e-07,0.4125,0.37689,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,1.7154e-07,0.41099,0.47214,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.001568,0.41053,0.35287,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.1282e-07,0.40673,0.37308,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,2.0853e-05,0.4061,0.38645,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,7.9617e-06,0.4054,0.36805,1,1
4,GO RESPONSE TO DIETARY EXCESS,5.9116e-09,0.40525,0.43003,1,1
4,GO RESPONSE TO INTERFERON GAMMA,1.4163e-06,0.40227,0.35394,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,7.0522e-08,0.40157,0.35674,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,1.8363e-05,0.40146,0.37582,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.3442e-05,0.40094,0.36162,1,1
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00033955,0.40052,0.33466,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.5684e-06,0.4001,0.33838,1,1
4,GO REGULATION OF BONE REMODELING,1.9546e-09,0.39967,0.40113,1,1
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.015329,0.39939,0.24745,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,5.2165e-11,0.39908,0.3876,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.064e-06,0.39885,0.36944,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,9.819e-05,0.39713,0.36698,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,7.8052e-07,0.39658,0.40449,1,1
4,GO RESPONSE TO COLD,1.9402e-11,0.39654,0.40195,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9228e-07,0.39644,0.36481,1,1
4,GO REGULATION OF TISSUE REMODELING,1.8135e-09,0.3953,0.38107,1,1
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0017517,0.39479,0.3769,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00022208,0.39453,0.28886,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,4.9361e-06,0.39449,0.3544,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,8.4262e-06,0.394,0.394,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,3.4098e-06,0.39339,0.4048,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,4.6359e-05,0.39198,0.39952,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2444e-07,0.39058,0.46873,1,1
4,GO ADHESION OF SYMBIONT TO HOST,4.0678e-07,0.39039,0.45728,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,4.5233e-07,0.39018,0.42772,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.01128,0.38778,0.18571,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,1.7154e-07,0.38699,0.38531,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,9.7998e-07,0.38695,0.37696,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,2.856e-06,0.38605,0.38221,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.2505e-06,0.38408,0.35317,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0013633,0.3835,0.30116,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.003654,0.38286,0.25211,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,1.6062e-07,0.38278,0.33868,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,1.8573e-08,0.38233,0.45346,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,8.0712e-08,0.38151,0.40745,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,1.2482e-05,0.38052,0.3656,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,5.7582e-06,0.38003,0.38678,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,3.2057e-05,0.37794,0.33922,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,6.2993e-08,0.37676,0.40635,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,4.9872e-09,0.37657,0.40213,1,1
4,GO ZYMOGEN ACTIVATION,7.4873e-07,0.37337,0.38565,1,1
4,GO SUPEROXIDE ANION GENERATION,2.8271e-07,0.37334,0.38135,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.8198e-07,0.3733,0.40377,1,1
4,GO STEROID ESTERIFICATION,5.2303e-06,0.3732,0.45167,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,4.3236e-05,0.37175,0.37239,1,1
4,GO MAGNESIUM ION TRANSPORT,3.4796e-08,0.37112,0.34856,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.8419e-06,0.37097,0.36576,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,3.5461e-06,0.37096,0.37098,1,1
4,GO CORNIFICATION,3.3435e-06,0.36984,0.33601,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00011033,0.36729,0.42136,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.3948e-05,0.3667,0.3713,1,1
4,GO PROTEIN DEGLYCOSYLATION,1.8723e-07,0.36638,0.35455,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.7536e-08,0.36611,0.35493,1,1
4,GO IMMUNOGLOBULIN SECRETION,2.2505e-06,0.36599,0.31891,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.2686e-06,0.36564,0.39785,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.2482e-05,0.36479,0.33501,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,9.4341e-06,0.36479,0.47281,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.00017176,0.36424,0.39521,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,2.0881e-08,0.36363,0.35124,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,7.6657e-06,0.36333,0.35207,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.342e-06,0.36312,0.41185,1,1
4,GO LIPID TRANSLOCATION,3.8118e-09,0.36119,0.35268,1,1
4,GO B CELL APOPTOTIC PROCESS,1.3351e-08,0.36092,0.3832,1,1
4,GO LIPID DIGESTION,8.3013e-05,0.36043,0.45993,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.7963e-08,0.35997,0.3338,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.4434e-08,0.35992,0.33079,1,1
4,GO INTERLEUKIN 10 PRODUCTION,1.064e-06,0.35972,0.29234,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,1.2604e-07,0.35942,0.37834,1,1
4,GO FOAM CELL DIFFERENTIATION,1.6418e-07,0.35905,0.35369,1,1
4,GO LUNG CELL DIFFERENTIATION,9.2118e-07,0.35881,0.41169,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.3214e-05,0.3587,0.33816,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,5.02e-08,0.35758,0.37048,1,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00015083,0.3571,0.32891,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,1.0557e-05,0.35516,0.36474,1,1
4,GO CERAMIDE CATABOLIC PROCESS,9.9803e-06,0.35497,0.39497,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.00065224,0.35482,0.30281,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,2.2958e-06,0.35401,0.37014,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,6.7105e-06,0.3534,0.39888,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,1.0212e-06,0.35318,0.40404,1,1
4,GO LIVER MORPHOGENESIS,1.6321e-06,0.35304,0.37942,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,6.0759e-07,0.35273,0.43115,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.00032408,0.35266,0.48098,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,5.6487e-06,0.35197,0.32891,1,1
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.6162e-06,0.35193,0.32037,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,2.7676e-09,0.35133,0.43954,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.018091,0.35109,0.31575,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,4.7999e-05,0.35062,0.34102,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0018256,0.34986,0.29715,1,1
4,GO RESPONSE TO INTERLEUKIN 15,1.2954e-05,0.34938,0.29209,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,4.2271e-06,0.34896,0.26209,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,4.8359e-10,0.34819,0.38387,1,1
4,GO DNA DEAMINATION,0.0005211,0.34672,0.31557,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.3774e-08,0.34607,0.36797,1,1
4,GO PLASMINOGEN ACTIVATION,0.00010852,0.34603,0.33307,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,4.7999e-05,0.34598,0.36584,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,4.1026e-05,0.34594,0.32019,1,1
4,GO TISSUE REMODELING,2.5164e-08,0.34515,0.33008,1,1
4,GO MAST CELL ACTIVATION,1.7922e-07,0.34473,0.32171,1,1
4,GO RESPONSE TO EPINEPHRINE,3.6877e-06,0.3441,0.38592,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,6.7105e-06,0.34342,0.34596,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,3.4516e-10,0.34339,0.40529,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,1.5014e-05,0.34286,0.38748,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,2.3891e-06,0.34285,0.28784,1,1
4,GO MICROVILLUS ASSEMBLY,0.00011596,0.3426,0.30397,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.5052e-06,0.34239,0.31448,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,9.03e-05,0.34195,0.27973,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0001803,0.3413,0.38165,1,1
4,GO DETECTION OF BIOTIC STIMULUS,1.1165e-05,0.34126,0.3414,1,1
4,GO KERATINIZATION,5.4701e-07,0.34097,0.32127,1,1
4,GO MYELIN MAINTENANCE,2.5424e-05,0.34076,0.37562,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,2.3274e-07,0.34044,0.39247,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.7172e-05,0.34006,0.31472,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,6.895e-08,0.33885,0.35635,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,3.2631e-05,0.33796,0.32772,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,3.6924e-05,0.33794,0.30854,1,1
4,GO REGULATION OF CELL KILLING,1.8419e-06,0.33743,0.29494,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,4.2444e-07,0.33707,0.33294,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,3.6924e-05,0.33704,0.34936,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00019541,0.33682,0.26585,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,9.2118e-07,0.33615,0.286,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.2824e-05,0.33603,0.33241,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,8.9166e-06,0.33553,0.3431,1,1
4,GO REGULATION OF NEURON MATURATION,1.1282e-07,0.33524,0.34043,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.5906e-08,0.33519,0.33025,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.0212e-06,0.33504,0.28448,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.7963e-08,0.33477,0.41176,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,3.2057e-05,0.33443,0.37418,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,3.094e-05,0.33412,0.27054,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,8.4415e-08,0.3341,0.30876,1,1
4,GO OPTIC NERVE DEVELOPMENT,3.2631e-05,0.33383,0.33037,1,1
4,GO REGULATION OF COAGULATION,3.2146e-06,0.33377,0.31892,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.155e-06,0.3335,0.29019,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,2.0776e-06,0.33325,0.30073,1,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0042636,0.33323,0.24908,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,1.5576e-05,0.33303,0.39307,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0012177,0.33297,0.28163,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,1.0958e-05,0.33185,0.32859,1,1
4,GO BONE RESORPTION,4.6356e-09,0.33123,0.35904,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00011406,0.33122,0.37132,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.2032e-06,0.33102,0.30154,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,3.9613e-05,0.33095,0.28572,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.9047e-09,0.33053,0.35763,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,3.3713e-09,0.33034,0.3136,1,1
4,GO KERATINOCYTE DEVELOPMENT,7.1274e-05,0.33029,0.37144,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.00042777,0.33001,0.24939,1,1
4,GO MYOBLAST FUSION,1.4163e-06,0.32979,0.30788,1,1
4,GO BLOOD VESSEL REMODELING,3.0302e-06,0.32956,0.29903,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,2.342e-06,0.3283,0.29294,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,1.9175e-06,0.32799,0.32148,1,1
4,GO PLASMA MEMBRANE FUSION,1.0361e-05,0.32785,0.33839,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.3236e-05,0.32737,0.30991,1,1
4,GO MAST CELL MEDIATED IMMUNITY,3.4098e-06,0.32707,0.29292,1,1
4,GO VASCULAR WOUND HEALING,3.0302e-06,0.32688,0.34969,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,6.3569e-09,0.32654,0.35417,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,3.1494e-05,0.3265,0.26654,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.0005618,0.32643,0.27189,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.00047589,0.3264,0.30493,1,1
4,GO N GLYCAN PROCESSING,5.8698e-06,0.32623,0.35858,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,1.2058e-07,0.32588,0.32309,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,3.2146e-06,0.3257,0.35261,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.0337e-07,0.32545,0.34168,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,4.3946e-06,0.32538,0.30505,1,1
4,GO RESPONSE TO TUMOR CELL,6.9711e-06,0.3252,0.34935,1,1
4,GO RESPONSE TO LITHIUM ION,3.4003e-08,0.32512,0.38075,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,5.7582e-06,0.32484,0.33108,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,9.4959e-05,0.32483,0.28162,1,1
4,GO REGULATION OF B CELL PROLIFERATION,7.7166e-08,0.32481,0.31817,1,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.001118,0.32386,0.2829,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,2.0398e-08,0.32374,0.32038,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.6407e-09,0.32369,0.32983,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00015331,0.32303,0.27507,1,1
4,GO REGULATION OF MYOBLAST FUSION,1.0212e-06,0.32183,0.35194,1,1
4,GO RESPONSE TO MUSCLE STRETCH,3.152e-06,0.32171,0.40163,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.0212e-06,0.32169,0.28735,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,5.1304e-06,0.32119,0.32118,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,3.0905e-06,0.32103,0.29522,1,1
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,7.1274e-05,0.32095,0.36177,1,1
4,GO DEFENSE RESPONSE TO VIRUS,2.7452e-06,0.32053,0.27315,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00040235,0.3202,0.31277,1,1
4,GO LEYDIG CELL DIFFERENTIATION,2.011e-05,0.3201,0.40502,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,4.1552e-07,0.3201,0.43475,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.2397e-08,0.31958,0.38198,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0007901,0.31896,0.29117,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,2.206e-06,0.31814,0.30507,1,1
4,GO STEROID HORMONE SECRETION,9.9803e-06,0.31802,0.30461,1,1
4,GO REGULATION OF ACROSOME REACTION,8.1138e-06,0.3177,0.29743,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.7804e-05,0.31749,0.266,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00011406,0.31722,0.28812,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.012227,0.31703,0.19806,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,4.5822e-08,0.31641,0.27601,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.5713e-07,0.31635,0.32302,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0023321,0.31622,0.26058,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,2.1621e-05,0.31581,0.33109,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,9.2321e-08,0.31543,0.31709,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.0169e-05,0.31542,0.29605,1,1
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.022446,0.31537,0.29567,1,1
4,GO BONE REMODELING,9.7991e-09,0.31531,0.36051,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00069207,0.31507,0.27764,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.6881e-08,0.3149,0.30249,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,5.2344e-05,0.31451,0.29706,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,3.0302e-06,0.3144,0.31554,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,8.5858e-05,0.3139,0.33016,1,1
4,GO T CELL EXTRAVASATION,0.00012804,0.31377,0.3653,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,7.6446e-07,0.31372,0.31217,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.5233e-07,0.31349,0.33265,1,1
4,GO ADRENAL GLAND DEVELOPMENT,1.536e-06,0.31348,0.3622,1,1
4,GO OSTEOBLAST PROLIFERATION,1.5052e-06,0.31323,0.32946,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.3806e-05,0.31309,0.2365,1,1
4,GO GLIAL CELL FATE COMMITMENT,0.0025961,0.31305,0.31398,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,1.5037e-07,0.31195,0.30836,1,1
4,GO ACTIN FILAMENT SEVERING,0.00053704,0.31177,0.29143,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00020835,0.31143,0.40854,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,2.1196e-06,0.31138,0.27597,1,1
4,GO ANOIKIS,3.0295e-08,0.31118,0.36766,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,5.5412e-06,0.31101,0.29483,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,1.1588e-05,0.3108,0.26344,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.2859e-07,0.31077,0.3076,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,4.7963e-08,0.31077,0.31095,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.1621e-05,0.31072,0.28415,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,3.4098e-06,0.31036,0.25023,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,1.3948e-05,0.3103,0.27357,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,4.1456e-06,0.31022,0.25725,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.8419e-06,0.31003,0.29024,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,8.8796e-05,0.30998,0.27109,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.000286,0.30986,0.30206,1,1
4,GO T CELL MEDIATED IMMUNITY,3.4098e-06,0.30983,0.30323,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,2.8886e-07,0.30938,0.32032,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.011022,0.30899,0.23625,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.71e-09,0.30869,0.3474,1,1
4,GO APICAL JUNCTION ASSEMBLY,3.9941e-08,0.3085,0.32882,1,1
4,GO VASODILATION,1.7534e-07,0.30812,0.35022,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,2.7804e-05,0.30744,0.28211,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,2.2775e-07,0.30722,0.31966,1,1
4,GO RESPONSE TO STEROL DEPLETION,1.4677e-08,0.30708,0.38142,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00032408,0.30698,0.31377,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,4.2271e-06,0.30694,0.28757,1,1
4,GO ENTRY INTO HOST,8.9166e-06,0.30602,0.27853,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,4.4771e-05,0.30464,0.29707,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.5674e-06,0.3046,0.26918,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.5359e-06,0.30424,0.2956,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,5.4356e-06,0.30412,0.32152,1,1
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,4.31e-06,0.30386,0.33131,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.6828e-05,0.30371,0.23558,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,1.734e-06,0.3037,0.30815,1,1
4,GO ICOSANOID METABOLIC PROCESS,3.6567e-07,0.30361,0.30528,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.01585,0.3035,0.21644,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.8983e-07,0.30339,0.28131,1,1
4,GO CELL KILLING,4.4285e-07,0.30334,0.25972,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,4.2487e-05,0.30229,0.30815,1,1
4,GO RESPONSE TO COPPER ION,5.5127e-05,0.30199,0.35143,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,6.4592e-06,0.30183,0.29787,1,1
4,GO SENSORY PERCEPTION OF SMELL,5.2538e-08,0.30166,0.28784,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00010152,0.30156,0.22322,1,1
4,GO REGULATION OF B CELL ACTIVATION,1.4076e-07,0.30156,0.25928,1,1
4,GO RESPONSE TO ACIDIC PH,3.758e-05,0.30108,0.31003,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,7.8911e-05,0.3004,0.26722,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00011986,0.30028,0.2166,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.00013673,0.30022,0.30464,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,2.8814e-05,0.30017,0.33789,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,4.4771e-05,0.30015,0.25237,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,2.402e-08,0.30012,0.27702,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,7.1819e-07,0.30004,0.29187,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,1.155e-06,0.30003,0.30885,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00017741,0.29991,0.26863,1,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00069207,0.29985,0.19462,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00099681,0.29968,0.21841,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.3803e-06,0.29946,0.27371,1,1
4,GO STEROL HOMEOSTASIS,9.2118e-07,0.2992,0.27571,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.7706e-05,0.29905,0.25837,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,7.8124e-06,0.29852,0.29674,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,2.7078e-07,0.29847,0.25348,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,2.6362e-08,0.29835,0.26567,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,6.5837e-06,0.2983,0.30639,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,1.2032e-06,0.29825,0.31067,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.094e-05,0.29776,0.26468,1,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0012177,0.29697,0.22837,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.00017176,0.29676,0.30851,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.155e-06,0.29654,0.27104,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,6.2046e-07,0.29653,0.25861,1,1
4,GO RESPONSE TO REDOX STATE,0.00020835,0.29652,0.23966,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.8389e-07,0.29644,0.27019,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00040235,0.29627,0.29798,1,1
4,GO GLYCOSYLATION,2.1543e-10,0.2952,0.29497,1,1
4,GO POSITIVE REGULATION OF COAGULATION,4.7999e-05,0.29506,0.27468,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,9.819e-05,0.29453,0.27758,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,3.3806e-05,0.29441,0.33413,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0005133,0.29434,0.27014,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.795e-06,0.29433,0.25858,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.1338e-07,0.29426,0.29791,1,1
4,GO B CELL PROLIFERATION,2.5934e-07,0.29419,0.27355,1,1
4,GO INTERLEUKIN 12 PRODUCTION,7.8052e-07,0.29402,0.28071,1,1
4,GO FUCOSE METABOLIC PROCESS,8.7502e-06,0.29397,0.30189,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00012594,0.29353,0.29955,1,1
4,GO RESPONSE TO WATER,3.3435e-06,0.29336,0.31754,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.3239e-05,0.29324,0.24663,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,1.471e-07,0.29309,0.38285,1,1
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,1.9393e-05,0.29288,0.30211,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,5.4701e-07,0.29284,0.23079,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,5.4184e-05,0.2927,0.36712,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.5424e-05,0.29221,0.27801,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,7.5451e-08,0.29183,0.31068,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.1004e-08,0.29178,0.29349,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,3.8347e-06,0.29169,0.28748,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.2057e-05,0.29159,0.28243,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00016361,0.2914,0.28236,1,1
4,GO PROTEIN DEMANNOSYLATION,2.3274e-07,0.29136,0.36138,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.6418e-07,0.29122,0.25167,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,4.5233e-07,0.29058,0.26525,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.971e-06,0.2904,0.25447,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.0905e-06,0.29032,0.22589,1,1
4,GO INTERLEUKIN 8 PRODUCTION,5.332e-06,0.29029,0.26758,1,1
4,GO CHEMOKINE PRODUCTION,3.2784e-06,0.28932,0.26216,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,5.1351e-07,0.28921,0.3055,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,6.545e-05,0.28899,0.29399,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00010323,0.28887,0.23735,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,3.0811e-07,0.28877,0.30897,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.357e-07,0.28865,0.38781,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.9332e-05,0.2886,0.25158,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.3946e-06,0.28853,0.30101,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.4773e-06,0.28839,0.24178,1,1
4,GO INTERLEUKIN 5 PRODUCTION,0.00086244,0.28817,0.26866,1,1
4,GO REGULATION OF FIBRINOLYSIS,0.00024819,0.28804,0.29981,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,3.7605e-06,0.288,0.35408,1,1
4,GO INNATE IMMUNE RESPONSE,5.1351e-07,0.28759,0.24626,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,1.5674e-06,0.28757,0.26636,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,2.5695e-09,0.28744,0.27035,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,4.4771e-05,0.28743,0.28418,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,1.9749e-05,0.2866,0.31583,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,9.3415e-09,0.28651,0.37163,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,1.155e-06,0.28637,0.27317,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,2.913e-06,0.28587,0.29469,1,1
4,GO REGULATION OF DENDRITE EXTENSION,2.1621e-05,0.28585,0.31271,1,1
4,GO VIRAL GENOME REPLICATION,3.8347e-06,0.28582,0.25126,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0019819,0.28565,0.25004,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,2.4091e-05,0.28551,0.26834,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,5.1446e-05,0.28505,0.25267,1,1
4,GO LEUKOCYTE PROLIFERATION,3.2146e-06,0.28431,0.22562,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,9.6129e-06,0.2842,0.30291,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00099681,0.28419,0.2331,1,1
4,GO PROTEIN KINASE C SIGNALING,0.00025617,0.28417,0.25672,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.971e-06,0.28412,0.30223,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00016629,0.28396,0.19437,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,5.02e-08,0.28368,0.26821,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,3.3435e-06,0.2835,0.29489,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.00026858,0.28341,0.23239,1,1
4,GO T CELL PROLIFERATION,1.4472e-05,0.28271,0.21807,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,4.2271e-06,0.28242,0.26695,1,1
4,GO PROTEIN HYDROXYLATION,0.00031414,0.28229,0.26034,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,9.819e-05,0.28222,0.267,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.3325e-06,0.28178,0.27814,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.6066e-07,0.28176,0.24531,1,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.0043737,0.28134,0.24605,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,6.7105e-06,0.2812,0.2478,1,1
4,GO B CELL MEDIATED IMMUNITY,1.6654e-06,0.28097,0.30017,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,2.5934e-07,0.28077,0.26352,1,1
4,GO IMMUNE EFFECTOR PROCESS,5.5864e-07,0.28017,0.24139,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.7582e-06,0.28007,0.23776,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,1.996e-06,0.27966,0.2605,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.0811e-07,0.27893,0.25766,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,2.4371e-06,0.27859,0.26743,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,6.6066e-07,0.27851,0.28877,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,8.0256e-05,0.27851,0.28802,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,8.3066e-07,0.27849,0.26884,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,5.332e-06,0.27793,0.23266,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00040857,0.27786,0.21637,1,1
4,GO B CELL HOMEOSTASIS,4.5684e-06,0.27768,0.26281,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,2.2015e-05,0.27758,0.25556,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,9.2585e-06,0.27713,0.26276,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,4.3236e-05,0.27698,0.33387,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,7.3803e-06,0.27673,0.2632,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,9.9844e-05,0.27664,0.24901,1,1
4,GO TRANSPOSITION,8.5858e-05,0.27662,0.29777,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00011218,0.27659,0.23531,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00019541,0.27658,0.30643,1,1
4,GO REGULATION OF ICOSANOID SECRETION,2.7614e-08,0.27646,0.31006,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.5674e-06,0.27623,0.24943,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.1535e-07,0.27621,0.28071,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,1.7385e-05,0.27619,0.28712,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,5.7582e-06,0.27593,0.28816,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.6487e-06,0.27572,0.25701,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.206e-06,0.2757,0.35956,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.3435e-06,0.2757,0.23163,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,2.7668e-07,0.27526,0.29372,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,1.7693e-06,0.27503,0.2533,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.1138e-06,0.27484,0.25008,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.2146e-06,0.27444,0.23196,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,4.7172e-05,0.27423,0.24617,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.1494e-05,0.27403,0.25702,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,4.5233e-07,0.27399,0.26588,1,1
4,GO CYTOKINE METABOLIC PROCESS,2.206e-06,0.27376,0.2567,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,3.3214e-05,0.27373,0.25935,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,1.0756e-05,0.2734,0.21759,1,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.00021511,0.27335,0.22881,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,2.2416e-05,0.27307,0.25733,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,1.7154e-07,0.27282,0.26863,1,1
4,GO AMYLOID BETA CLEARANCE,0.00011986,0.27249,0.2226,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.4972e-05,0.27245,0.21366,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00027716,0.2724,0.28301,1,1
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00159,0.27239,0.22652,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00016361,0.27234,0.23772,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00015331,0.27234,0.26887,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,2.4528e-05,0.2723,0.24757,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.2954e-05,0.27207,0.25736,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,8.7316e-05,0.27196,0.23573,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,9.6129e-06,0.2717,0.31938,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,1.5576e-05,0.27141,0.2273,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,2.5359e-06,0.27136,0.25485,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,5.8262e-07,0.27121,0.23713,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.00039018,0.27116,0.21333,1,1
4,GO HAIR CELL DIFFERENTIATION,4.31e-06,0.2707,0.24315,1,1
4,GO LINOLEIC ACID METABOLIC PROCESS,5.2344e-05,0.27046,0.30693,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.8053e-06,0.27045,0.23688,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.6994e-06,0.27035,0.32851,1,1
4,GO POSITIVE REGULATION OF HEART RATE,4.5684e-06,0.26971,0.29718,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.00033432,0.26945,0.29043,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.9393e-05,0.26941,0.25282,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.4091e-05,0.26936,0.291,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,3.0905e-06,0.26924,0.26182,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.028e-08,0.26922,0.27792,1,1
4,GO ZYMOGEN INHIBITION,4.2487e-05,0.26918,0.27108,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,4.2444e-07,0.26876,0.25552,1,1
4,GO DIOL METABOLIC PROCESS,2.971e-06,0.26855,0.29395,1,1
4,GO AMYLOID FIBRIL FORMATION,8.7316e-05,0.26819,0.32467,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0001803,0.2679,0.22422,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00011596,0.26739,0.27882,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.3769e-07,0.26727,0.2844,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,9.028e-08,0.26727,0.28483,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.31e-06,0.26724,0.27298,1,1
4,GO DETECTION OF CALCIUM ION,4.7999e-05,0.2668,0.31037,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0023321,0.26666,0.27205,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,9.3381e-05,0.2666,0.30112,1,1
4,GO RESPONSE TO INTERLEUKIN 6,5.5412e-06,0.26658,0.24627,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.7051e-07,0.26651,0.25603,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.3891e-06,0.26636,0.25047,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,3.9822e-07,0.26619,0.2759,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.4454e-06,0.26617,0.26706,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,4.9228e-07,0.26605,0.23501,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,4.4807e-06,0.266,0.24345,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,9.03e-05,0.26598,0.33744,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00014599,0.26592,0.20631,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00028155,0.26586,0.27453,1,1
4,GO TYPE I INTERFERON PRODUCTION,2.2505e-06,0.26586,0.23248,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,6.4341e-05,0.26579,0.24173,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,4.5684e-06,0.26578,0.23039,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,3.8161e-07,0.26521,0.27042,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,7.0072e-05,0.265,0.24152,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.6359e-05,0.26496,0.31916,1,1
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00069207,0.26495,0.32025,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00011406,0.26494,0.21378,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,3.2057e-05,0.26479,0.19863,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,7.2414e-06,0.26475,0.32233,1,1
4,GO RESPONSE TO VIRUS,4.0657e-06,0.26467,0.23213,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00084997,0.26448,0.25396,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,9.5677e-09,0.26429,0.25302,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00015083,0.26421,0.27532,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00020504,0.26394,0.24997,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,5.5412e-06,0.26356,0.25013,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.2954e-05,0.26331,0.23264,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,2.7804e-05,0.26275,0.28185,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00044103,0.26251,0.25406,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.1588e-05,0.26243,0.34891,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,3.9613e-05,0.26213,0.2861,1,1
4,GO REGULATION OF CELL CELL ADHESION,6.8396e-06,0.26203,0.2185,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,4.6578e-06,0.26191,0.25454,1,1
4,GO KERATINOCYTE DIFFERENTIATION,3.0156e-07,0.26189,0.27442,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00029052,0.26177,0.22271,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,3.8246e-05,0.26168,0.26649,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00013673,0.26164,0.1851,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,7.8124e-06,0.26162,0.21567,1,1
4,GO RESPONSE TO GONADOTROPIN,1.4163e-06,0.26154,0.26528,1,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.001422,0.26144,0.29867,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,4.3236e-05,0.26142,0.25819,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,9.4341e-06,0.2614,0.28001,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,1.9749e-05,0.26136,0.29654,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,1.5576e-05,0.26135,0.22973,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.6567e-07,0.26128,0.2708,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.0958e-05,0.26118,0.24352,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.00013899,0.26109,0.27834,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.2175e-05,0.26093,0.22616,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0037985,0.26091,0.23674,1,1
4,GO ENDOCARDIUM DEVELOPMENT,0.00017741,0.2606,0.25849,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0023957,0.26055,0.1821,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,3.2162e-07,0.26025,0.24962,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.7488e-06,0.26008,0.31872,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.4528e-05,0.25993,0.34929,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,7.892e-08,0.25989,0.26673,1,1
4,GO HEART TRABECULA FORMATION,0.0014022,0.25976,0.24791,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00062378,0.25967,0.22721,1,1
4,GO ANDROGEN METABOLIC PROCESS,2.538e-07,0.25964,0.34967,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,2.4972e-05,0.25957,0.21552,1,1
4,GO INTERLEUKIN 6 PRODUCTION,3.8161e-07,0.25953,0.24157,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,5.6487e-06,0.25936,0.27134,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1.2716e-05,0.25911,0.27236,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,7.2497e-05,0.25902,0.28757,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.7154e-07,0.25876,0.25502,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.4677e-08,0.2587,0.30229,1,1
4,GO PLATELET DEGRANULATION,2.2015e-05,0.25869,0.26908,1,1
4,GO RESPONSE TO PROTOZOAN,9.819e-05,0.25833,0.2336,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.7105e-06,0.25822,0.24536,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.0025961,0.2582,0.21896,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,2.971e-06,0.25819,0.28531,1,1
4,GO DOPAMINE TRANSPORT,3.8924e-05,0.25811,0.33554,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,9.4341e-06,0.2579,0.28366,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0012705,0.25777,0.17665,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.5217e-06,0.25769,0.22738,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0049019,0.25767,0.20696,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0005133,0.25762,0.22448,1,1
4,GO SPHINGOID METABOLIC PROCESS,1.4207e-05,0.25747,0.27825,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,2.3467e-08,0.25725,0.24857,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.5646e-05,0.25719,0.20212,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.0013443,0.25713,0.2498,1,1
4,GO FUCOSYLATION,4.2271e-06,0.257,0.27114,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,5.4982e-08,0.25669,0.25121,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,7.969e-07,0.25628,0.26881,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,5.6487e-06,0.25569,0.28698,1,1
4,GO PHOSPHOLIPID TRANSPORT,1.6907e-08,0.25567,0.27055,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,7.3803e-06,0.25565,0.25855,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,8.6579e-07,0.25535,0.26723,1,1
4,GO RESPONSE TO GROWTH HORMONE,8.4805e-07,0.25525,0.31313,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00016629,0.25501,0.40143,1,1
4,GO PLATELET ACTIVATION,2.8305e-05,0.2546,0.21762,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.2321e-08,0.25454,0.28665,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00016361,0.25438,0.20903,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00036124,0.25414,0.27516,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.6386e-06,0.25411,0.23787,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,1.7721e-08,0.25409,0.26101,1,1
4,GO CYTOKINE PRODUCTION,2.7452e-06,0.254,0.21908,1,1
4,GO NECROTIC CELL DEATH,1.6418e-07,0.25397,0.27367,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.017699,0.25388,0.20037,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,2.0776e-06,0.25385,0.27106,1,1
4,GO RESPONSE TO FORSKOLIN,0.0035146,0.25374,0.22636,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00019857,0.25373,0.48248,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,8.0712e-08,0.25363,0.25326,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0018508,0.25309,0.17503,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,1.8419e-06,0.25307,0.25867,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,2.3891e-06,0.25305,0.24648,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,3.1479e-07,0.25281,0.28568,1,1
4,GO CATECHOLAMINE UPTAKE,0.00019857,0.25269,0.2836,1,1
4,GO ACYLGLYCEROL HOMEOSTASIS,0.00068191,0.25267,0.20109,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.4003e-08,0.2525,0.23607,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,5.0323e-06,0.25249,0.27197,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,1.9558e-07,0.25237,0.29695,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00017741,0.25222,0.2696,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,1.5293e-05,0.2522,0.24907,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.1446e-05,0.25211,0.24351,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,3.2162e-07,0.25199,0.27195,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.1274e-05,0.25198,0.2426,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.6877e-06,0.25196,0.25629,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0047798,0.2517,0.16951,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,2.4091e-05,0.25162,0.20734,1,1
4,GO RETINAL METABOLIC PROCESS,0.0077327,0.25157,0.33942,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0015249,0.25136,0.22347,1,1
4,GO ALPHA BETA T CELL ACTIVATION,2.8814e-05,0.25135,0.20224,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0279e-08,0.25127,0.32246,1,1
4,GO STEROID METABOLIC PROCESS,1.4334e-08,0.25102,0.27055,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,1.6457e-05,0.25099,0.26454,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0054192,0.25099,0.35468,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.002631,0.25086,0.22573,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00012594,0.2508,0.29095,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,2.7668e-07,0.25048,0.24521,1,1
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.0048405,0.25042,0.1802,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5753e-08,0.25025,0.34746,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.8347e-06,0.24974,0.23123,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,4.5558e-05,0.24974,0.20959,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.4454e-06,0.24964,0.23195,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.7172e-05,0.24947,0.24262,1,1
4,GO PLATELET AGGREGATION,2.1621e-05,0.24911,0.25728,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,4.3946e-06,0.24876,0.23873,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,3.1479e-07,0.24872,0.22868,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,3.4773e-06,0.24868,0.22566,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.2497e-05,0.24849,0.21114,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0078263,0.2482,0.20431,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.4262e-06,0.24816,0.20773,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.00092737,0.24811,0.19448,1,1
4,GO AMELOGENESIS,0.00095459,0.24803,0.22573,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0019819,0.24801,0.3271,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00013673,0.24791,0.25298,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0048405,0.24789,0.22086,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,2.4305e-07,0.24762,0.25377,1,1
4,GO ALANINE TRANSPORT,9.9844e-05,0.24755,0.2598,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.7582e-06,0.24754,0.23525,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,5.9116e-09,0.24745,0.25658,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.5038e-07,0.24743,0.22661,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,4.1456e-06,0.24742,0.30281,1,1
4,GO REGULATION OF WOUND HEALING,4.6202e-07,0.24733,0.29756,1,1
4,GO INTERLEUKIN 1 PRODUCTION,7.3739e-05,0.24697,0.23052,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.0557e-05,0.24674,0.23443,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.7078e-07,0.24669,0.25318,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,9.6562e-05,0.24668,0.21553,1,1
4,GO REGULATION OF RECEPTOR CLUSTERING,0.011151,0.24628,0.23038,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.6283e-05,0.24624,0.20166,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.2497e-05,0.24593,0.23258,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.8416e-06,0.24587,0.28053,1,1
4,GO GLYCINE TRANSPORT,0.041789,0.24586,0.15771,1,1
4,GO MANNOSYLATION,5.0278e-07,0.24515,0.25186,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,9.795e-06,0.24514,0.31896,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,5.8049e-05,0.24514,0.23078,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.4472e-05,0.24506,0.26768,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.3774e-08,0.24502,0.2999,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00010323,0.24493,0.23668,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,2.1234e-05,0.24491,0.2531,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.014658,0.24488,0.15451,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00011406,0.24485,0.24025,1,1
4,GO DEFENSE RESPONSE,1.5037e-07,0.24481,0.22822,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,1.5865e-05,0.24475,0.2177,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,1.5027e-08,0.24471,0.23721,1,1
4,GO ETHER METABOLIC PROCESS,9.9803e-06,0.24466,0.23185,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,3.357e-07,0.24443,0.2642,1,1
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.013856,0.24407,0.22286,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,6.0565e-09,0.24401,0.25364,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00042777,0.24386,0.17258,1,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.0018006,0.24382,0.22084,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,6.1583e-08,0.24376,0.23427,1,1
4,GO RESPONSE TO INTERLEUKIN 2,7.5217e-06,0.24375,0.24691,1,1
4,GO CYTOPLASM ORGANIZATION,0.00016901,0.24367,0.23338,1,1
4,GO B CELL ACTIVATION,1.5674e-06,0.24364,0.2047,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,1.3468e-07,0.24344,0.27806,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00080175,0.24316,0.17258,1,1
4,GO LEUKOCYTE MIGRATION,6.4699e-07,0.24305,0.23649,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,9.404e-07,0.24276,0.28794,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.2482e-05,0.24271,0.2443,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00010852,0.2423,0.20688,1,1
4,GO REGULATION OF CELL ADHESION,4.3236e-05,0.24209,0.19579,1,1
4,GO CERAMIDE METABOLIC PROCESS,1.0322e-07,0.24168,0.24498,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,1.1806e-05,0.24149,0.2375,1,1
4,GO REGULATION OF HEART RATE,3.1479e-07,0.24128,0.24468,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00023294,0.24103,0.21629,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,9.1793e-10,0.24092,0.26269,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,9.086e-06,0.24077,0.23299,1,1
4,GO RESPONSE TO FATTY ACID,5.8049e-05,0.24065,0.19163,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,2.7452e-06,0.24056,0.21722,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,5.0278e-07,0.24054,0.22712,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.020166,0.24048,0.17826,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,1.3468e-07,0.24045,0.24249,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00069207,0.24019,0.19456,1,1
4,GO ACROSOME REACTION,0.00027284,0.24017,0.18539,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.628e-05,0.24003,0.21253,1,1
4,GO MYOTUBE DIFFERENTIATION,7.6446e-07,0.24003,0.23277,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00091404,0.23997,0.28219,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.4098e-06,0.23985,0.22455,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,3.4773e-06,0.23978,0.24049,1,1
4,GO PHAGOSOME ACIDIFICATION,3.8983e-07,0.2396,0.26104,1,1
4,GO LIPID LOCALIZATION,1.6907e-08,0.23954,0.24193,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,5.2344e-05,0.23926,0.20759,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0010865,0.23922,0.24552,1,1
4,GO DIGESTIVE SYSTEM PROCESS,2.3784e-07,0.23904,0.2496,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,4.3997e-05,0.23904,0.19925,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,6.5837e-06,0.23899,0.2031,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,2.5868e-06,0.23898,0.19618,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,3.2859e-07,0.23883,0.31377,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,8.3013e-05,0.23882,0.29182,1,1
4,GO REGULATION OF TRANSPOSITION,0.00045468,0.23861,0.29282,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00033432,0.23857,0.28915,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,1.5293e-05,0.23843,0.28881,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.5372e-07,0.23837,0.22964,1,1
4,GO CYTOKINE SECRETION,3.7356e-07,0.23833,0.24319,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011596,0.23832,0.21714,1,1
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.0033799,0.23821,0.25339,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,2.0478e-05,0.23816,0.23638,1,1
4,GO NUCLEOTIDE TRANSPORT,2.2775e-07,0.23815,0.22269,1,1
4,GO LYTIC VACUOLE ORGANIZATION,6.586e-10,0.23815,0.30037,1,1
4,GO SECONDARY METABOLIC PROCESS,1.9393e-05,0.23812,0.27876,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,4.6881e-08,0.23805,0.23647,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,9.2118e-07,0.23793,0.21877,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,4.1456e-06,0.23744,0.22529,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0002443,0.23713,0.23695,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.0861e-06,0.2371,0.24665,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,8.5858e-05,0.23708,0.20763,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.00013451,0.23701,0.2353,1,1
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00048316,0.23683,0.20146,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.000286,0.23682,0.21846,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00031907,0.23668,0.20655,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0001179,0.23664,0.19782,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.4091e-05,0.23662,0.2111,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00017457,0.2366,0.2583,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00013232,0.23656,0.23135,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,7.3739e-05,0.23653,0.24387,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.3599e-06,0.23652,0.2309,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,4.9694e-05,0.23628,0.25314,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,9.3381e-05,0.23627,0.18875,1,1
4,GO STEROL METABOLIC PROCESS,2.5756e-08,0.23622,0.24943,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.00016361,0.23575,0.2219,1,1
4,GO INTEGRIN ACTIVATION,6.4699e-07,0.23559,0.28613,1,1
4,GO SIGNAL PEPTIDE PROCESSING,2.4371e-06,0.23553,0.29806,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.2497e-05,0.23548,0.22898,1,1
4,GO RESPONSE TO CYTOKINE,3.0302e-06,0.23545,0.20286,1,1
4,GO REGULATION OF T CELL ACTIVATION,6.3249e-05,0.23539,0.18095,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,1.3196e-05,0.23496,0.26953,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,7.105e-06,0.23495,0.23161,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,8.4262e-06,0.23491,0.21202,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,4.249e-10,0.23488,0.26458,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1588e-05,0.23457,0.32847,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.2958e-06,0.23436,0.32151,1,1
4,GO WATER HOMEOSTASIS,4.9228e-07,0.23429,0.26601,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.0004e-06,0.23425,0.27928,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,2.7676e-09,0.23402,0.26086,1,1
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.000286,0.23388,0.19147,1,1
4,GO LIPID STORAGE,5.6487e-06,0.2334,0.21668,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.4807e-06,0.23339,0.24591,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.03006,0.23297,0.18563,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.00036124,0.23289,0.34302,1,1
4,GO REGULATION OF FERTILIZATION,7.969e-07,0.23284,0.2422,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0019023,0.23281,0.22208,1,1
4,GO INFLAMMATORY RESPONSE,5.2445e-07,0.23227,0.22352,1,1
4,GO UBIQUINONE METABOLIC PROCESS,6.4592e-06,0.23226,0.22386,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,4.1751e-05,0.23225,0.2788,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.4296e-07,0.23223,0.22795,1,1
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00055343,0.23213,0.23686,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,8.4877e-09,0.23207,0.24414,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,5.1351e-07,0.2319,0.24939,1,1
4,GO RESPONSE TO ISCHEMIA,1.3056e-06,0.23168,0.23612,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,1.3599e-06,0.23148,0.21969,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,4.9228e-07,0.23141,0.2742,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00039622,0.23101,0.24766,1,1
4,GO SYNCYTIUM FORMATION,2.8305e-05,0.23084,0.23259,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.0563e-05,0.23078,0.22346,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00042777,0.23067,0.20744,1,1
4,GO LEUKOCYTE CHEMOTAXIS,4.6578e-06,0.23061,0.2027,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,5.7059e-05,0.23051,0.25457,1,1
4,GO INTERFERON ALPHA PRODUCTION,7.4873e-07,0.23049,0.2775,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,4.8839e-05,0.23037,0.21188,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00030928,0.23036,0.20663,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,6.0079e-05,0.23024,0.17402,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,7.3803e-06,0.23023,0.2218,1,1
4,GO NUCLEOTIDE SALVAGE,0.0074579,0.23014,0.16858,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0074579,0.23,0.18792,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.4296e-07,0.22996,0.22904,1,1
4,GO DIGESTION,3.8161e-07,0.22983,0.25664,1,1
4,GO T CELL ACTIVATION,2.2824e-05,0.2297,0.18627,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.1729e-08,0.22966,0.22362,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0016347,0.22952,0.1568,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.00018923,0.22947,0.22835,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0013826,0.22915,0.24712,1,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.00031907,0.22914,0.22067,1,1
4,GO ENDOCRINE PROCESS,1.2534e-06,0.22892,0.24559,1,1
4,GO HUMORAL IMMUNE RESPONSE,5.7051e-07,0.22891,0.23708,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0078263,0.22864,0.30207,1,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.00041488,0.22835,0.26528,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.001704,0.22818,0.19471,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00064263,0.22817,0.25972,1,1
4,GO CELL ACTIVATION,5.0323e-06,0.22816,0.19685,1,1
4,GO PEPTIDE SECRETION,2.5756e-08,0.22805,0.2101,1,1
4,GO BILE ACID METABOLIC PROCESS,1.0861e-06,0.22788,0.28412,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,7.3739e-05,0.22773,0.25675,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00033955,0.22769,0.19924,1,1
4,GO NERVE DEVELOPMENT,0.0005211,0.22767,0.21623,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,1.3599e-06,0.22753,0.22571,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0005789,0.22748,0.17356,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,4.8416e-06,0.22733,0.21221,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,5.1304e-06,0.22703,0.19733,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,1.3599e-06,0.22697,0.20351,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00090088,0.22691,0.20502,1,1
4,GO T CELL MIGRATION,0.00040857,0.22691,0.18502,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,2.0853e-05,0.22691,0.26085,1,1
4,GO EPIDERMIS DEVELOPMENT,2.8001e-06,0.22655,0.21543,1,1
4,GO CELL CHEMOTAXIS,2.913e-06,0.22649,0.21347,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,2.4861e-06,0.22647,0.2508,1,1
4,GO MEMBRANE DEPOLARIZATION,8.1361e-07,0.22622,0.25933,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,2.0429e-07,0.22592,0.21674,1,1
4,GO SKIN DEVELOPMENT,5.5412e-06,0.22587,0.21726,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,6.2169e-06,0.22586,0.22151,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00021511,0.22585,0.21801,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,1.0554e-07,0.22576,0.2494,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,1.4677e-08,0.22572,0.23543,1,1
4,GO CD40 SIGNALING PATHWAY,0.00082553,0.22555,0.16684,1,1
4,GO QUINONE METABOLIC PROCESS,0.00037835,0.2255,0.32011,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,1.5052e-06,0.22542,0.26468,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.000662,0.22533,0.23041,1,1
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00015838,0.22523,0.17197,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,1.3599e-06,0.22491,0.227,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00036686,0.22482,0.25042,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,4.2444e-07,0.22478,0.24601,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0041031,0.22465,0.20714,1,1
4,GO INTERFERON BETA PRODUCTION,7.0072e-05,0.22449,0.20694,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,8.4805e-07,0.2244,0.22391,1,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.0010865,0.22439,0.20944,1,1
4,GO STEROL TRANSPORT,6.8396e-06,0.2242,0.22735,1,1
4,GO RESPONSE TO CAFFEINE,0.00016361,0.22417,0.19936,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,9.086e-06,0.22405,0.18598,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0052854,0.22402,0.25055,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,9.7998e-07,0.22389,0.21341,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,1.8701e-05,0.22371,0.25386,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,4.7999e-05,0.22361,0.25973,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0088198,0.2235,0.1953,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00063314,0.22343,0.21974,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5164e-08,0.22331,0.26137,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,5.8049e-05,0.22326,0.21319,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0046018,0.2231,0.14929,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.2015e-05,0.22308,0.21217,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00034485,0.22301,0.17926,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0013443,0.223,0.42179,1,1
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0046018,0.22298,0.25746,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,3.3435e-06,0.22284,0.20245,1,1
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0077327,0.22278,0.17624,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,5.8049e-05,0.22277,0.21018,1,1
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.01251,0.2227,0.1798,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,7.3739e-05,0.2227,0.17777,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00012594,0.22261,0.27078,1,1
4,GO LIPID OXIDATION,9.086e-06,0.22248,0.19131,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.2416e-05,0.22234,0.2115,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.5233e-07,0.22226,0.23273,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.8716e-08,0.22224,0.22017,1,1
4,GO PIGMENT ACCUMULATION,0.018693,0.22218,0.15068,1,1
4,GO SECRETION BY TISSUE,0.00014362,0.22207,0.20394,1,1
4,GO MONOCYTE CHEMOTAXIS,0.00029052,0.22187,0.19147,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.1456e-06,0.22182,0.1914,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0001179,0.22166,0.24052,1,1
4,GO REGULATION OF ACTION POTENTIAL,4.0314e-05,0.22166,0.23588,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,2.8305e-05,0.22163,0.24046,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0137,0.22124,0.17504,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,9.6129e-06,0.22122,0.26228,1,1
4,GO DOPAMINE METABOLIC PROCESS,2.2015e-05,0.22113,0.25903,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,2.342e-06,0.22109,0.20858,1,1
4,GO CELL CELL ADHESION,3.8924e-05,0.22109,0.18055,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.0478e-05,0.22095,0.19517,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,3.3806e-05,0.22085,0.23278,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0001803,0.22081,0.21656,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.734e-06,0.22067,0.2626,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,7.8124e-06,0.22061,0.22241,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.9044e-05,0.22057,0.18691,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,6.2169e-06,0.22047,0.31875,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.6761e-05,0.22043,0.25597,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,1.0756e-05,0.22042,0.22708,1,1
4,GO COMPLEMENT ACTIVATION,0.001704,0.22026,0.23548,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7452e-06,0.22017,0.21316,1,1
4,GO LIPID EXPORT FROM CELL,2.9332e-05,0.22004,0.23251,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.00010323,0.21995,0.2605,1,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,9.1829e-05,0.21989,0.21883,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,7.105e-06,0.21975,0.22778,1,1
4,GO HORMONE METABOLIC PROCESS,8.4262e-06,0.21975,0.22347,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,6.8885e-07,0.21975,0.2136,1,1
4,GO REGULATION OF CELL ACTIVATION,2.6828e-05,0.21972,0.1751,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0055559,0.21963,0.22681,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.0005056,0.21955,0.19536,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,2.1624e-06,0.21952,0.27335,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0012705,0.21951,0.1826,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,8.4262e-06,0.21928,0.29093,1,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0028118,0.2192,0.20038,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.004964,0.21914,0.34394,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.00026858,0.21886,0.20285,1,1
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0098086,0.21865,0.205,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,1.2253e-05,0.21841,0.22082,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,3.758e-05,0.2183,0.18338,1,1
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.011022,0.21826,0.1418,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00020504,0.21816,0.2063,1,1
4,GO T CELL CYTOKINE PRODUCTION,0.00029052,0.21786,0.19593,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,3.8347e-06,0.21783,0.2228,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.00011218,0.21778,0.18723,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00017741,0.2172,0.27643,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,2.5884e-05,0.21704,0.26348,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.00041488,0.21684,0.15496,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,5.4184e-05,0.21679,0.19629,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00034485,0.21651,0.21898,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0001803,0.21649,0.19684,1,1
4,GO CARBOHYDRATE TRANSPORT,3.5606e-08,0.21646,0.21924,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.00014129,0.21636,0.1758,1,1
4,GO HEPARIN METABOLIC PROCESS,0.027118,0.21634,0.1417,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,1.5052e-06,0.21629,0.24377,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.0958e-05,0.21629,0.17875,1,1
4,GO ISOPRENOID METABOLIC PROCESS,2.5884e-05,0.21621,0.19505,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,3.628e-05,0.21614,0.18193,1,1
4,GO ACUTE PHASE RESPONSE,2.7804e-05,0.216,0.21923,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00040857,0.21586,0.22998,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.011949,0.21573,0.24502,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,5.6085e-05,0.2157,0.25941,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.01251,0.21549,0.19221,1,1
4,GO CHOLESTEROL STORAGE,0.00019229,0.21547,0.23266,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.5867e-06,0.21527,0.18908,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0081133,0.2152,0.14896,1,1
4,GO DRUG METABOLIC PROCESS,1.6158e-05,0.21518,0.25507,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,3.6567e-07,0.21491,0.24367,1,1
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0023957,0.2148,0.14672,1,1
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.00088789,0.2148,0.19773,1,1
4,GO REGULATION OF ANION TRANSPORT,1.3599e-06,0.21461,0.20483,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,1.4472e-05,0.21439,0.21198,1,1
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.020385,0.21426,0.15508,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0062877,0.21414,0.22155,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.9613e-05,0.2141,0.20303,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00082553,0.21392,0.25058,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,5.2303e-06,0.21375,0.21973,1,1
4,GO MACROPHAGE PROLIFERATION,0.0086125,0.21366,0.23125,1,1
4,GO TRANSCYTOSIS,0.00026858,0.21359,0.20031,1,1
4,GO REGULATION OF IMMUNE RESPONSE,1.1165e-05,0.2135,0.18545,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,3.357e-07,0.21341,0.21424,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0042095,0.21339,0.15571,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.0001803,0.21312,0.18278,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,4.1751e-05,0.2131,0.17367,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00073415,0.21294,0.18234,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0042636,0.21267,0.20136,1,1
4,GO RESPONSE TO METAL ION,1.1858e-08,0.21259,0.20681,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00046872,0.21248,0.17061,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00014599,0.21247,0.20561,1,1
4,GO GRANULOCYTE CHEMOTAXIS,3.8924e-05,0.21227,0.17718,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,2.8814e-05,0.21216,0.27428,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2482e-05,0.21216,0.1914,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.758e-05,0.21206,0.18157,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,3.6877e-06,0.21189,0.21315,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00010852,0.2118,0.20334,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.8049e-05,0.2118,0.2036,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0010408,0.21159,0.18316,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0012705,0.21133,0.19507,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,9.6129e-06,0.2111,0.22983,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,8.1623e-05,0.21107,0.22408,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.0007786,0.21066,0.19649,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,3.628e-05,0.21048,0.16355,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0005618,0.21036,0.2464,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00026438,0.21032,0.21976,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.7804e-05,0.21028,0.25556,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.0563e-05,0.21023,0.16146,1,1
4,GO TISSUE HOMEOSTASIS,7.969e-07,0.20983,0.19628,1,1
4,GO RENAL SYSTEM PROCESS,2.6352e-05,0.20981,0.20763,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0005211,0.20979,0.17954,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001422,0.20964,0.18163,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00039018,0.20962,0.15444,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,7.8911e-05,0.20949,0.20094,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,2.2505e-06,0.20941,0.2058,1,1
4,GO CRANIAL NERVE DEVELOPMENT,0.0016347,0.20923,0.19208,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0007786,0.20907,0.17535,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.00099681,0.209,0.21253,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00017741,0.20899,0.21884,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.0032501,0.20897,0.15827,1,1
4,GO AMINE METABOLIC PROCESS,1.0527e-08,0.20897,0.20984,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0003557,0.20892,0.25509,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,3.2631e-05,0.20874,0.28593,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.001568,0.20871,0.21723,1,1
4,GO MEMBRANE FUSION,5.1351e-07,0.20856,0.20637,1,1
4,GO REGULATION OF DEFENSE RESPONSE,4.9228e-07,0.20851,0.20399,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,4.2271e-06,0.20847,0.21435,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,1.2328e-07,0.20847,0.22227,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.0056255,0.20844,0.1697,1,1
4,GO WOUND HEALING,0.0001179,0.20824,0.19236,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,5.7582e-06,0.2082,0.25228,1,1
4,GO CYTOLYSIS,0.020166,0.20794,0.16498,1,1
4,GO RESPONSE TO BACTERIUM,2.4861e-06,0.20794,0.20134,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0015463,0.20788,0.19974,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.3442e-05,0.20781,0.23383,1,1
4,GO RESPONSE TO INACTIVITY,0.0029645,0.20771,0.20942,1,1
4,GO ACTIVATED T CELL PROLIFERATION,6.8888e-05,0.2077,0.19794,1,1
4,GO ORGANELLE MEMBRANE FUSION,4.2271e-06,0.20764,0.199,1,1
4,GO COPPER ION TRANSPORT,0.00060545,0.20716,0.20995,1,1
4,GO ACTION POTENTIAL,3.4773e-06,0.207,0.20818,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.00013232,0.20692,0.18374,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,2.5424e-05,0.20666,0.21321,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.00018323,0.20656,0.22731,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0052197,0.20655,0.16923,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,8.0256e-05,0.20654,0.19189,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00016361,0.2064,0.23228,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,2.4861e-06,0.20625,0.28159,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.012227,0.20612,0.24506,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,7.5001e-05,0.20607,0.20229,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.6877e-06,0.20601,0.21001,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,9.2585e-06,0.20598,0.17958,1,1
4,GO MEMBRANE FISSION,0.002631,0.20573,0.17362,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0022095,0.20537,0.21615,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0020646,0.20536,0.1695,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0018006,0.20529,0.19893,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.0096941,0.20527,0.15124,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.0712e-08,0.20526,0.21655,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.00074504,0.20521,0.22415,1,1
4,GO AMYLOID BETA FORMATION,0.00022927,0.205,0.21633,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,9.086e-06,0.20491,0.2654,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,9.2118e-07,0.20465,0.20897,1,1
4,GO HYALURONAN CATABOLIC PROCESS,0.047827,0.20464,0.13455,1,1
4,GO GAMMA DELTA T CELL ACTIVATION,0.0047198,0.20448,0.2091,1,1
4,GO PHAGOSOME MATURATION,5.8698e-06,0.20412,0.23089,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0021215,0.20412,0.20721,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.00039622,0.2041,0.1677,1,1
4,GO B CELL DIFFERENTIATION,2.3891e-06,0.204,0.19442,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,6.5906e-08,0.20389,0.20045,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.8573e-08,0.2037,0.20342,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00025617,0.20358,0.20733,1,1
4,GO REGULATION OF PEPTIDE SECRETION,2.4586e-08,0.20355,0.20386,1,1
4,GO VIRAL LIFE CYCLE,2.0478e-05,0.20342,0.18382,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,6.3359e-07,0.20328,0.22282,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0022396,0.20323,0.16521,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,1.8363e-05,0.20312,0.20853,1,1
4,GO PROTEIN AUTOPROCESSING,5.1304e-06,0.20286,0.23228,1,1
4,GO MUSCLE HYPERTROPHY,1.3878e-06,0.20284,0.22105,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00022565,0.20257,0.20234,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,2.7804e-05,0.20256,0.18941,1,1
4,GO RESPONSE TO CADMIUM ION,0.00076726,0.20248,0.19581,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.00017457,0.20221,0.19493,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.00027716,0.20221,0.19093,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,2.2286e-07,0.20218,0.19355,1,1
4,GO LIPID HOMEOSTASIS,3.6162e-06,0.20208,0.20817,1,1
4,GO CELLULAR RESPONSE TO STEROL,3.094e-05,0.202,0.23467,1,1
4,GO ENERGY HOMEOSTASIS,0.00018323,0.20185,0.21733,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.2057e-05,0.2018,0.2099,1,1
4,GO FIBRINOLYSIS,0.05357,0.20177,0.14987,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.00021511,0.20173,0.20944,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00044103,0.20169,0.1994,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0005618,0.20162,0.22472,1,1
4,GO LYMPHOCYTE ACTIVATION,4.2487e-05,0.20145,0.1599,1,1
4,GO REGULATION OF BLOOD PRESSURE,2.971e-06,0.20144,0.18784,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.4341e-06,0.20142,0.22281,1,1
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.001568,0.20127,0.24076,1,1
4,GO MUSCLE ADAPTATION,3.0302e-06,0.20091,0.21201,1,1
4,GO REGULATION OF BONE DEVELOPMENT,0.0048405,0.20086,0.14139,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0022701,0.20083,0.14234,1,1
4,GO GRANULOCYTE MIGRATION,9.9803e-06,0.20083,0.2016,1,1
4,GO GLOMERULUS DEVELOPMENT,0.0014624,0.20057,0.22023,1,1
4,GO EXOCYTOSIS,2.3784e-07,0.20049,0.20918,1,1
4,GO TISSUE MIGRATION,0.00029976,0.20043,0.18323,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.020385,0.20042,0.18323,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.1588e-05,0.20031,0.19641,1,1
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0099244,0.20005,0.2284,1,1
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0034692,0.19987,0.16215,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,3.9102e-06,0.19975,0.21147,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.6761e-05,0.19972,0.16744,1,1
4,GO POSITIVE REGULATION OF SECRETION,5.7536e-08,0.19971,0.20124,1,1
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.003654,0.19959,0.15635,1,1
4,GO RESPONSE TO NUTRIENT,4.6359e-05,0.19956,0.18282,1,1
4,GO METHIONINE METABOLIC PROCESS,0.00018323,0.19955,0.18883,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00020504,0.19944,0.21999,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0012886,0.19939,0.19216,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.2534e-06,0.19936,0.2022,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,6.7411e-08,0.19934,0.20799,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0005056,0.1993,0.2164,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,4.0314e-05,0.19921,0.18504,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.019523,0.19917,0.15869,1,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.012087,0.19885,0.14075,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00087508,0.1988,0.18656,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00040857,0.19877,0.16869,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,4.5822e-08,0.19867,0.23663,1,1
4,GO FATTY ACID CATABOLIC PROCESS,8.9166e-06,0.19861,0.19993,1,1
4,GO LYMPHOCYTE MIGRATION,2.2416e-05,0.19843,0.18434,1,1
4,GO NADP METABOLIC PROCESS,0.0011341,0.19826,0.2001,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.0020367,0.19804,0.27704,1,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.00082553,0.19803,0.28765,1,1
4,GO BONE CELL DEVELOPMENT,0.044722,0.19803,0.12612,1,1
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0015038,0.1978,0.16681,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0001862,0.19773,0.21228,1,1
4,GO PARAXIAL MESODERM DEVELOPMENT,0.0081133,0.19757,0.16617,1,1
4,GO PROTEIN PROCESSING,1.8318e-07,0.1975,0.22775,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0066851,0.1975,0.29555,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.8262e-08,0.19746,0.19778,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0086125,0.19732,0.13408,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,1.0958e-05,0.19729,0.16689,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.00023294,0.19726,0.17015,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00011986,0.19716,0.17154,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,6.5837e-06,0.19715,0.17342,1,1
4,GO BIOMINERALIZATION,0.00012594,0.19715,0.18833,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00025617,0.19706,0.1971,1,1
4,GO PROTEIN ADP RIBOSYLATION,0.00059648,0.19706,0.17196,1,1
4,GO RESPONSE TO PH,3.2057e-05,0.19691,0.21611,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00075607,0.19672,0.19917,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,1.2281e-06,0.19668,0.21294,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00099681,0.19645,0.22136,1,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00091404,0.19643,0.26415,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.9749e-05,0.19638,0.21464,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.0010865,0.19637,0.27417,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0011021,0.19637,0.2026,1,1
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00044103,0.19627,0.14092,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0050269,0.19625,0.17796,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,3.0905e-06,0.19603,0.22675,1,1
4,GO VACUOLAR ACIDIFICATION,6.7105e-06,0.19597,0.23316,1,1
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0031247,0.19596,0.24664,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,2.8814e-05,0.19595,0.2354,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0003557,0.19591,0.18909,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.1446e-05,0.19591,0.19163,1,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.012087,0.19589,0.18303,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0054872,0.19586,0.17169,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,0.00019229,0.19586,0.19987,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,7.9617e-06,0.19581,0.18361,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00046872,0.19567,0.20074,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,6.7724e-05,0.19566,0.19231,1,1
4,GO CARNITINE METABOLIC PROCESS,0.006444,0.1956,0.16625,1,1
4,GO RESPONSE TO WOUNDING,0.00020178,0.19553,0.18018,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,2.2416e-05,0.19551,0.17048,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.000662,0.19533,0.20023,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.8698e-06,0.19527,0.22819,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.3066e-07,0.19516,0.19421,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.2686e-06,0.19513,0.18563,1,1
4,GO SODIUM ION HOMEOSTASIS,1.7071e-05,0.19512,0.18619,1,1
4,GO PANCREATIC JUICE SECRETION,0.0099244,0.19501,0.14973,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.5934e-07,0.19486,0.2019,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.6828e-05,0.19481,0.18292,1,1
4,GO VESICLE TARGETING,5.2344e-05,0.19467,0.18076,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.0027747,0.1946,0.18119,1,1
4,GO INTERACTION WITH HOST,2.0853e-05,0.19459,0.1991,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.004156,0.19452,0.1707,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.2534e-06,0.19446,0.20944,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,9.5999e-07,0.19443,0.18207,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00037835,0.19427,0.19102,1,1
4,GO PROSTAGLANDIN SECRETION,0.0010259,0.19411,0.18021,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,2.4837e-07,0.19409,0.18638,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00043435,0.19391,0.16081,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.0015463,0.19391,0.17146,1,1
4,GO STEROID CATABOLIC PROCESS,0.0002117,0.19355,0.28563,1,1
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0016347,0.19346,0.17675,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00040235,0.19333,0.20789,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00070238,0.19328,0.17729,1,1
4,GO MACROPHAGE ACTIVATION,1.2716e-05,0.19323,0.22791,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.00040857,0.19302,0.20415,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00039622,0.19299,0.19774,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00026024,0.19288,0.18037,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0016347,0.19282,0.19121,1,1
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.01585,0.19277,0.1422,1,1
4,GO BIOLOGICAL ADHESION,0.00034485,0.1927,0.15941,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0005056,0.19255,0.17644,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00043435,0.19247,0.23632,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.0038977,0.1923,0.13467,1,1
4,GO DEVELOPMENTAL INDUCTION,0.00065224,0.19203,0.17215,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.4091e-05,0.19188,0.2732,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.00045468,0.19174,0.20737,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.0007901,0.19171,0.15213,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,7.8124e-06,0.19167,0.27897,1,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.020385,0.1916,0.1515,1,1
4,GO RESPONSE TO INSULIN,2.206e-06,0.19153,0.17381,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.00023667,0.1915,0.19225,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,7.6283e-05,0.19146,0.22564,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,8.4805e-07,0.19145,0.24643,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,9.404e-07,0.19143,0.26609,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,4.3997e-05,0.19135,0.19624,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.001704,0.19122,0.17151,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,8.6328e-08,0.19117,0.19272,1,1
4,GO REGULATION OF LIPID TRANSPORT,1.9749e-05,0.1911,0.19462,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0050904,0.19107,0.14404,1,1
4,GO GLIAL CELL PROLIFERATION,0.00090088,0.19101,0.1809,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00052901,0.19096,0.24165,1,1
4,GO PEROXISOMAL TRANSPORT,2.7312e-05,0.19095,0.18221,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,4.31e-06,0.19093,0.20615,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.5052e-06,0.19089,0.25837,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0014624,0.19089,0.24151,1,1
4,GO SPERM CAPACITATION,2.3239e-05,0.19089,0.23573,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00098255,0.1908,0.15609,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.0001862,0.19076,0.17445,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00029052,0.19075,0.23481,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.0235e-07,0.19072,0.19596,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,4.3946e-06,0.1907,0.24953,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00037257,0.19066,0.189,1,1
4,GO MULTICELLULAR ORGANISM AGING,5.0563e-05,0.19066,0.17986,1,1
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.013546,0.19062,0.11787,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.014658,0.19055,0.17996,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,7.6283e-05,0.19044,0.19779,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,2.8001e-06,0.1903,0.18741,1,1
4,GO PROTEIN DESTABILIZATION,3.5461e-06,0.19027,0.18752,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.7721e-08,0.19016,0.20587,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,9.9803e-06,0.19014,0.2074,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00013232,0.19014,0.22264,1,1
4,GO DETOXIFICATION,0.0029256,0.19011,0.14821,1,1
4,GO DETECTION OF STIMULUS,8.0712e-08,0.18981,0.16633,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.001442,0.1898,0.17049,1,1
4,GO REGULATION OF BODY FLUID LEVELS,1.4207e-05,0.18955,0.18654,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,5.9056e-05,0.18941,0.28815,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,2.8305e-05,0.18924,0.17515,1,1
4,GO PLACENTA DEVELOPMENT,0.0010865,0.18909,0.15491,1,1
4,GO NEUTROPHIL MIGRATION,1.7706e-05,0.18889,0.18141,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,7.7586e-05,0.18889,0.20724,1,1
4,GO REGULATION OF HORMONE LEVELS,1.2328e-07,0.18887,0.19761,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,5.9834e-06,0.18883,0.19486,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,8.3013e-05,0.1888,0.21007,1,1
4,GO LIPID DROPLET ORGANIZATION,1.0958e-05,0.18865,0.23078,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,1.0169e-05,0.1886,0.17255,1,1
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00058763,0.1885,0.19782,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.0028872,0.18842,0.17173,1,1
4,GO SECONDARY PALATE DEVELOPMENT,0.0065235,0.18842,0.17026,1,1
4,GO LIPID CATABOLIC PROCESS,1.3878e-06,0.18838,0.20055,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.8198e-07,0.18831,0.1908,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.00019229,0.18822,0.19795,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.00064263,0.18812,0.16406,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.0879e-07,0.18804,0.19776,1,1
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0044864,0.18792,0.15874,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0023637,0.18789,0.18161,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,1.6457e-05,0.18782,0.19227,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.0023321,0.18778,0.14187,1,1
4,GO BICARBONATE TRANSPORT,2.6352e-05,0.18755,0.22416,1,1
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0041031,0.18738,0.1307,1,1
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.013394,0.18726,0.22016,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.00039622,0.18725,0.14643,1,1
4,GO SENSORY PERCEPTION OF TASTE,7.6657e-06,0.18718,0.17738,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00011033,0.18717,0.21671,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,3.2631e-05,0.18701,0.2184,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00018923,0.18691,0.20363,1,1
4,GO CELL CELL RECOGNITION,0.00011596,0.18684,0.16336,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,1.0361e-05,0.18683,0.20777,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0023957,0.18681,0.17295,1,1
4,GO ENDOCRINE HORMONE SECRETION,1.0169e-05,0.18667,0.20878,1,1
4,GO CARDIAC CELL DEVELOPMENT,0.00062378,0.18665,0.14754,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,2.4972e-05,0.18662,0.15975,1,1
4,GO ER OVERLOAD RESPONSE,0.00023294,0.18659,0.22514,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.1588e-05,0.18656,0.19322,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00033955,0.18652,0.17238,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,1.3196e-05,0.18618,0.19535,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.00037257,0.18618,0.20128,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00014129,0.18613,0.18421,1,1
4,GO ORGANIC ANION TRANSPORT,1.3174e-07,0.18566,0.18803,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0013633,0.18565,0.23904,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00076726,0.18563,0.16267,1,1
4,GO GLUCOSE METABOLIC PROCESS,5.3747e-08,0.1856,0.20977,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0084096,0.18549,0.15097,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,1.1375e-05,0.18546,0.19838,1,1
4,GO COAGULATION,8.7316e-05,0.18542,0.18462,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.1234e-05,0.18535,0.17969,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.00042777,0.18525,0.22017,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,9.795e-06,0.18523,0.19451,1,1
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0034243,0.18515,0.14646,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00040235,0.18513,0.1762,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0032928,0.1851,0.25743,1,1
4,GO TRANSFERRIN TRANSPORT,6.7461e-07,0.18509,0.22388,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.00075607,0.18501,0.1557,1,1
4,GO I KAPPAB PHOSPHORYLATION,0.0098086,0.18495,0.13427,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,2.971e-06,0.18487,0.18032,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.00033955,0.18468,0.16506,1,1
4,GO ADAPTIVE THERMOGENESIS,4.1815e-08,0.18465,0.20124,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,3.0395e-05,0.1846,0.17577,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.00011406,0.18451,0.20222,1,1
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.00040857,0.18443,0.1564,1,1
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0021798,0.18432,0.19401,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00017457,0.18421,0.17796,1,1
4,GO TERPENOID METABOLIC PROCESS,0.00017176,0.18409,0.18436,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.00048316,0.18396,0.19274,1,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.003166,0.18385,0.16568,1,1
4,GO RETINOL METABOLIC PROCESS,0.0003557,0.18374,0.25058,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,5.9056e-05,0.18354,0.23207,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.00019541,0.18344,0.17259,1,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0020646,0.18336,0.18295,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0020646,0.18326,0.19196,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,4.5558e-05,0.18317,0.21243,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,3.5646e-05,0.183,0.20813,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,3.357e-07,0.18293,0.22147,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.00064263,0.18281,0.16251,1,1
4,GO RESPONSE TO STEROL,0.00013451,0.18267,0.19909,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0019285,0.18265,0.1423,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,8.1138e-06,0.18244,0.21281,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.1338e-07,0.18238,0.23346,1,1
4,GO RESPONSE TO FUNGUS,1.9749e-05,0.18221,0.17816,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.0083098,0.18202,0.15557,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.03006,0.18187,0.098089,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0087156,0.18185,0.19133,1,1
4,GO PHAGOCYTOSIS,0.00055343,0.18179,0.16397,1,1
4,GO AMINO ACID IMPORT,0.0038977,0.1817,0.14911,1,1
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0028118,0.18169,0.14995,1,1
4,GO RESPONSE TO CALCIUM ION,7.105e-06,0.18158,0.18752,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00011596,0.18145,0.19375,1,1
4,GO RENAL TUBULE DEVELOPMENT,0.0011836,0.1812,0.15798,1,1
4,GO MYELIN ASSEMBLY,0.00044781,0.18102,0.23534,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,3.8924e-05,0.181,0.14889,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0047798,0.18096,0.19246,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.017894,0.18089,0.15074,1,1
4,GO SECRETION,1.1535e-07,0.18076,0.18636,1,1
4,GO CHEMICAL HOMEOSTASIS,1.8723e-07,0.18061,0.16783,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00055343,0.1806,0.16625,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,3.3806e-05,0.18033,0.21495,1,1
4,GO PIGMENTATION,6.4341e-05,0.18022,0.15043,1,1
4,GO LEUKOCYTE DIFFERENTIATION,2.0853e-05,0.17998,0.16484,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00029511,0.17997,0.1889,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.000662,0.17995,0.20694,1,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.0011341,0.17994,0.16007,1,1
4,GO INOSITOL METABOLIC PROCESS,0.00065224,0.17992,0.19401,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.00034485,0.17968,0.18849,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00091404,0.17962,0.20208,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,3.2146e-06,0.17953,0.20271,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.2886e-07,0.17945,0.20926,1,1
4,GO REGULATION OF T CELL MIGRATION,0.00019857,0.17942,0.19121,1,1
4,GO CELL MATRIX ADHESION,0.00073415,0.1794,0.17963,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00020835,0.17922,0.1619,1,1
4,GO MUSCLE CELL MIGRATION,0.00027716,0.17919,0.2057,1,1
4,GO POSITIVE CHEMOTAXIS,8.4424e-05,0.17899,0.19425,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.3249e-05,0.17884,0.17267,1,1
4,GO ANION TRANSPORT,2.0429e-07,0.17876,0.17394,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.4091e-05,0.17866,0.1944,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,1.1806e-05,0.17866,0.17874,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,5.4701e-07,0.17863,0.1832,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00068191,0.17861,0.18393,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.00088789,0.17823,0.16021,1,1
4,GO REGULATION OF PROTEOLYSIS,7.3803e-06,0.17815,0.16833,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.000286,0.17772,0.169,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,3.9872e-06,0.17769,0.20668,1,1
4,GO XENOBIOTIC TRANSPORT,0.00033955,0.17766,0.20491,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.012227,0.17747,0.1747,1,1
4,GO ENDOCYTIC RECYCLING,0.00013451,0.17744,0.16577,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00011033,0.17718,0.16492,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0001179,0.17713,0.19949,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00021511,0.17697,0.21252,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00013673,0.17688,0.18182,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00014839,0.17686,0.15647,1,1
4,GO CAMP METABOLIC PROCESS,0.0045438,0.17679,0.16864,1,1
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.0025277,0.17676,0.24738,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0007786,0.17672,0.20822,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.9749e-05,0.17668,0.15991,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00047589,0.17666,0.16867,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,6.8885e-07,0.1766,0.21265,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.0478e-05,0.17659,0.15646,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,0.00033432,0.17655,0.20498,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.00031414,0.1765,0.18408,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.001955,0.17649,0.15009,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.000662,0.17632,0.17683,1,1
4,GO PROTEIN ACTIVATION CASCADE,0.036772,0.17623,0.14398,1,1
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0018508,0.17617,0.18005,1,1
4,GO LIPID METABOLIC PROCESS,2.9514e-07,0.1761,0.18405,1,1
4,GO GLAND DEVELOPMENT,0.00011986,0.17608,0.15224,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,2.4972e-05,0.17606,0.20185,1,1
4,GO BONE MINERALIZATION,0.00080175,0.17589,0.1779,1,1
4,GO GLIAL CELL DEVELOPMENT,0.00018923,0.17588,0.18348,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00044103,0.17567,0.16198,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,8.5867e-06,0.17548,0.22152,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.7693e-06,0.17545,0.1972,1,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022396,0.17538,0.15699,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0015249,0.17529,0.18487,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.00026438,0.17528,0.17085,1,1
4,GO VITAMIN TRANSPORT,0.00037257,0.17517,0.18231,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0016575,0.17511,0.16352,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001776,0.17504,0.21205,1,1
4,GO ENAMEL MINERALIZATION,0.027401,0.17496,0.18747,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,2.8305e-05,0.17491,0.2054,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00069207,0.17483,0.18972,1,1
4,GO TUMOR NECROSIS FACTOR SECRETION,0.0014022,0.17473,0.13812,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,9.4959e-05,0.17426,0.16564,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010408,0.17407,0.20728,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00017176,0.17407,0.19613,1,1
4,GO T CELL APOPTOTIC PROCESS,0.0025617,0.17398,0.14895,1,1
4,GO VESICLE ORGANIZATION,7.2414e-06,0.17392,0.16855,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,2.6352e-05,0.1737,0.18107,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,3.3214e-05,0.17368,0.21011,1,1
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0092477,0.17364,0.24119,1,1
4,GO GANGLIOSIDE METABOLIC PROCESS,0.019312,0.17355,0.13192,1,1
4,GO OUTER DYNEIN ARM ASSEMBLY,0.021509,0.17346,0.12664,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.0361e-05,0.17346,0.22057,1,1
4,GO REGULATION OF LIPID LOCALIZATION,3.4409e-05,0.17339,0.17755,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0073682,0.17328,0.18435,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,3.094e-05,0.17321,0.17734,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.5293e-05,0.1731,0.1731,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.003654,0.17303,0.15748,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00019229,0.17279,0.20647,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,5.1446e-05,0.17274,0.17066,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.000662,0.17272,0.14015,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00011986,0.17261,0.15933,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,2.9859e-05,0.17258,0.17059,1,1
4,GO INTERLEUKIN 17 PRODUCTION,0.012227,0.17241,0.15257,1,1
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.0027381,0.1724,0.14174,1,1
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00098255,0.17239,0.17603,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00041488,0.17233,0.17444,1,1
4,GO DENDRITIC CELL MIGRATION,0.01128,0.17222,0.13132,1,1
4,GO RESPONSE TO INTERLEUKIN 1,4.0314e-05,0.17205,0.14877,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,4.719e-07,0.17198,0.19207,1,1
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0048405,0.17189,0.13396,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,2.5359e-06,0.17188,0.18675,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00064263,0.17162,0.18162,1,1
4,GO NEPHRON DEVELOPMENT,0.0050269,0.17161,0.14202,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.8305e-05,0.17154,0.20383,1,1
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,5.1446e-05,0.17143,0.16278,1,1
4,GO EATING BEHAVIOR,7.1274e-05,0.17141,0.17783,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0030038,0.17128,0.2186,1,1
4,GO LYSOSOME LOCALIZATION,0.00011218,0.17116,0.17218,1,1
4,GO FATTY ACID METABOLIC PROCESS,9.2118e-07,0.1711,0.20523,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.00017457,0.17108,0.14497,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.00016901,0.17094,0.14933,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,9.9844e-05,0.17069,0.19163,1,1
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.013546,0.17054,0.11095,1,1
4,GO ALCOHOL METABOLIC PROCESS,2.7452e-06,0.17052,0.19275,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.00032408,0.17049,0.21939,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0049019,0.17018,0.21675,1,1
4,GO REGULATION OF LIPID STORAGE,0.00013673,0.17017,0.17573,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,4.8416e-06,0.17016,0.19835,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.3196e-05,0.17015,0.16517,1,1
4,GO RESPONSE TO PROGESTERONE,0.00017741,0.17008,0.2058,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0011341,0.16998,0.1505,1,1
4,GO REGULATION OF OSSIFICATION,0.00059648,0.16994,0.17339,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.9332e-05,0.16994,0.20333,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.0015249,0.16987,0.26927,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.008211,0.16976,0.1591,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00040857,0.16974,0.13822,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,6.9711e-06,0.16972,0.17257,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,7.1819e-07,0.16937,0.22071,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,5.4356e-06,0.16931,0.20872,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,1.1086e-06,0.16926,0.19292,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,9.795e-06,0.16923,0.20135,1,1
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0037016,0.16922,0.16227,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0056958,0.16908,0.1628,1,1
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.027973,0.16907,0.16259,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00053704,0.16904,0.17676,1,1
4,GO LOCOMOTOR RHYTHM,0.0037985,0.16885,0.17607,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,1.7071e-05,0.1688,0.18683,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.00011986,0.16877,0.17428,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0018764,0.16872,0.19257,1,1
4,GO NEURON MATURATION,0.002702,0.16868,0.16768,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00029511,0.16859,0.15661,1,1
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.014823,0.1685,0.11295,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.001235,0.16849,0.14539,1,1
4,GO FIBROBLAST PROLIFERATION,0.00068191,0.16834,0.19388,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7804e-05,0.168,0.19516,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0051547,0.16786,0.15133,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.5424e-05,0.16785,0.18686,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.0020092,0.16763,0.18502,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00021857,0.16757,0.16526,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,1.2058e-07,0.16747,0.1736,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00159,0.16743,0.19524,1,1
4,GO AMINE TRANSPORT,9.1829e-05,0.16742,0.2357,1,1
4,GO INSULIN SECRETION,4.4807e-06,0.16739,0.18602,1,1
4,GO FATTY ACYL COA METABOLIC PROCESS,4.3236e-05,0.16739,0.22109,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00042128,0.16738,0.19287,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00021857,0.16719,0.14588,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0002443,0.16701,0.1458,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00048316,0.16698,0.16595,1,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.00025215,0.16689,0.17609,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,8.7316e-05,0.16669,0.16634,1,1
4,GO RESPONSE TO DSRNA,0.0002117,0.16632,0.15402,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0012527,0.16632,0.14298,1,1
4,GO REGULATION OF HORMONE SECRETION,5.5412e-06,0.16611,0.17374,1,1
4,GO PROTEIN KINASE B SIGNALING,0.00026438,0.1659,0.15296,1,1
4,GO CELLULAR RESPONSE TO STARVATION,4.5233e-07,0.16581,0.18675,1,1
4,GO RESPONSE TO AMPHETAMINE,0.0031247,0.1658,0.18231,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.00011596,0.1658,0.15864,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.047827,0.16574,0.12798,1,1
4,GO TEMPERATURE HOMEOSTASIS,1.1789e-06,0.16569,0.17942,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,5.2445e-07,0.16564,0.17404,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.00057029,0.16557,0.19122,1,1
4,GO MONOAMINE TRANSPORT,0.00037835,0.16555,0.23504,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0023637,0.16535,0.15155,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,4.3236e-05,0.1653,0.22173,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.00091404,0.16529,0.15842,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.026013,0.16521,0.16186,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,3.2631e-05,0.16519,0.15227,1,1
4,GO MESONEPHROS DEVELOPMENT,0.00057029,0.16519,0.16885,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,1.7071e-05,0.16518,0.17546,1,1
4,GO T CELL DIFFERENTIATION,5.6085e-05,0.16508,0.15587,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00017176,0.16503,0.14988,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,6.0991e-06,0.16491,0.20016,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.023173,0.16479,0.1419,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,1.7071e-05,0.16455,0.20073,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.0050269,0.16454,0.18349,1,1
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0037985,0.16443,0.2328,1,1
4,GO REGULATION OF CELLULAR PH,1.4076e-07,0.16428,0.19018,1,1
4,GO RESPONSE TO IRON ION,7.6283e-05,0.16422,0.20752,1,1
4,GO DNA DEMETHYLATION,0.023919,0.16411,0.11869,1,1
4,GO NOTCH SIGNALING PATHWAY,8.1138e-06,0.1641,0.1925,1,1
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.036048,0.16398,0.13988,1,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.027401,0.16391,0.12687,1,1
4,GO PROTEIN MANNOSYLATION,0.00014839,0.16389,0.1945,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.004964,0.16383,0.19673,1,1
4,GO CIRCULATORY SYSTEM PROCESS,5.8698e-06,0.16361,0.16384,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,1.5037e-07,0.16359,0.19343,1,1
4,GO EPITHELIUM DEVELOPMENT,4.5558e-05,0.16356,0.1546,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0040509,0.16346,0.13272,1,1
4,GO MANGANESE ION TRANSPORT,0.00043435,0.16331,0.16666,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.00040857,0.16321,0.19248,1,1
4,GO ION HOMEOSTASIS,2.3891e-06,0.16305,0.14776,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,2.5884e-05,0.16294,0.20952,1,1
4,GO DRUG CATABOLIC PROCESS,0.00060545,0.16293,0.20203,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,5.5127e-05,0.16285,0.19497,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.00039622,0.16273,0.17616,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,1.7071e-05,0.16261,0.13763,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.00014362,0.1625,0.1437,1,1
4,GO PEROXISOME ORGANIZATION,5.3256e-05,0.1625,0.16991,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.002702,0.16236,0.14716,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00035024,0.16222,0.18748,1,1
4,GO RIG I SIGNALING PATHWAY,0.0013069,0.16218,0.14204,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0099244,0.16215,0.16464,1,1
4,GO REGULATION OF SECRETION,4.719e-07,0.16204,0.17057,1,1
4,GO REGULATION OF TUBE SIZE,1.3693e-05,0.16202,0.17177,1,1
4,GO NEUROINFLAMMATORY RESPONSE,0.00036686,0.16178,0.16619,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.001704,0.16178,0.14846,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0062108,0.16172,0.13648,1,1
4,GO METAL ION HOMEOSTASIS,5.8698e-06,0.16169,0.14276,1,1
4,GO RESPONSE TO AMINE,0.0095807,0.16169,0.12232,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,6.2169e-06,0.16162,0.16136,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00075607,0.16156,0.14059,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,1.1165e-05,0.16139,0.17837,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.064418,0.16127,0.11865,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,2.0879e-07,0.16088,0.18125,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,4.3997e-05,0.16071,0.17942,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0023637,0.16063,0.14904,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0015038,0.16061,0.15967,1,1
4,GO ION TRANSPORT,9.404e-07,0.16057,0.15435,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.016027,0.1605,0.14204,1,1
4,GO GLIAL CELL ACTIVATION,0.00091404,0.16007,0.17623,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0016806,0.16,0.15979,1,1
4,GO REGULATION OF PH,5.2538e-08,0.15978,0.19225,1,1
4,GO INNERVATION,0.062684,0.15956,0.19859,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,3.9613e-05,0.15925,0.16734,1,1
4,GO LUNG MORPHOGENESIS,0.0075485,0.15912,0.15046,1,1
4,GO FATTY ACID BETA OXIDATION,0.00081356,0.15909,0.15216,1,1
4,GO GOLGI VESICLE BUDDING,1.7385e-05,0.15887,0.17595,1,1
4,GO REGULATION OF BIOMINERALIZATION,0.0067673,0.15882,0.14284,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0078263,0.15866,0.1574,1,1
4,GO MEMBRANE REPOLARIZATION,0.0007901,0.15862,0.19071,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,3.9613e-05,0.15852,0.15329,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00075607,0.1585,0.17714,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0010259,0.15842,0.13441,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.01829,0.15838,0.12175,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.001955,0.15837,0.12872,1,1
4,GO LIPID MODIFICATION,1.9749e-05,0.15836,0.15407,1,1
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0072795,0.15831,0.17002,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,3.3214e-05,0.1583,0.1633,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0010865,0.1583,0.16711,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,8.8796e-05,0.15829,0.14178,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00012594,0.15822,0.19598,1,1
4,GO PEPTIDE HORMONE SECRETION,2.4528e-05,0.15805,0.17383,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,9.795e-06,0.15804,0.17546,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,3.8347e-06,0.15782,0.16206,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.6386e-06,0.15779,0.15924,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,3.8246e-05,0.15777,0.19222,1,1
4,GO RESPONSE TO STARVATION,1.2792e-06,0.15774,0.17673,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,9.3381e-05,0.15771,0.13844,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.0025617,0.15767,0.15247,1,1
4,GO REGULATION OF BLOOD CIRCULATION,1.6158e-05,0.15766,0.173,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,8.8796e-05,0.15765,0.22145,1,1
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0024609,0.15758,0.15223,1,1
4,GO STRIATED MUSCLE ADAPTATION,5.9056e-05,0.15742,0.2092,1,1
4,GO PROTEIN MATURATION,1.1086e-06,0.15741,0.17899,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.00010673,0.1573,0.15855,1,1
4,GO FATTY ACID TRANSPORT,3.8924e-05,0.15725,0.17047,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,2.0776e-06,0.15722,0.157,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0013255,0.1572,0.15063,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.8262e-07,0.15718,0.17085,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,7.8911e-05,0.15716,0.14226,1,1
4,GO INCLUSION BODY ASSEMBLY,0.012945,0.15711,0.18447,1,1
4,GO THYMIC T CELL SELECTION,0.0020646,0.15706,0.12657,1,1
4,GO HORMONE TRANSPORT,1.1789e-06,0.15699,0.19018,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,3.6162e-06,0.15693,0.20066,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,5.5864e-07,0.1569,0.17097,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00016901,0.15688,0.14195,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0018006,0.15688,0.1938,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0037498,0.15678,0.13797,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0013633,0.15672,0.14815,1,1
4,GO ASTROCYTE ACTIVATION,0.010041,0.15664,0.16444,1,1
4,GO POSITIVE REGULATION OF SIGNALING,1.7071e-05,0.15662,0.13854,1,1
4,GO PH REDUCTION,3.9872e-06,0.15659,0.18932,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00030449,0.15639,0.14618,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0017277,0.15629,0.21597,1,1
4,GO RESPONSE TO ALCOHOL,0.000286,0.15628,0.13423,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.00019541,0.15624,0.15153,1,1
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0012886,0.15624,0.15467,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.5868e-06,0.15623,0.15842,1,1
4,GO ERK1 AND ERK2 CASCADE,0.0021798,0.15622,0.15947,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.054582,0.15594,0.11905,1,1
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.057711,0.15593,0.15687,1,1
4,GO ORGANELLE FUSION,1.6761e-05,0.15578,0.16127,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.001776,0.15566,0.15539,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,4.5684e-06,0.15558,0.19161,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,8.3066e-07,0.15554,0.17714,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.4296e-07,0.1554,0.1701,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00021857,0.15538,0.16926,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00040857,0.15535,0.17688,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00060545,0.15524,0.16768,1,1
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0030436,0.15521,0.12085,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.050154,0.15513,0.10273,1,1
4,GO POLYOL CATABOLIC PROCESS,0.001442,0.15502,0.14266,1,1
4,GO MAMMARY GLAND MORPHOGENESIS,0.0054872,0.15495,0.16833,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00020178,0.15489,0.14427,1,1
4,GO FAT CELL DIFFERENTIATION,6.3249e-05,0.15483,0.18411,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00017176,0.15461,0.16879,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0022095,0.1546,0.1802,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.0066039,0.1546,0.18175,1,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0013443,0.15459,0.16025,1,1
4,GO RESPONSE TO KETONE,0.00020504,0.15459,0.15366,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0012177,0.1542,0.14969,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0013255,0.15402,0.14488,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.7172e-05,0.154,0.15172,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0076401,0.15391,0.12086,1,1
4,GO REGULATION OF HEMOPOIESIS,9.819e-05,0.15378,0.14683,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.00046872,0.15351,0.1388,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,3.4098e-06,0.15342,0.15237,1,1
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0071918,0.15337,0.14364,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.00011596,0.15335,0.18232,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.01128,0.1533,0.1539,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00030928,0.15311,0.17367,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,3.7605e-06,0.15308,0.19272,1,1
4,GO OSTEOCLAST DIFFERENTIATION,0.0071918,0.15302,0.11727,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0013443,0.15298,0.13773,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,8.5858e-05,0.15287,0.14438,1,1
4,GO ERBB SIGNALING PATHWAY,0.0029645,0.15284,0.14187,1,1
4,GO GLAND MORPHOGENESIS,0.004156,0.15284,0.1848,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00088789,0.15268,0.1369,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.00011218,0.15267,0.14831,1,1
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0059116,0.15266,0.17588,1,1
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0058389,0.15248,0.16387,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,4.4771e-05,0.15247,0.21569,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00019857,0.15232,0.15108,1,1
4,GO MIDGUT DEVELOPMENT,0.063836,0.15229,0.14969,1,1
4,GO INORGANIC ANION TRANSPORT,2.206e-06,0.15209,0.15556,1,1
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0012177,0.15199,0.12868,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00015331,0.15195,0.1867,1,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00053704,0.15179,0.20167,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0037498,0.15171,0.13406,1,1
4,GO VACUOLE ORGANIZATION,9.4407e-08,0.15163,0.20513,1,1
4,GO RESPONSE TO AMYLOID BETA,0.059331,0.15163,0.11056,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00024045,0.15158,0.1359,1,1
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.05357,0.15158,0.12328,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,2.8814e-05,0.15152,0.14879,1,1
4,GO REGULATION OF GLUCONEOGENESIS,3.0302e-06,0.15139,0.2124,1,1
4,GO RESPONSE TO LIPID,0.00010497,0.15131,0.14768,1,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.03429,0.15123,0.10949,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.0005618,0.15116,0.14501,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,6.6578e-05,0.15101,0.16425,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.019735,0.15094,0.16045,1,1
4,GO POSITIVE THYMIC T CELL SELECTION,0.0047198,0.1509,0.16425,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00013451,0.15082,0.16889,1,1
4,GO PROTEOLYSIS,7.6657e-06,0.1508,0.14071,1,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0067673,0.15075,0.12853,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.1456e-06,0.15074,0.16266,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.038637,0.15059,0.1653,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0010113,0.15057,0.14835,1,1
4,GO RESPONSE TO CARBOHYDRATE,4.7999e-05,0.15055,0.14497,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00033432,0.15049,0.13278,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00058763,0.15048,0.19557,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0032078,0.15041,0.15669,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,3.8924e-05,0.15029,0.14903,1,1
4,GO GRANULOCYTE DIFFERENTIATION,0.043444,0.15027,0.12618,1,1
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.0037498,0.15019,0.13171,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.006444,0.15013,0.15805,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0018764,0.14993,0.18664,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0080166,0.1499,0.16283,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.00065224,0.14977,0.18336,1,1
4,GO NEGATIVE T CELL SELECTION,0.0032501,0.14971,0.15602,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,5.6085e-05,0.14969,0.166,1,1
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0090315,0.14962,0.13696,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0011021,0.14949,0.12836,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,3.0905e-06,0.1494,0.21265,1,1
4,GO MACROPHAGE MIGRATION,0.0021505,0.14934,0.14366,1,1
4,GO RESPONSE TO HORMONE,6.1119e-05,0.14917,0.14461,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,7.9617e-06,0.14909,0.14204,1,1
4,GO GLUCOSE IMPORT,0.00041488,0.14898,0.13734,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.00010323,0.1489,0.13996,1,1
4,GO COPII COATED VESICLE BUDDING,7.1274e-05,0.14883,0.16,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.8363e-05,0.14873,0.18396,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00010152,0.14865,0.20139,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00011596,0.14862,0.12533,1,1
4,GO CELL MOTILITY,0.00058763,0.14861,0.13693,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0001179,0.14856,0.17242,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.031953,0.14838,0.10275,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0050904,0.14837,0.14097,1,1
4,GO REGULATION OF CHEMOTAXIS,0.00015331,0.14833,0.15999,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0012005,0.14823,0.12039,1,1
4,GO ETHER BIOSYNTHETIC PROCESS,0.033608,0.14819,0.107,1,1
4,GO SULFUR COMPOUND TRANSPORT,5.2344e-05,0.14814,0.1796,1,1
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0023009,0.14812,0.18649,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00040235,0.14808,0.1543,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00011986,0.14793,0.14307,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.015159,0.14774,0.11537,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.00014839,0.14769,0.14839,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,8.1138e-06,0.14761,0.17347,1,1
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.017506,0.14761,0.12432,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.0062108,0.14741,0.18373,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,1.7693e-06,0.1473,0.16223,1,1
4,GO ENDOTHELIAL CELL PROLIFERATION,0.0013443,0.14729,0.1645,1,1
4,GO HOMEOSTATIC PROCESS,3.6162e-06,0.14727,0.13771,1,1
4,GO ZINC ION TRANSPORT,0.00087508,0.14725,0.15823,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.00024819,0.14725,0.1896,1,1
4,GO PRO B CELL DIFFERENTIATION,0.015329,0.14714,0.15706,1,1
4,GO SPLEEN DEVELOPMENT,0.0013443,0.14683,0.14425,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.00029511,0.14678,0.15733,1,1
4,GO CATECHOLAMINE SECRETION,0.00063314,0.14671,0.25825,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,7.1274e-05,0.1467,0.15977,1,1
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.001235,0.1465,0.14368,1,1
4,GO REGULATION OF INSULIN SECRETION,5.5127e-05,0.14645,0.1577,1,1
4,GO MYELOID CELL HOMEOSTASIS,0.00060545,0.14644,0.14662,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00065224,0.14634,0.16891,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00086244,0.14618,0.17188,1,1
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.006444,0.14613,0.12448,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0020367,0.14606,0.20009,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,8.5867e-06,0.14599,0.16429,1,1
4,GO CHLORIDE TRANSPORT,1.1375e-05,0.14598,0.15565,1,1
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0059116,0.14596,0.14103,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,7.1274e-05,0.14585,0.13542,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.032938,0.14585,0.18762,1,1
4,GO CELLULAR PIGMENTATION,0.00045468,0.14575,0.14881,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00035024,0.1457,0.14282,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00018323,0.14562,0.14356,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0019023,0.14543,0.17128,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,9.3381e-05,0.14536,0.14223,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001422,0.14535,0.14663,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,1.4207e-05,0.14534,0.14161,1,1
4,GO POSITIVE REGULATION OF OSSIFICATION,0.0025961,0.1452,0.1795,1,1
4,GO RESPONSE TO HYPEROXIA,0.049681,0.14514,0.11125,1,1
4,GO ERAD PATHWAY,0.00086244,0.14504,0.1268,1,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0044298,0.14501,0.13896,1,1
4,GO FATTY ACID HOMEOSTASIS,0.0070192,0.14485,0.20865,1,1
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0056958,0.14478,0.18458,1,1
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.032278,0.14474,0.15288,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,9.1829e-05,0.14464,0.14776,1,1
4,GO SERTOLI CELL DIFFERENTIATION,0.0099244,0.14454,0.18824,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.012798,0.14443,0.16455,1,1
4,GO KERATINOCYTE MIGRATION,0.00049802,0.14439,0.16381,1,1
4,GO CELLULAR ION HOMEOSTASIS,1.0756e-05,0.14436,0.1317,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00023294,0.14429,0.15637,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.0015249,0.14419,0.14722,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0022701,0.14417,0.18601,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,3.9872e-06,0.14398,0.15207,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0022095,0.14396,0.1527,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00067188,0.14379,0.17387,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.003607,0.1436,0.12913,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00037257,0.14358,0.14696,1,1
4,GO HEART PROCESS,4.5558e-05,0.14331,0.16181,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00017457,0.14325,0.16236,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.029754,0.14317,0.16098,1,1
4,GO REGULATION OF MAPK CASCADE,0.00016098,0.14305,0.15123,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.032607,0.14302,0.14055,1,1
4,GO LYMPHOCYTE CHEMOTAXIS,0.0018508,0.14288,0.12512,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0005789,0.14286,0.16932,1,1
4,GO REGULATION OF RECEPTOR RECYCLING,0.0028492,0.14281,0.16324,1,1
4,GO RESPONSE TO VITAMIN,0.020385,0.1428,0.13431,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,3.1494e-05,0.14276,0.15999,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00058763,0.14255,0.1225,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,3.0905e-06,0.14246,0.16346,1,1
4,GO CELL JUNCTION ASSEMBLY,0.0016122,0.14242,0.13177,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.7502e-06,0.14229,0.17981,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0016347,0.14199,0.1208,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0045438,0.14197,0.1262,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,4.9694e-05,0.14186,0.15149,1,1
4,GO VACUOLAR TRANSPORT,0.00010323,0.14184,0.15326,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00025617,0.14184,0.12928,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,1.3442e-05,0.14181,0.14564,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,1.8363e-05,0.14167,0.16213,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.00031907,0.14164,0.15045,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0081133,0.14145,0.12774,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0012886,0.14129,0.13558,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.004964,0.14116,0.13113,1,1
4,GO CELL REDOX HOMEOSTASIS,0.00019541,0.14114,0.17572,1,1
4,GO RESPONSE TO TESTOSTERONE,0.00046165,0.14089,0.17756,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0012177,0.14084,0.18953,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,2.2015e-05,0.1408,0.14666,1,1
4,GO RESPONSE TO MONOSACCHARIDE,5.9056e-05,0.14072,0.14596,1,1
4,GO REGULATION OF APPETITE,0.02128,0.14071,0.087115,1,1
4,GO LYSOSOMAL TRANSPORT,0.00062378,0.1407,0.15657,1,1
4,GO CELLULAR RESPONSE TO IRON ION,0.02174,0.14061,0.12886,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,5.6085e-05,0.14059,0.1383,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.023919,0.14034,0.11738,1,1
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0030436,0.14024,0.17221,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00035024,0.14022,0.16513,1,1
4,GO REGULATION OF TRANSPORT,3.5022e-05,0.14012,0.12156,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,3.0395e-05,0.13994,0.12968,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.000286,0.13976,0.13011,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.001955,0.13966,0.16409,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00020178,0.13966,0.14866,1,1
4,GO IRON ION TRANSPORT,4.1456e-06,0.13963,0.18058,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.00033955,0.13957,0.12779,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0022095,0.13954,0.15003,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0018006,0.1393,0.12432,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0046604,0.13926,0.15099,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,3.5461e-06,0.13892,0.15765,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0018508,0.13873,0.13528,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0021505,0.13873,0.15536,1,1
4,GO RESPONSE TO DRUG,4.6359e-05,0.1387,0.15701,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.0025961,0.13858,0.12963,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,4.1552e-07,0.13857,0.15896,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00084997,0.13842,0.13486,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.057179,0.13834,0.12853,1,1
4,GO RESPONSE TO RETINOIC ACID,0.022928,0.13823,0.11044,1,1
4,GO KERATINOCYTE PROLIFERATION,0.0063654,0.13819,0.1617,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00063314,0.1381,0.18067,1,1
4,GO VIRION ASSEMBLY,0.00084997,0.13806,0.1157,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.00045468,0.13802,0.12741,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0034243,0.13795,0.14486,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,9.9803e-06,0.13791,0.13855,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00098255,0.1379,0.13714,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00068191,0.13778,0.12857,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0044298,0.13776,0.14679,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,2.9859e-05,0.13772,0.14681,1,1
4,GO SPERM EGG RECOGNITION,0.00046165,0.13756,0.12232,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.018898,0.13753,0.12906,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,3.094e-05,0.13738,0.14219,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00062378,0.13736,0.13627,1,1
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0030839,0.13735,0.15396,1,1
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.03429,0.1373,0.14169,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0054872,0.13727,0.12487,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.001568,0.1371,0.13036,1,1
4,GO ATP TRANSPORT,0.034984,0.13695,0.087462,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.014823,0.13691,0.13124,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0047798,0.13659,0.1302,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0084096,0.13654,0.1209,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,5.0323e-06,0.13653,0.17059,1,1
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.00069207,0.13647,0.2088,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,1.155e-06,0.13644,0.16526,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,4.3997e-05,0.13636,0.13934,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0092477,0.13624,0.16399,1,1
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0022701,0.13624,0.13918,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.034636,0.13622,0.089443,1,1
4,GO CATION TRANSPORT,1.1806e-05,0.13616,0.13688,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0053519,0.13613,0.13668,1,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.00087508,0.13609,0.17358,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,2.2416e-05,0.13604,0.17646,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0022095,0.13594,0.13694,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,7.1274e-05,0.13594,0.14032,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.010895,0.13591,0.14673,1,1
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00029976,0.1358,0.18663,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.031311,0.13576,0.14035,1,1
4,GO LIPID IMPORT INTO CELL,0.0062108,0.13571,0.16784,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.00073415,0.13556,0.13445,1,1
4,GO POSITIVE T CELL SELECTION,0.0027747,0.13553,0.13053,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00031414,0.13553,0.1599,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.7172e-05,0.1355,0.14144,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.00076726,0.13547,0.15121,1,1
4,GO MEMBRANE ORGANIZATION,5.7059e-05,0.13529,0.12743,1,1
4,GO CARDIAC MUSCLE CONTRACTION,0.00044103,0.13528,0.14696,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0090315,0.13526,0.15237,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0005618,0.13518,0.16778,1,1
4,GO MUSCLE CELL PROLIFERATION,0.007921,0.13514,0.11771,1,1
4,GO OSSIFICATION,0.0018764,0.1351,0.15159,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0001862,0.13509,0.14996,1,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.012087,0.13497,0.15163,1,1
4,GO REGULATION OF PROTEIN MATURATION,0.014494,0.13493,0.11462,1,1
4,GO ANION HOMEOSTASIS,0.0047798,0.13488,0.14189,1,1
4,GO RESPONSE TO PEPTIDE,8.1623e-05,0.13454,0.13456,1,1
4,GO T CELL SELECTION,0.00036686,0.13452,0.13744,1,1
4,GO ENDOSOME ORGANIZATION,7.5001e-05,0.13439,0.16298,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0055559,0.13439,0.15653,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.015329,0.1343,0.14271,1,1
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.010895,0.13426,0.18302,1,1
4,GO REGULATION OF BONE MINERALIZATION,0.019523,0.13419,0.14244,1,1
4,GO RELAXATION OF MUSCLE,0.0022701,0.13407,0.16712,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00049802,0.13407,0.1492,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.015501,0.13398,0.14831,1,1
4,GO CALCIUM ION IMPORT,0.001118,0.13397,0.12271,1,1
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0020646,0.13393,0.12902,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00013451,0.13386,0.15276,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,7.6657e-06,0.13383,0.18428,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0033361,0.13378,0.15197,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.059331,0.1337,0.22262,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.012087,0.13366,0.14428,1,1
4,GO TISSUE REGENERATION,0.0067673,0.13365,0.14088,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.015501,0.13362,0.17508,1,1
4,GO ACTIN NUCLEATION,0.0012005,0.13354,0.15163,1,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.031953,0.1335,0.096498,1,1
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00099681,0.13348,0.15681,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.022928,0.1334,0.12156,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,9.6562e-05,0.13334,0.13157,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0014624,0.13334,0.16355,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00049802,0.13318,0.14625,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.031631,0.13314,0.12765,1,1
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.051595,0.13305,0.11499,1,1
4,GO EXOCYTIC PROCESS,0.00026438,0.13293,0.18172,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.0070192,0.1329,0.13401,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00030928,0.13283,0.19876,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.012087,0.13275,0.11414,1,1
4,GO TRANSMEMBRANE TRANSPORT,1.996e-06,0.13274,0.14167,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0056958,0.13246,0.10951,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0028492,0.13244,0.14472,1,1
4,GO OXIDATION REDUCTION PROCESS,9.6129e-06,0.1324,0.1562,1,1
4,GO REGULATION OF RESPONSE TO STRESS,5.9056e-05,0.13235,0.13317,1,1
4,GO RUFFLE ORGANIZATION,0.00020178,0.13213,0.16517,1,1
4,GO MOLTING CYCLE,0.01128,0.13195,0.10429,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.0018764,0.13184,0.11676,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,9.819e-05,0.13152,0.12845,1,1
4,GO CHOLESTEROL EFFLUX,0.0039481,0.13152,0.13624,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.4091e-05,0.13151,0.14245,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00013016,0.13148,0.12715,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00025215,0.13146,0.12103,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00058763,0.13142,0.11776,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.00018323,0.13124,0.15263,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,7.6283e-05,0.13121,0.11611,1,1
4,GO REGULATION OF ION TRANSPORT,0.00010497,0.13121,0.13242,1,1
4,GO COPPER ION HOMEOSTASIS,0.0047198,0.1312,0.15039,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00076726,0.13119,0.16407,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,6.6578e-05,0.13102,0.12937,1,1
4,GO SIGNAL RELEASE,1.7706e-05,0.13074,0.15338,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.00020178,0.1306,0.1522,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0043737,0.13051,0.11319,1,1
4,GO IMPORT INTO CELL,0.0046604,0.1305,0.1152,1,1
4,GO CELLULAR HOMEOSTASIS,1.7385e-05,0.13042,0.12324,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0025961,0.13026,0.15319,1,1
4,GO REGULATION OF CELL MATURATION,0.0005789,0.13016,0.14052,1,1
4,GO CELL MATURATION,2.0478e-05,0.1301,0.14509,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.00065224,0.13005,0.12885,1,1
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00094089,0.13,0.14135,1,1
4,GO AGING,1.2482e-05,0.12986,0.15058,1,1
4,GO FEAR RESPONSE,0.0068504,0.12974,0.11053,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00012388,0.12971,0.12926,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,5.7582e-06,0.12969,0.16002,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0052854,0.1296,0.12472,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0032078,0.12946,0.11097,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,2.2416e-05,0.12931,0.13399,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0011668,0.12917,0.14322,1,1
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0024941,0.1289,0.1435,1,1
4,GO METAL ION TRANSPORT,3.0395e-05,0.12889,0.13246,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.00042128,0.12886,0.11872,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,9.4959e-05,0.12871,0.13054,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0022095,0.12871,0.14084,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.014172,0.12856,0.12808,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.013394,0.12843,0.11125,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.001568,0.12837,0.13586,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.012798,0.12828,0.12186,1,1
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0012177,0.12827,0.12715,1,1
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00043435,0.12826,0.16517,1,1
4,GO MUSCLE SYSTEM PROCESS,0.00042777,0.12821,0.12374,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,3.094e-05,0.12808,0.19191,1,1
4,GO SODIUM ION TRANSPORT,7.105e-06,0.12804,0.17221,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,8.8796e-05,0.12799,0.13029,1,1
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0081133,0.1279,0.11291,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.001704,0.12775,0.12,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0007901,0.12758,0.16106,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0017277,0.12736,0.11891,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00159,0.12731,0.13831,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00016901,0.12719,0.14041,1,1
4,GO NEGATIVE REGULATION OF SECRETION,6.2175e-05,0.12703,0.12822,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0042095,0.12695,0.11605,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0021215,0.12692,0.11792,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00014839,0.12689,0.13462,1,1
4,GO SINGLE FERTILIZATION,0.00029052,0.12682,0.10944,1,1
4,GO EPITHELIAL CELL MATURATION,0.040981,0.12679,0.14404,1,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0054192,0.12678,0.11399,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,8.4805e-07,0.12676,0.14918,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.00028155,0.1267,0.12541,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0005618,0.1265,0.1566,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0012886,0.12634,0.13126,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.023173,0.12632,0.11474,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0059852,0.12623,0.12877,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,2.3239e-05,0.12588,0.14507,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0025617,0.12583,0.10948,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00059648,0.12582,0.11787,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.00016901,0.12579,0.14067,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,1.6457e-05,0.12576,0.13691,1,1
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.011022,0.12557,0.1007,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.00014599,0.12553,0.1541,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.024947,0.12552,0.13667,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.0013633,0.12546,0.17034,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00042128,0.12535,0.15593,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00031907,0.12521,0.12774,1,1
4,GO PROTEIN PALMITOYLATION,0.017125,0.12518,0.12935,1,1
4,GO CALCIUM MEDIATED SIGNALING,1.4207e-05,0.12504,0.12306,1,1
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0019285,0.12492,0.13848,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.026838,0.12486,0.15339,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.00049802,0.12479,0.11531,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00011986,0.12478,0.16113,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00023294,0.12473,0.17851,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.0047198,0.12442,0.13058,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0052197,0.12429,0.14351,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0021505,0.12428,0.19977,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0017517,0.12414,0.12674,1,1
4,GO REGULATION OF TOR SIGNALING,6.1119e-05,0.12414,0.13332,1,1
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.00029511,0.12406,0.12342,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.00092737,0.12404,0.11936,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.001483,0.12401,0.15136,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,8.4424e-05,0.124,0.12818,1,1
4,GO TUBE MORPHOGENESIS,0.0072795,0.12399,0.11825,1,1
4,GO MUSCLE CELL DIFFERENTIATION,0.00068191,0.1236,0.13065,1,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.058247,0.12351,0.12946,1,1
4,GO ASTROCYTE DIFFERENTIATION,0.01829,0.12342,0.1435,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.9694e-05,0.12331,0.14377,1,1
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0029645,0.12324,0.1238,1,1
4,GO REGULATION OF CHROMATIN BINDING,0.052083,0.12318,0.094747,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00054518,0.12303,0.15563,1,1
4,GO ORGANIC ACID TRANSPORT,8.2686e-06,0.12297,0.16097,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0032078,0.12284,0.12938,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,1.9749e-05,0.12278,0.13368,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0050269,0.12277,0.1917,1,1
4,GO FEEDING BEHAVIOR,0.001955,0.1227,0.1222,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0005133,0.12268,0.12315,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0053519,0.12263,0.13278,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.0015463,0.12231,0.13041,1,1
4,GO CARDIAC CONDUCTION,0.00049053,0.12225,0.1652,1,1
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.028264,0.1222,0.19214,1,1
4,GO NIK NF KAPPAB SIGNALING,0.00042128,0.12211,0.13006,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00032408,0.1221,0.15575,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.00025617,0.12205,0.13615,1,1
4,GO TUBE DEVELOPMENT,0.0029645,0.12204,0.12349,1,1
4,GO RESPONSE TO ETHER,0.010041,0.12177,0.11286,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00065224,0.12171,0.1201,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.02174,0.12158,0.096069,1,1
4,GO THYROID HORMONE METABOLIC PROCESS,0.014823,0.12132,0.15764,1,1
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.029754,0.12129,0.1028,1,1
4,GO MALE SEX DIFFERENTIATION,0.0024281,0.12123,0.12488,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.016938,0.12093,0.117,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.00013232,0.1207,0.12135,1,1
4,GO TRANSITION METAL ION TRANSPORT,5.0323e-06,0.12053,0.17011,1,1
4,GO SELECTIVE AUTOPHAGY,0.00029511,0.12048,0.15148,1,1
4,GO VIRAL RNA GENOME REPLICATION,0.015159,0.12036,0.11543,1,1
4,GO CELLULAR OXIDANT DETOXIFICATION,0.042609,0.12031,0.10993,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00010852,0.12022,0.14616,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,6.6578e-05,0.1202,0.14333,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00080175,0.12018,0.16288,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.00070238,0.12014,0.12729,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,3.6924e-05,0.11998,0.12667,1,1
4,GO FIBROBLAST MIGRATION,0.066192,0.1199,0.10229,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00036686,0.11981,0.11473,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.0051547,0.11963,0.16143,1,1
4,GO VITAMIN METABOLIC PROCESS,0.0022701,0.1196,0.14832,1,1
4,GO BLOOD VESSEL MORPHOGENESIS,0.010645,0.11951,0.12291,1,1
4,GO CIRCADIAN RHYTHM,5.1446e-05,0.11948,0.13405,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.012945,0.11943,0.12468,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.02945,0.11935,0.12477,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00033955,0.11911,0.13985,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0085105,0.11891,0.10424,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.00031907,0.11861,0.12136,1,1
4,GO RESPONSE TO ACTIVITY,0.00091404,0.11861,0.14614,1,1
4,GO RESPONSE TO BMP,0.014494,0.11855,0.12722,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.024173,0.11849,0.11462,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00013673,0.11843,0.11889,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00080175,0.11842,0.11705,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0034243,0.11824,0.12177,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.00016098,0.11813,0.11673,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,1.9749e-05,0.11792,0.13845,1,1
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0035146,0.11785,0.11585,1,1
4,GO CELL SUBSTRATE ADHESION,0.021053,0.11784,0.12756,1,1
4,GO CARNITINE SHUTTLE,0.01585,0.11768,0.14919,1,1
4,GO REGULATION OF AUTOPHAGY,2.1234e-05,0.11761,0.13257,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0023009,0.11756,0.1328,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00014129,0.11755,0.15564,1,1
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.0087156,0.11752,0.15825,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.00062378,0.11747,0.14794,1,1
4,GO POSITIVE REGULATION OF CELL AGING,0.0052854,0.11745,0.1571,1,1
4,GO JNK CASCADE,0.00086244,0.11735,0.12261,1,1
4,GO REGULATION OF PROTEIN BINDING,0.00069207,0.11727,0.12995,1,1
4,GO CELLULAR IRON ION HOMEOSTASIS,0.012798,0.11726,0.11185,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,8.4424e-05,0.11723,0.14564,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.00084997,0.11703,0.13021,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.03068,0.117,0.096613,1,1
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.024687,0.11693,0.11971,1,1
4,GO ENDOCYTOSIS,0.0039481,0.11692,0.10749,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.0074579,0.11676,0.13914,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0003557,0.11668,0.11317,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,9.6562e-05,0.11659,0.1233,1,1
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.01251,0.11659,0.10053,1,1
4,GO STRESS FIBER ASSEMBLY,0.015674,0.11659,0.12708,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,2.9332e-05,0.11654,0.1218,1,1
4,GO GOLGI ORGANIZATION,7.8124e-06,0.11653,0.16331,1,1
4,GO REGULATION OF CELL DEATH,0.00031414,0.11652,0.11569,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00069207,0.11641,0.11638,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00036686,0.11614,0.13584,1,1
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.016938,0.11612,0.08605,1,1
4,GO CELL JUNCTION ORGANIZATION,0.048285,0.1161,0.085829,1,1
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.033608,0.11604,0.10381,1,1
4,GO EAR DEVELOPMENT,0.01499,0.11588,0.10007,1,1
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.023173,0.11575,0.075246,1,1
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.046921,0.11564,0.092311,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.001568,0.11563,0.11893,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0011668,0.11546,0.17094,1,1
4,GO RUFFLE ASSEMBLY,0.0043184,0.11544,0.13085,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.020828,0.11525,0.11118,1,1
4,GO RESPONSE TO ATP,0.011151,0.11521,0.10797,1,1
4,GO RESPONSE TO ETHANOL,0.00024819,0.11515,0.12418,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0048405,0.11513,0.12587,1,1
4,GO REGULATION OF MACROPHAGE MIGRATION,0.00049802,0.11511,0.15998,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.003607,0.11483,0.098341,1,1
4,GO RESPONSE TO GROWTH FACTOR,0.0060595,0.1148,0.11326,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00020504,0.1148,0.1254,1,1
4,GO DEVELOPMENTAL MATURATION,0.0020646,0.11475,0.11922,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.001483,0.11471,0.10836,1,1
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.061549,0.11449,0.11501,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.046474,0.11434,0.095184,1,1
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.006444,0.11401,0.10481,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.0021505,0.11383,0.10222,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.001071,0.11378,0.10931,1,1
4,GO MACROPHAGE CHEMOTAXIS,0.0062877,0.11372,0.1408,1,1
4,GO SKIN EPIDERMIS DEVELOPMENT,0.02945,0.11363,0.1033,1,1
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.033271,0.11357,0.082226,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00040857,0.11333,0.12747,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.03006,0.11317,0.139,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.032938,0.11311,0.1307,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.048285,0.11299,0.088125,1,1
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.052575,0.11287,0.075112,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0062877,0.11273,0.14669,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.011022,0.11268,0.16313,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0016806,0.11261,0.12591,1,1
4,GO OSTEOBLAST DIFFERENTIATION,0.054582,0.1126,0.10746,1,1
4,GO FORMATION OF PRIMARY GERM LAYER,0.027401,0.11259,0.12604,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,5.9056e-05,0.11239,0.15285,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.00015083,0.1123,0.14849,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,3.0395e-05,0.11228,0.12767,1,1
4,GO TRANSLESION SYNTHESIS,0.00030449,0.11226,0.11922,1,1
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.0037016,0.11226,0.15808,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.00014362,0.11202,0.14103,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.012945,0.11197,0.098397,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.00019541,0.11195,0.12531,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0045438,0.11182,0.11965,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.020605,0.11154,0.11302,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.00032916,0.11149,0.11511,1,1
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.021509,0.11128,0.10245,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.010522,0.11106,0.092434,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.003607,0.11105,0.11316,1,1
4,GO NADPH REGENERATION,0.03902,0.111,0.12196,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00095459,0.11098,0.2076,1,1
4,GO LOCOMOTORY BEHAVIOR,0.059331,0.11092,0.09907,1,1
4,GO ACID SECRETION,0.0005789,0.11091,0.13607,1,1
4,GO GOLGI RIBBON FORMATION,0.010041,0.11085,0.15413,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00057029,0.11075,0.14395,1,1
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.0035605,0.1107,0.13223,1,1
4,GO POLYOL METABOLIC PROCESS,0.0011668,0.11051,0.11238,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00039622,0.11017,0.13476,1,1
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.010645,0.10987,0.13945,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0028872,0.1097,0.11986,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00062378,0.10952,0.10845,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.020828,0.10926,0.10951,1,1
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.016752,0.10925,0.097666,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.015674,0.10915,0.11031,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.0096941,0.10909,0.10798,1,1
4,GO T CELL DIFFERENTIATION IN THYMUS,0.010645,0.10872,0.11016,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,4.7999e-05,0.10869,0.15728,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.0012177,0.10849,0.11553,1,1
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.035691,0.10832,0.074831,1,1
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.056652,0.1081,0.092292,1,1
4,GO SENSORY PERCEPTION OF PAIN,0.0035605,0.1081,0.12022,1,1
4,GO AUTOPHAGIC CELL DEATH,0.029754,0.10791,0.11679,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00014599,0.1079,0.14016,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00039018,0.10768,0.10922,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0010865,0.10733,0.12717,1,1
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0043184,0.10729,0.11749,1,1
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.012653,0.10721,0.10883,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.0067673,0.10659,0.11828,1,1
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.0030038,0.10654,0.16211,1,1
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.024173,0.10634,0.0966,1,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0022095,0.10628,0.13804,1,1
4,GO ACTIN FILAMENT BASED PROCESS,0.032607,0.10625,0.087586,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0088198,0.10599,0.13575,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00090088,0.1059,0.1321,1,1
4,GO APOPTOTIC PROCESS,0.00013451,0.1059,0.1191,1,1
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.019312,0.10589,0.10259,1,1
4,GO POTASSIUM ION TRANSPORT,0.0034243,0.10589,0.12842,1,1
4,GO ANIMAL ORGAN MATURATION,0.0066851,0.10587,0.15687,1,1
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.00038422,0.10586,0.13546,1,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.041789,0.10579,0.10615,1,1
4,GO RECEPTOR RECYCLING,0.0034243,0.10577,0.14352,1,1
4,GO SENSORY PERCEPTION,0.00011406,0.10571,0.11351,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.0043184,0.10561,0.10215,1,1
4,GO SOMITOGENESIS,0.002631,0.10558,0.11937,1,1
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.01849,0.10553,0.12574,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.0104,0.10543,0.10935,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0001803,0.10487,0.11992,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.0007901,0.10486,0.10986,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00042777,0.10473,0.13488,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0035605,0.10463,0.10367,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.001422,0.10458,0.10544,1,1
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01829,0.10452,0.1225,1,1
4,GO MEMBRANE INVAGINATION,0.019312,0.10449,0.11803,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0012886,0.10445,0.12522,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0066851,0.1044,0.19277,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.014823,0.10427,0.1072,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0023637,0.1042,0.1328,1,1
4,GO MAINTENANCE OF LOCATION,0.00081356,0.10415,0.11732,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0018764,0.10415,0.1046,1,1
4,GO CELLULAR EXTRAVASATION,0.019312,0.10409,0.11454,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.001118,0.10406,0.10746,1,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.032938,0.10393,0.11961,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00087508,0.10381,0.12045,1,1
4,GO DE NOVO PROTEIN FOLDING,0.017699,0.10377,0.11118,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0032928,0.10372,0.1153,1,1
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.019523,0.10363,0.10472,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.001118,0.10312,0.15273,1,1
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.019312,0.10292,0.10158,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.00044781,0.10288,0.15276,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.052575,0.10281,0.09292,1,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.049681,0.10271,0.1324,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.011813,0.10264,0.13125,1,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.046031,0.1026,0.067326,1,1
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.046031,0.10256,0.10752,1,1
4,GO SYMBIOTIC PROCESS,0.0030436,0.10224,0.090737,1,1
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.019104,0.10206,0.10441,1,1
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.058787,0.10184,0.14488,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.00010152,0.10174,0.11431,1,1
4,GO REGULATION OF GROWTH,0.0030436,0.10158,0.10136,1,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.027973,0.1015,0.08999,1,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.004964,0.10143,0.099173,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0018764,0.10138,0.10947,1,1
4,GO AMINO SUGAR METABOLIC PROCESS,0.0047198,0.10133,0.15036,1,1
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.022928,0.10084,0.091467,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.0958e-05,0.10061,0.12816,1,1
4,GO RETINA HOMEOSTASIS,0.0032928,0.10026,0.080062,1,1
4,GO ACTIN MEDIATED CELL CONTRACTION,0.0066851,0.10024,0.12737,1,1
4,GO RESPONSE TO ALKALOID,0.001776,0.10022,0.11849,1,1
4,GO MUSCLE CONTRACTION,0.001235,0.10018,0.1171,1,1
4,GO ENSHEATHMENT OF NEURONS,0.0033361,0.10005,0.12919,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00024045,0.099987,0.11081,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0043184,0.099769,0.10653,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.020166,0.099684,0.11102,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.01016,0.099617,0.094341,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.012367,0.09937,0.098652,1,1
4,GO REPRODUCTION,0.0013069,0.099319,0.095989,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0030038,0.099298,0.096411,1,1
4,GO ORGANELLE DISASSEMBLY,0.00011218,0.099139,0.12842,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00019541,0.098845,0.11859,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0047798,0.09858,0.1061,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0015038,0.098375,0.10724,1,1
4,GO RESPONSE TO ESTRADIOL,0.0090315,0.097732,0.10184,1,1
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.051595,0.097671,0.12354,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0012005,0.097617,0.12351,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0030038,0.097567,0.1407,1,1
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.039795,0.097433,0.12305,1,1
4,GO DENDRITE EXTENSION,0.0086125,0.097094,0.18387,1,1
4,GO TOR SIGNALING,0.00016361,0.09703,0.10769,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.00071283,0.096801,0.11537,1,1
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.020166,0.096535,0.12012,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.039795,0.096498,0.082394,1,1
4,GO IRON ION HOMEOSTASIS,0.0017517,0.096436,0.13865,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.0089251,0.096353,0.12345,1,1
4,GO TISSUE MORPHOGENESIS,0.0093576,0.096321,0.10106,1,1
4,GO GLIOGENESIS,0.011813,0.09624,0.11584,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.013093,0.095985,0.12031,1,1
4,GO DEPHOSPHORYLATION,0.0026663,0.095596,0.088982,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.059331,0.095468,0.091397,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00010323,0.095192,0.14202,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.0018006,0.094834,0.096271,1,1
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.0088198,0.094828,0.13017,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0019285,0.094666,0.10252,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.02174,0.094449,0.082876,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.041383,0.09441,0.071493,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00016901,0.09435,0.12843,1,1
4,GO PHOSPHATE ION TRANSPORT,0.036048,0.094245,0.090079,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.060988,0.094229,0.079672,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0073682,0.094178,0.10817,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0081133,0.094175,0.092664,1,1
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.044292,0.094037,0.094587,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.00038422,0.093965,0.10175,1,1
4,GO RESPONSE TO CHEMOKINE,0.0010865,0.093825,0.10429,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0053519,0.093702,0.10427,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.0089251,0.093666,0.076008,1,1
4,GO GASTRULATION,0.03006,0.093573,0.10977,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.023419,0.093421,0.12687,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.0050904,0.093164,0.11064,1,1
4,GO ASSOCIATIVE LEARNING,0.060432,0.093107,0.082088,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00071283,0.09306,0.14016,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0030839,0.09272,0.10903,1,1
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0018006,0.092706,0.11617,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.016027,0.092645,0.14526,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0024941,0.09258,0.12229,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0048405,0.092494,0.096509,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0025617,0.092287,0.11462,1,1
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0032501,0.092276,0.099296,1,1
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.010895,0.091884,0.10894,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0066039,0.091807,0.16798,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.0050269,0.091797,0.088964,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.026286,0.09162,0.073273,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.051595,0.09141,0.081148,1,1
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.01128,0.091312,0.10217,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0016575,0.091189,0.1104,1,1
4,GO REGULATION OF METAL ION TRANSPORT,0.0066851,0.091109,0.092644,1,1
4,GO T CELL HOMEOSTASIS,0.052575,0.091036,0.078988,1,1
4,GO APOPTOTIC CELL CLEARANCE,0.046474,0.091035,0.15383,1,1
4,GO DNA CATABOLIC PROCESS,0.00076726,0.090986,0.10553,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0028492,0.090736,0.10363,1,1
4,GO EXCRETION,0.0012177,0.090589,0.14355,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0056255,0.090487,0.13942,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0085105,0.090141,0.085799,1,1
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0094686,0.090043,0.10197,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0047198,0.089951,0.13161,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.041383,0.089794,0.093766,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.062684,0.089742,0.07815,1,1
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0056958,0.089619,0.090328,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.037882,0.089575,0.11975,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.003607,0.089444,0.088683,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.021053,0.089408,0.12134,1,1
4,GO GLIAL CELL DIFFERENTIATION,0.015329,0.089324,0.11841,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0029645,0.089263,0.1072,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.016386,0.089198,0.14658,1,1
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.013394,0.08914,0.093778,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.014013,0.089119,0.093299,1,1
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0068504,0.089086,0.098285,1,1
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.019104,0.088814,0.09478,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.011022,0.088786,0.09155,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.0021505,0.088543,0.12531,1,1
4,GO THIOESTER METABOLIC PROCESS,0.00038422,0.087917,0.15136,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.014494,0.087817,0.097311,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0020367,0.087603,0.11458,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.017506,0.087603,0.076135,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0090315,0.08749,0.095507,1,1
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0073682,0.08713,0.10319,1,1
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043444,0.086438,0.12855,1,1
4,GO POSTREPLICATION REPAIR,0.0088198,0.085867,0.075385,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.022209,0.085558,0.081982,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.013093,0.08528,0.12297,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.028264,0.085128,0.1033,1,1
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0092477,0.084979,0.11534,1,1
4,GO KIDNEY MORPHOGENESIS,0.02174,0.084947,0.11191,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023173,0.084417,0.083672,1,1
4,GO FEMALE SEX DIFFERENTIATION,0.032938,0.08427,0.081697,1,1
4,GO GROWTH,0.03068,0.084137,0.078532,1,1
4,GO NEGATIVE REGULATION OF TRANSPORT,0.0016806,0.08382,0.094128,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0089251,0.083614,0.082723,1,1
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0077327,0.083576,0.14347,1,1
4,GO CELLULAR RESPONSE TO CAMP,0.019735,0.083571,0.10125,1,1
4,GO REGENERATION,0.024428,0.083314,0.096919,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.017894,0.083274,0.10443,1,1
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0066039,0.083265,0.12262,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.066192,0.083219,0.094447,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0056255,0.08262,0.1058,1,1
4,GO REGULATION OF CELL DIFFERENTIATION,0.038258,0.082482,0.077952,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.041383,0.08246,0.12676,1,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.061549,0.082342,0.079832,1,1
4,GO ATP METABOLIC PROCESS,0.0027747,0.082115,0.091069,1,1
4,GO REGULATION OF HAIR CYCLE,0.024173,0.08211,0.11217,1,1
4,GO RHYTHMIC PROCESS,0.0035146,0.081985,0.090873,1,1
4,GO FERTILIZATION,0.0013443,0.081887,0.08887,1,1
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.061549,0.081499,0.10423,1,1
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.015501,0.081379,0.088681,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.025743,0.081283,0.11891,1,1
4,GO SULFATE TRANSPORT,0.036048,0.081282,0.10774,1,1
4,GO ANIMAL ORGAN MORPHOGENESIS,0.048285,0.081182,0.081547,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0071918,0.081129,0.086417,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.030368,0.080893,0.08327,1,1
4,GO RENAL SODIUM EXCRETION,0.012087,0.080726,0.14105,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0037016,0.080421,0.11285,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.041789,0.080079,0.08382,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0061347,0.079728,0.081438,1,1
4,GO MULTI ORGANISM PROCESS,0.0043184,0.079688,0.078375,1,1
4,GO NEURON DEATH,0.0053519,0.07953,0.093004,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.062684,0.079448,0.076657,1,1
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.017315,0.079385,0.082714,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0012886,0.079311,0.11567,1,1
4,GO ENDOSOMAL TRANSPORT,0.0053519,0.078753,0.085834,1,1
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.065596,0.078688,0.068472,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0018764,0.07837,0.11893,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.026286,0.078221,0.063908,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.053071,0.078115,0.077071,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0048405,0.078112,0.096583,1,1
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.011411,0.078105,0.082329,1,1
4,GO CELL CELL SIGNALING,0.020828,0.077578,0.078541,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.025475,0.077531,0.095312,1,1
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.015329,0.077139,0.11396,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.03006,0.076702,0.10667,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.02915,0.076633,0.099488,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.00029052,0.076126,0.10546,1,1
4,GO BODY FLUID SECRETION,0.046474,0.075342,0.084664,1,1
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.012367,0.075324,0.096322,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0023957,0.07529,0.10534,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0010113,0.074942,0.13763,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.017699,0.074896,0.11495,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.024173,0.074346,0.083574,1,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.020605,0.074262,0.073341,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.009139,0.074231,0.10767,1,1
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.0087156,0.073912,0.074653,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.028556,0.073867,0.08105,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.020605,0.073738,0.10309,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0071918,0.0736,0.085881,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.0058389,0.073443,0.095958,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.00020504,0.073442,0.1135,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.013243,0.073312,0.083087,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.047827,0.073271,0.081832,1,1
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.023919,0.072827,0.070159,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0072795,0.072144,0.093481,1,1
4,GO RECEPTOR METABOLIC PROCESS,0.026561,0.072092,0.091416,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.055093,0.072066,0.092832,1,1
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.051111,0.07182,0.09483,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0039992,0.071415,0.090614,1,1
4,GO NERVOUS SYSTEM PROCESS,0.021973,0.069791,0.079401,1,1
4,GO MATING,0.016205,0.069399,0.099969,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.03902,0.069396,0.074573,1,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.037509,0.06934,0.072401,1,1
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.03006,0.069199,0.081935,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.015674,0.068983,0.076115,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.0043184,0.068731,0.083348,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.05357,0.068674,0.121,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0016575,0.068505,0.08772,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.00054518,0.068276,0.096064,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0023957,0.067682,0.11496,1,1
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.066192,0.067436,0.064128,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.031953,0.067384,0.067808,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0071918,0.067067,0.076191,1,1
4,GO CELL GROWTH,0.018898,0.066972,0.090321,1,1
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.044722,0.066056,0.097084,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.016205,0.06548,0.074482,1,1
4,GO MITOPHAGY,0.040981,0.064353,0.10058,1,1
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.048746,0.064018,0.080806,1,1
4,GO SEXUAL REPRODUCTION,0.012227,0.062597,0.063512,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0099244,0.062541,0.14864,1,1
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.015159,0.062397,0.064622,1,1
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.037139,0.061987,0.065552,1,1
4,GO BLASTOCYST DEVELOPMENT,0.001704,0.061727,0.092257,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.026838,0.060212,0.06579,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.051111,0.059498,0.07565,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.017315,0.058867,0.11781,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0050269,0.057547,0.091425,1,1
4,GO PROTEIN STABILIZATION,0.0075485,0.057496,0.088156,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0044298,0.057279,0.084053,1,1
4,GO RESPONSE TO CAMP,0.027401,0.056891,0.094078,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.021509,0.056807,0.072003,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.019104,0.056704,0.066985,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.048285,0.054781,0.070141,1,1
4,GO CYTOSOLIC TRANSPORT,0.0065235,0.053791,0.096445,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.055093,0.052783,0.101,1,1
4,GO MACROAUTOPHAGY,0.00063314,0.051806,0.11117,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.055093,0.049988,0.080678,1,1
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.036048,0.049548,0.079551,1,1
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.01829,0.049455,0.057385,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.016938,0.048701,0.057678,1,1
4,GO MALE GAMETE GENERATION,0.040582,0.048392,0.052147,1,1
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.036409,0.046985,0.089429,1,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.058787,0.045789,0.057242,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.010895,0.044528,0.068822,1,1
4,GO MITOCHONDRION ORGANIZATION,0.020166,0.04349,0.06683,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0092477,0.042754,0.074596,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.0089251,0.040704,0.090835,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,0.032278,0.04016,0.058931,1,1
